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The mucosal surfaces of metazoan organisms provide niches for colonization by commensal microbes.
However, these barrier surfaces also encounter pathogens. Therefore, sentinel immune cells must be
capable of distinguishing between pathogenic and non-pathogenic organisms to tailor appropriate
immune responses. Virulent microorganisms often uniquely possess mechanisms for accessing the host
cell cytosol. Therefore, to detect pathogens, innate immune cells encode cytosolic receptors, which
recognize conserved, pathogen-associated molecular patterns. Many mammalian cytosolic receptors
activate the inflammasome, a multi-protein complex that activates the host enzyme caspase-1.
Caspase-1 mediates IL-1 family cytokine release and a pro-inflammatory form of cell death, which are
important for host defense. The canonical inflammasome activates caspase-1, but recent studies have
shown that a related enzyme, caspase-11, contributes to inflammasome activation. However, it remains
unclear if caspase-11 mediates inflammasome responses against bacteria that use virulence-associated
secretion systems to deliver bacterial products into the host cytosol. Additionally, humans encode two
orthologs of caspase-11, caspase-4 and caspase-5, and it is unclear if either enzyme contributes to
inflammasome activation in primary macrophages. Furthermore, the bacterial ligands that trigger
inflammasome activation in human cells are poorly defined. Legionella pneumophila, which causes
pneumonia, uses a specialized secretion system to access the host cytosol to establish a replicative
niche in both murine and human cells. Therefore, we investigated the host and bacterial requirements for
inflammasome activation in response to L. pneumophila, and we interrogated if these requirements are
conserved for the response against other Gram-negative bacterial pathogens. Our studies demonstrate
that caspase-11 contributes to IL-1 release and cell death in response to bacterial pathogens in murine
macrophages, and we find that inflammasome activation requires the presence of virulence-associated
secretion systems. Using neutralizing antibodies, we show that IL-1α and IL-1β have distinct roles in
pulmonary defense against L. pneumophila in vivo. Through siRNA knockdown studies, we demonstrate
that human caspase-4 has a conserved role in inflammasome activation in response to multiple Gramnegative bacterial pathogens. Finally, using bacterial mutants, we show that flagellin is a trigger for
inflammasome activation in human macrophages. Overall, our studies help define the mechanism by
which host cells initiate defense against bacterial pathogens.
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ABSTRACT
INVESTIGATING INFLAMMASOME ACTIVATION IN RESPONSE TO LEGIONELLA
PNEUMOPHILA AND ITS APPLICATION TO OTHER BACTERIAL PATHOGENS
Cierra N. Casson
Sunny Shin
The mucosal surfaces of metazoan organisms provide niches for colonization by
commensal microbes. However, these barrier surfaces also encounter pathogens.
Therefore, sentinel immune cells must be capable of distinguishing between pathogenic
and non-pathogenic organisms to tailor appropriate immune responses. Virulent
microorganisms often uniquely possess mechanisms for accessing the host cell cytosol.
Therefore, to detect pathogens, innate immune cells encode cytosolic receptors, which
recognize conserved, pathogen-associated molecular patterns. Many mammalian
cytosolic receptors activate the inflammasome, a multi-protein complex that activates the
host enzyme caspase-1. Caspase-1 mediates IL-1 family cytokine release and a proinflammatory form of cell death, which are important for host defense. The canonical
inflammasome activates caspase-1, but recent studies have shown that a related
enzyme, caspase-11, contributes to inflammasome activation. However, it remains
unclear if caspase-11 mediates inflammasome responses against bacteria that use
virulence-associated secretion systems to deliver bacterial products into the host
cytosol. Additionally, humans encode two orthologs of caspase-11, caspase-4 and
caspase-5, and it is unclear if either enzyme contributes to inflammasome activation in
primary macrophages. Furthermore, the bacterial ligands that trigger inflammasome
activation in human cells are poorly defined. Legionella pneumophila, which causes
pneumonia, uses a specialized secretion system to access the host cytosol to establish
a replicative niche in both murine and human cells. Therefore, we investigated the host
and bacterial requirements for inflammasome activation in response to L. pneumophila,
and we interrogated if these requirements are conserved for the response against other
Gram-negative bacterial pathogens. Our studies demonstrate that caspase-11
contributes to IL-1 release and cell death in response to bacterial pathogens in murine
macrophages, and we find that inflammasome activation requires the presence of
virulence-associated secretion systems. Using neutralizing antibodies, we show that IL1α and IL-1β have distinct roles in pulmonary defense against L. pneumophila in vivo.
Through siRNA knockdown studies, we demonstrate that human caspase-4 has a
conserved role in inflammasome activation in response to multiple Gram-negative
bacterial pathogens. Finally, using bacterial mutants, we show that flagellin is a trigger
for inflammasome activation in human macrophages. Overall, our studies help define the
mechanism by which host cells initiate defense against bacterial pathogens.
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CHAPTER 1
INTRODUCTION

Sections of this chapter have been adapted from a published peer-reviewed mini-review
titled “Inflammasome-mediated cell death in response to bacterial pathogens that access
the host cell cytosol: lessons from Legionella pneumophila” by Cierra N. Casson and
Sunny Shin. Frontiers in Cellular and Infection Microbiology, 2013.
1	
  

	
  

The mucosal surfaces of metazoan organisms, such as the intestinal epithelium and
upper respiratory tract, provide diverse niches for microbial colonization. However, in
addition to commensal microbes, these barrier surfaces have the potential to encounter
pathogenic organisms as well. When cells of the innate immune system encounter a
microorganism, they must have the capacity to accurately determine if the
microorganism is pathogenic or not to mount an appropriate immune response while
minimizing damage to the host (Janeway and Medzhitov, 2002). If the immune response
is unnecessarily over-exuberant, immune cells can cause damage to host tissue or
induce autoimmunity (Dube et al., 2001; Kurashima et al., 2013; Meng et al., 2009).
Conversely, if the immune response is not effective and the organism is virulent, the
pathogen can replicate and cause damage to or even kill the host (Flynn et al., 1995;
Franchi et al., 2012; Reddick and Alto, 2014). Therefore, the ability of the innate immune
system to distinguish pathogenic organisms from non-pathogenic or commensal
organisms is key for the maintenance of homeostatic barrier function and survival of the
host (Belkaid and Artis, 2013; Belkaid and Hand, 2014).

A. Extracellular sensing of microorganisms
To detect pathogens, cells of the innate immune system encode pattern recognition
receptors (PRRs), which detect conserved microbial products. These conserved
microbial products are known as pathogen-associated molecular patterns (PAMPs), and
they include components of the bacterial cell wall, such as lipopolysaccharide (LPS) and
peptidoglycan, bacterial flagellin, and viral and bacterial nucleic acids (Janeway and
Medzhitov, 2002). Germline-encoded PRRs are critical initiators of host defense against
invading microorganisms (Medzhitov, 2007).
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The C-type lectin receptors (CLRs) are a subset of PRRs that bind to carbohydrates and
lipids in the extracellular space (Dambuza and Brown, 2015). The CLR dectin-1
responds to β-glucans from fungi (Brown and Gordon, 2001), while dectin-2 senses αmanins during fungal infection (Saijo et al., 2010). CLRs signal through Syk kinase to
generate cytokines important for anti-fungal defense (Robinson et al., 2009; Rogers et
al., 2005). Recently, however, it has been appreciated that CLRs can detect PAMPs
from bacterial species as well, including mycobacterial components (Dambuza and
Brown, 2015; Yonekawa et al., 2014).

The Toll-like receptors (TLRs) are a subset of PRRs that are surface and endosomallyassociated trans-membrane proteins that detect PAMPs found in the extracellular space
(Janeway and Medzhitov, 2002) through leucine-rich repeat (LRR) domains (Bell et al.,
2003). TLR1,2,4,5, and 6 are found on the cell surface, while TLR3,7,8, and 9 are
expressed in intracellular vesicles (Kawai and Akira, 2010). TLR2 detects bacterial
lipoproteins (Aliprantis et al., 1999; Brightbill et al., 1999). TLR2 works in concert with
TLR1 or TLR6 to form heterodimers to detect peptidoglycan and other lipopeptide
components of Gram-positive bacterial cells walls and zymosan, a yeast cell wall
component (Ozinsky et al., 2000; Takeuchi et al., 2001; 2002; Underhill et al., 1999).
TLR4 detects LPS from Gram-negative bacteria (Medzhitov et al., 1997; Poltorak et al.,
1998), and TLR5 detects bacterial flagellin (Hayashi et al., 2001). Some TLRs form
complexes with accessory proteins to detect their ligands. For example, TLR4 requires
CD14 (Haziot et al., 1996) and MD-2 (Shimazu et al., 1999) to efficiently detect LPS.
Interestingly, the detection of PAMPs through any given TLR does not necessarily
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distinguish between bacterial and viral organisms, as TLR4 recognizes a respiratory
syncytial virus protein in addition to LPS (Kurt-Jones et al., 2000).

The endosomal TLRs (TLR3,7,8, and 9) respond to viral and bacterial nucleic acids.
TLR3 detects double-stranded RNA, including the synthetic analog polyinosinicpolycytidylic acid (poly(I:C)) (Alexopoulou et al., 2001). TLR7 and TLR8 were originally
shown to respond to small antiviral compounds, such as imidazoquinolines (Hemmi et
al., 2002; Jurk et al., 2002), but they also sense single-stranded RNA (Diebold et al.,
2004; Heil et al., 2004). TLR7 is particularly important for sensing single-stranded RNA
during viral infection (Lund et al., 2004). TLR9 recognizes unmethylated bacterial 2’deoxyribo cytidine-phosphate-guanosine (CpG) dinucleotides (Hemmi et al., 2000) and
also detects CpG motifs during infection with DNA viruses, such as Herpes simplex
virus-2 (Lund et al., 2003).

TLRs signal through the recruitment of Toll-interleukin-1 (IL-1) receptor (TIR) domain
containing proteins to generate cytokine responses. TLRs 1,2,5,6,7, and 8 signal
through the adaptor myeloid differentiation primary-response protein 88 (MyD88), while
TLR3 signals through TIR-domain-containing adaptor protein inducing interferon-β (IFNβ) (TRIF)/TIR-domain-containing molecule 1 (TICAM1) (Hoebe et al., 2003; Medzhitov et
al., 1998; Yamamoto et al., 2003). TLR4 can signal through both MyD88 and TRIF
(Hoebe et al., 2003; Yamamoto et al., 2003), and there is recent evidence that TLR2 can
signal through TRIF in response to certain lipopeptides (Nilsen et al., 2015). MyD88
signaling generally leads to pro-inflammatory cytokine production, while TRIF signaling
leads to type I IFN production, and both pathways modulate signaling through the
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transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) to produce inflammatory mediators that provide defense against microbial organisms
(Kawai and Akira, 2010). Therefore, TLRs are critical initiators of many immune
responses. However, detection through TLRs alone is often not sufficient to distinguish
between pathogenic and non-pathogenic organisms, as non-pathogens encode many of
the same PAMPS as pathogens. For example, both commensal and pathogenic bacteria
may express LPS if they are Gram-negative organisms, and both may express flagellin if
they are motile organisms. Therefore, innate immune cells must possess additional
PRRs to help distinguish between pathogenic and non-pathogenic microbes.

B. Intracellular sensing of pathogens
As TLRs cannot always distinguish between pathogens and non-pathogens, innate
immune cells encode an additional set of PRRs to more specifically detect pathogenic
microbes. Though PAMPs associated with commensal organisms may be sensed via
surface or endosomal TLRs in the extracellular space, many pathogenic organisms
uniquely have mechanisms for accessing the host cytosol, a cellular compartment where
microorganisms are typically not found. Thus, to detect pathogenic activities, many cells
encode cytosolic PRRs, such as retinoic acid-inducible gene I (RIG-I)-like receptors
(RLRs) (Yoneyama et al., 2015) and nucleotide-binding domain, leucine rich repeat
containing proteins (NLRs) (Harton et al., 2002), many of which respond to PAMPs that
are present within the host cell cytosol.

RLRs detect cytosolic RNA, particularly during viral infection. The founding member of
the RLR family, RIG-I, senses double-stranded RNA to initiate type I IFN production
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(Yoneyama et al., 2004). Melanoma differentiation associated gene 5 (MDA5) is another
cytosolic RLR that induces type I IFN through IRF-3 (Yoneyama et al., 2005). Though
both RIG-I and MDA-5 detect double-stranded RNA, they are not completely functionally
redundant, as they are each required for type I IFN production in response to distinct
viruses (Kato et al., 2006). Both RIG-I and MDA5 signal through the adaptor protein
interferon-β promoter stimulator 1 (IPS-1)/mitochondrial antiviral signaling
(MAVS)/caspase recruitment domain (CARD) adaptor inducing IFN-β (CARDIF) to
initiate antiviral defense (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005).

In addition to sensing RNA, mammalian cells have mechanisms for sensing cytosolic
DNA independently of TLRs and inducing type I IFN as well (Stetson and Medzhitov,
2006; Stetson et al., 2008). For example, stimulator of interferon genes (STING)
responds to non-CpG containing DNA during viral infection to trigger anti-viral defense
(Ishikawa and Barber, 2008; Ishikawa et al., 2009). Interferon-inducible protein 16
(IFI16) (Unterholzner et al., 2010) and interferon-inducible tripartite-motif 56 (TRIM56)
(Tsuchida et al., 2010) both interact with STING to mediate the response against
cytosolic DNA. Recently, the cytosolic double-stranded DNA sensor cyclic guanosine
monophosphate–adenosine monophosphate (cGAMP) synthase (cGAS) was identified
(Ablasser et al., 2013; Sun et al., 2013). cGAS generates the cyclic di-nucleotide second
messenger cGAMP, which in turn binds to and activates STING to generate type I IFN
(Wu et al., 2013).

Nucleic acids are not the only cytosolic PAMPs detected by mammalian PRRs. The
nucleotide-binding oligomerization domain (NOD) proteins NOD1 (Bertin et al., 1999;
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Inohara et al., 1999) and NOD2 (Ogura et al., 2001) are the founding members of the
NLR family, and they respond to intracellular peptidoglycan (Chamaillard et al., 2003;
Girardin et al., 2003a; 2003b; Inohara et al., 2003). Both NOD1 and 2 signal through the
adaptor molecule receptor-interacting protein kinase 2 (RIP2)/CARD-containing IL-1β
converting enzyme (ICE) associated kinase (CARDIAK) (Chin et al., 2002; Kobayashi et
al., 2002). Signaling through NOD1 and 2 induces expression of pro-inflammatory
cytokines, anti-microbial peptides, and chemokines important for inflammatory cell
recruitment in vivo (Kobayashi et al., 2005; Masumoto et al., 2006).

Other members of the NLR family signal independently of RIP2 and activate multi-meric
complexes known as inflammasomes. These NLRs respond to ‘patterns of
pathogenesis’ and activities that are often associated with virulent organisms (Lamkanfi
and Dixit, 2009; Vance et al., 2009), such as membrane disruption, delivery of bacterial
molecules into the host cytosol via specialized secretion systems, or the use of poreforming toxins (Davis et al., 2011; Franchi et al., 2012; Fritz et al., 2006; Vance et al.,
2009). Inflammasome activation via NLRs initiates a cascade of events to produce key
pro-inflammatory cytokines and activate a pro-inflammatory form of cell death that can
eliminate the replicative niche for many pathogens (Rathinam et al., 2012a).

C. Caspase-1-dependent inflammasomes
The canonical inflammasome is a multi-protein complex that assembles in the cytosol to
activate the host enzyme caspase-1, also known as ICE (Martinon et al., 2002).
Caspase-1 is a cysteine protease with a catalytic cysteine at residue 285, and its active
tetramer form is produced from two heterodimers of a 10kDa (p10) and 20kDa (p20)
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subunit generated by auto-processing of the 45 kDa (p45) pro-enzyme (Cerretti et al.,
1992; Thornberry et al., 1992; Walker et al., 1994; Wilson et al., 1994). Caspase-1
regulates secretion of IL-1 family cytokines and a pro-inflammatory form of cell death
termed pyroptosis (Cookson and Brennan, 2001; Kuida et al., 1995; Li et al., 1995;
Rathinam et al., 2012a). Caspase-1 processes IL-1β and IL-18 into their mature forms
and aids in their secretion (Ghayur et al., 1997; Gu et al., 1997; Howard et al., 1991;
Thornberry et al., 1992), and caspase-1-dependent cleavage of cytokines occurs within
the cytosol of host cells (Singer et al., 1995). Caspase-1 does not cleave IL-1α, though it
can aid in IL-1α secretion as well (Howard et al., 1991; Keller et al., 2008). IL-1 family
cytokines act in vivo to enhance immune responses against invading microorganisms
(Bohn et al., 1998; Dinarello, 2009; Labow et al., 1997). Additionally, caspase-1mediated pyroptosis enhances clearance of bacterial pathogens in vivo (Miao et al.,
2010a).

Each NLR responds to a distinct stimulus (or range of stimuli) when activating the
inflammasome (Figure 1-1). Few NLRs have been shown to bind directly to their
implicated activators, and some are triggered by a wide variety of stimuli. For example,
NLR family, pyrin domain-containing 3 (NLRP3) responds to stimuli ranging from
bacterial RNA (Kanneganti et al., 2006) to extracellular adenosine triphosphate (ATP)
(Mariathasan et al., 2006) and uric acid crystals (Martinon et al., 2006). NLRP1 activates
the inflammasome in response to both anthrax lethal toxin (Boyden and Dietrich, 2006)
and infection by the intracellular parasite Toxoplasma gondii (Cavailles et al., 2014;
Cirelli et al., 2014; Ewald et al., 2014; Gorfu et al., 2014). In murine cells, ICE-protease
activating factor (IPAF)/NLR family, CARD domain containing 4 (NLRC4) mediates
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inflammasome activation in response to three distinct stimuli—flagellin, the conserved
inner rod component of the bacterial type III secretion system (T3SS) (PrgJ), and the
T3SS needle protein (Franchi et al., 2006; Lightfield et al., 2011; Miao et al., 2006;
2010b; Yang et al., 2013). Biochemical studies have shown that the NLRs neuronal
apoptosis inhibitory protein 5 (NAIP5) and NAIP6 co-immunoprecipitate with flagellin,
while NAIP2 interacts specifically with PrgJ (Kofoed and Vance, 2011; Zhao et al.,
2011). Additionally, NAIP1 specifically interacts with the needle protein of the T3SS
(Yang et al., 2013) (Figure 1-2). NLRC4 appears to be an important adaptor for the NAIP
receptors, acting as a scaffolding or signaling molecule downstream of NAIP1,2,5, and 6
to mediate inflammasome activation in response to all three stimuli.

The pyrin and hematopoietic expression, interferon-inducible nature and nuclear
localization (HIN) domain-containing protein (PYHIN) protein absent in melanoma 2
(AIM2), though not an NLR, recognizes cytosolic double-stranded DNA to activate a
caspase-1-dependent inflammasome (Hornung et al., 2009; Roberts et al., 2009). Unlike
NLRP3, AIM2 has been crystalized with its ligand, showing a direct interaction between
double-stranded DNA and the AIM2 sensor (Jin et al., 2012). The adaptor protein
apoptosis-associated speck-like protein containing a carboxy-terminal caspase
recruitment domain (ASC) often bridges the interaction between the NLRs or AIM2 and
caspase-1, allowing for oligomerization and auto-processing of caspase-1 for activation
(Mariathasan et al., 2004; Srinivasula et al., 2002). Caspase-1 auto-processing is
required for cytokine cleavage and secretion, though cell death can occur independently
of caspase-1 proteolysis (Broz et al., 2010).
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D. IL-1 family cytokines
The IL-1 family of cytokines consists of seven agonistic cytokines (IL-1α, IL-1β, IL-18, IL33, IL-36α, IL-36β, and IL-36γ) and one anti-inflammatory member (IL-37) (Garlanda et
al., 2013). The first identified members of the IL-1 family were IL-1α and IL-1β. IL-1α and
IL-1β are pro-inflammatory cytokines that were fist called “lymphocyte-activating factors”
in the 1970’s because of their potent ability to activate T-cells (Gery and Waksman,
1972; Gery et al., 1972). In addition to lymphocyte activation, IL-1α and IL-1β are
important for many other immune processes, such as fever and inflammation, and were
also called “leukocyte pyrogens” in the 1980’s because of their ability to mediate fever
(Rosenwasser and Dinarello, 1981). However, it was acknowledged that “lymphocyteactivating factor” and “leukocyte pyrogen” were the same molecules, and they were reclassified as IL-1 (Dinarello et al., 1983). It also became apparent that IL-1 was actually
two distinct molecules, IL-1α and IL-1β (March et al., 1985).

IL-1 family cytokines are uniquely regulated in that they do not require canonical
endoplasmic reticulum (ER)/Golgi trafficking for secretion, unlike other pro-inflammatory
cytokines, such as tumor necrosis factor (TNF) and IL-6 (Monteleone et al., 2015). Both
IL-1α and IL-1β lack signal sequences for canonical ER/Golgi trafficking and exit host
cells via a poorly-characterized mechanism (Auron et al., 1984; Monteleone et al., 2015).
IL-1β protein localizes mostly to the cytosol of LPS-stimulated monocytes (Singer et al.,
1988), and IL-1β is not immediately released after stimulation. A ‘two-step’ model for
secretion of IL-1β was first proposed when the observation was made that low doses of
LPS induced intracellular production of IL-1β but did not result in extracellular release of
IL-1β activity (Chin and Kostura, 1993; Newton, 1986). Therefore, release of IL-1α and
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IL-1β is tightly regulated, with caspase-1 activation via the inflammasome as ‘signal 2’
for secretion of these potent inflammatory mediators (Keller et al., 2008). Caspase-1
cleaves the pro-form of IL-1β for maturation (Howard et al., 1991). IL-1α is not
processed by caspase-1 but can be cleaved by calcium-dependent proteases known as
calpains (Carruth et al., 1991; Howard et al., 1991). However, unlike IL-1β, full-length IL1α is biologically active (Mosley et al., 1987), and the release of the full-length form is
also tightly regulated (Howard et al., 1991; Keller et al., 2008). Though the mechanism
leading to IL-1β secretion during inflammasome activation has been well-studied, the
cellular factors that contribute to IL-1α release are less clear.

IL-1α and IL-1β both bind to and signal through the same receptor, the IL-1 receptor (IL1R), in vivo (Dower et al., 1986). However, IL-1α has a higher affinity for the IL-1R than
IL-1β on certain cell types, such as T-cells (Dower et al., 1986). Though IL-1α and IL-1β
both bind the same receptor in vivo, there is evidence that suggests that they may have
different intracellular regulations. For example, in human monocytes, IL-1α has a longer
half-life, and its secretion is delayed compared to that of IL-1β (Hazuda et al., 1988).
Unlike IL-1β, the pro-form of IL-1α contains a nuclear localization signal (NLS) and can
translocate into the nucleus to promote production of other pro-inflammatory cytokines
(Cheng et al., 2008; Wessendorf et al., 1993). Additionally, IL-1α and IL-1β have newly
appreciated non-redundant roles in vivo as well, as recent data suggest that IL-1α is
required for protection during disease and for mounting an inflammatory response
against endogenous danger signals. For example, in a mouse model of Mycobacterium
tuberculosis infection, wild-type mice do not lose weight or die from inhalation of the
bacterium, but IL-1α-deficient mice succumb to infection, suggesting that IL-1β cannot
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always compensate for the loss of IL-1α during disease (Mayer-Barber et al., 2011).
Likewise, in a model of monosodium urate (MSU)-induced peritonitis, IL-1α is required
for neutrophil recruitment to the peritoneal cavity (Gross et al., 2012; Martinon et al.,
2006).

After the identification and characterization of IL-1α and IL-1β, several other members of
the IL-1 cytokine family were identified. IL-18 was first named IFN-γ-inducing factor
(IGIF) because of its ability to induce IFNγ from T-cells (Okamura et al., 1995). IL-18 is
also processed by caspase-1 for maturation and activation during inflammasome
activation and is important for T-helper type 1 (TH1)-associated immunity (Ghayur et al.,
1997; Gu et al., 1997; Kohno et al., 1997). IL-33 is an alarmin released from dying cells,
and it induces T-helper type 2 (TH2)-associated cytokines (Schmitz et al., 2005). Unlike
IL-1β and IL-18, IL-33 is inactivated by caspase-1 cleavage because it is processed into
a form that does not signal through its receptor, ST2 (Cayrol and Girard, 2009). IL-36α,
IL-36β, and IL-36γ can amplify pro-inflammatory cytokine production by dendritic cells
(Vigne et al., 2011), but they are not known to be cleaved by caspase-1 (Garlanda et al.,
2013). IL-37 is processed by caspase-1 but dampens IFNγ production by blocking the
ability of IL-18 to signal (Bufler et al., 2002; Kumar et al., 2002).

E. Cell death as an innate immune effector mechanism
In addition to release of IL-1 family cytokines, inflammasome activation leads to a proinflammatory form of cell death termed pyroptosis (Cookson and Brennan, 2001). Cell
death is an important innate immune effector mechanism to aid in clearance of
intracellular pathogens, as it can eliminate a pathogen’s replicative niche. Additionally,
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pro-inflammatory cell death can be critical for alerting neighboring cells to the presence
of invading pathogens (Bergsbaken et al., 2009; Kono and Rock, 2008). Pyroptosis is
critical both for clearance of bacterial pathogens and for release of important proinflammatory cytokines (Fink and Cookson, 2005; Miao et al., 2010a). Therefore, it has
been difficult to separate the role of cell death from the release of inflammatory
mediators in vivo. However, cell death itself can contribute to pathogen clearance
independently of cytokine production during some bacterial infections. For example,
caspase-1-deficient mice are more susceptible to infection with the Gram-negative
bacterial pathogens Salmonella enterica serovar Typhimurium (S. Typhimurium),
Legionella pneumophila, and Burkholderia thailandensis, and the defect is independent
of the cytokines IL-1β and IL-18, implying that a cytokine-independent effector
mechanism of caspase-1 controls bacterial infection (Miao et al., 2010a). However, it is
still possible that an additional uncharacterized alarmin released during caspase-1
activation controls bacterial infection in vivo, as caspase-1 is known to regulate the
unconventional secretion of many proteins outside of the IL-1 family cytokine members
(Keller et al., 2008). Therefore, the biological role of host cell death independent of
cytokine or alarmin release is still unclear.

F. The non-canonical inflammasome
Experiments examining inflammasome activation were first performed with macrophages
from mice that lack caspase-1, and it was concluded that caspase-1 is solely responsible
for inflammasome activation (Kuida et al., 1995; Li et al., 1995). However, the strain of
mice used to generate the original caspase-1 knockout has a polymorphism in caspase11 that eliminates caspase-11 protein expression. Thus, the original mice actually lack
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both caspase-1 and caspase-11 (Kayagaki et al., 2011). Though it was reported that
caspase-11 mediates septic shock in vivo, the cell-intrinsic role of caspase-11 in
response to bacterial pathogens remained unclear (Wang et al., 1996; 1998). Recently,
however, a non-canonical caspase-11-dependent inflammasome has been described
that contributes to IL-1α, IL-1β, and IL-18 secretion and cell death in response to many
Gram-negative bacteria. Caspase-11 is activated with delayed kinetics, taking 16-24
hours in vitro, in response to bacteria that do not typically access the host cell cytosol,
such as non-pathogenic Escherichia coli (Kayagaki et al., 2011). For many Gramnegative bacteria, non-canonical inflammasome activation requires TRIF and type I IFN
signaling downstream of TLR4 to upregulate caspase-11 (Broz et al., 2012; Gurung et
al., 2012; Rathinam et al., 2012b). Additionally, caspase-11 is robustly activated by
Gram-negative bacteria that escape the vacuole and replicate in the host cell cytosol,
such as B. thailandensis (Aachoui et al., 2013). However, it is unclear if pathogens that
naturally reside withinin vacuoles but use virulence-associated secretion systems to
deliver bacterial products into the host cell cytosol activate caspase-11. These Gramnegative bacterial pathogens, such as S. Typhimurium and L. pneumophila, have been
used to study caspase-1 activation, and they robustly activate the inflammasome in a
manner requiring the T3SS (Chen et al., 1996; Hersh et al., 1999) or type IV secretion
system (T4SS) (Sadosky et al., 1993; Zamboni et al., 2006).

G. Legionella pneumophila as a model organism to study inflammasome
activation
L. pneumophila is a Gram-negative bacterium that causes the severe pneumonia
Legionnaires’ disease (Fraser et al., 1977; McDade et al., 1977). L. pneumophila was
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first identified as the causative agent of pneumonia in 1977 (McDade et al., 1977)
following a massive outbreak of disease that occurred at the American Legion
convention in Philadelphia, Pennsylvania in the summer of 1976 (Fraser et al., 1977).
After isolation of L. pneumophila as the etiological agent, it was retrospectively deduced,
using preserved serum samples and serum-reactive tests, that L. pneumophila was the
causative organism behind previous outbreaks of pneumonia with unidentified
pathological agents, such as Pontiac Fever (McDade et al., 1977), ranging back to as
early as 1947 (McDade et al., 1979; Thacker et al., 1978). Original epidemiologic
evidence suggested that it was not person-to-person contact or foodborne illness that
caused Legionnaires’ disease (Fraser et al., 1977), and it was eventually determined
that aerosolization of the bacterium likely occurred in the air conditioning system of the
hotel where the American Legion convention occurred (Fraser and McDade, 1979). The
natural host for L. pneumophila is free-living, fresh water and soil-dwelling amoebae
(Rowbotham, 1980), and these infected amoebae can reside within industrial sources of
fresh water, such as air-conditioning systems. It is now well-established that modern
technologies that can aerosolize contaminated water droplets, such as heat, ventilation,
and air conditioning systems and cooling towers, are often associated with outbreaks of
respiratory disease caused by L. pneumophila (Fields, 1996). Once aerosolized, L.
pneumophila can be inhaled into the mammalian lung to cause disease by first infecting
alveolar macrophages (Nash et al., 1984).

L. pneumophila resides and replicates within a vacuole inside of human monocytic cells,
and the bacterium recruits host ribosomes to the Legionella-containing vacuole (LCV)
(Horwitz and Silverstein, 1980). L. pneumophila uses its dot/icm-encoded T4SS to
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translocate effector proteins into the host cytosol to establish an ER-derived vacuole that
supports bacterial replication (Berger and Isberg, 1993; Isaac and Isberg, 2014; Marra et
al., 1992; Sadosky et al., 1993). It was first observed in the 1980’s that live bacteria were
needed to establish the LCV and recruit host-derived organelles (Horwitz, 1983). Within
minutes of being phagocytosed by a host cell, L. pneumophila uses its T4SS to inhibit
phago-lysosomal fusion (Berger et al., 1994). Bacterial mutants that lack the protein
DotA, one components of the T4SS, fail to evade endocytic trafficking and localize to a
lysosomal-associated membrane protein 1 (LAMP-1)-positive host compartment within 5
minutes of uptake (Roy et al., 1998). The locus encoding the T4SS was first
characterized by identifying genes that, when mutated, resulted in a defect in
intracellular multiplication (icm) (Marra et al., 1992) or a defect in organelle trafficking
(dot) (Berger and Isberg, 1993). Evolutionarily, the T4SS is related to bacterial
conjugative systems used to transfer DNA (Segal et al., 2005), and the T4SS is capable
of conjugative transfer (Segal et al., 1998; Vogel et al., 1998).

The T4SS is a multi-subunit structure that is thought to form a channel from the inner
membrane of Gram-negative bacterial species, through the outer membrane of the
bacterium, and ending with a pore into the host cell membrane (Christie et al., 2014).
Therefore, the T4SS physically translocates effector proteins and bacterial products from
the bacterial cytosol, across the phagosomal membrane (Luo and Isberg, 2004), and
directly into the host cell cytosol. There are two major classifications of the T4SS, the
type IVA and type IVB secretion systems (Juhas et al., 2008). The most wellcharacterized T4SS is the type IVA VirB/virD4 secretion system from Agrobacterium
tumefaciens, an oncogenic pathogen of plant cells. The L. pneumophila T4SS, a type
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IVB secretion system, is encoded by 25 genes located across two different genetic loci
that assemble to form the translocation apparatus (Segal et al., 2005). The T4SS is
capable of creating a pore of ~3 nM in diameter in the host cell membrane (Kirby et al.,
1998), though unlike the needle-like structure for the T3SS, which is ~20 Å in diameter,
(Galán et al., 2014; Kubori et al., 1998), the T4SS pore has never been crystalized.

Currently, approximately 300 effector proteins have been identified that are translocated
by the T4SS, and many effectors modulate host cell processes to establish a replicative
niche for the bacterium (Isaac and Isberg, 2014; Nagai et al., 2002). Many of the
effectors are functionally redundant in mammalian cells, as deletion of regions of the L.
pneumophila genome containing ~100 effectors does not affect the ability of the
bacterium to replicate within murine macrophages (O'Connor et al., 2011). It remains
unclear precisely how the bacterial effector proteins interact with the T4SS to be
secreted, though the C-terminal region of the effectors are critical for translocation to
occur (Nagai et al., 2005).

L. pneumophila uses its T4SS to establish its replicative niche in both amoebae and
mammalian macrophages (Rowbotham, 1980). However, the natural host for L.
pneumophila is amoebae in aquatic reservoirs (Fliermans et al., 1981), and it is a recent,
opportunistic human pathogen (Phin et al., 2014). Therefore, while the bacterium has
evolved to evade amoebic host defenses, it is not thought to have evolved to evade
mammalian-specific immune responses. Thus, as a consequence of accessing the host
cytosol in mammalian cells, L. pneumophila triggers multiple pathways that elicit cellintrinsic immune responses and induce cell death (Shin and Roy, 2008). These robust
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immune responses make the bacterium valuable for studying host defense against
intracellular pathogens, including studying inflammasome activation.

H. Legionella pneumophila and caspase-1-dependent inflammasome activation
It is well-understood that L. pneumophila triggers inflammasome activation and
pyroptosis as a consequence of flagellin expression and T4SS activity (Figure 1-3). In
murine macrophages, detection of flagellin by baculoviral inhibitor of apoptosis (IAP)
repeat–containing 1e (BIRC1e)/NAIP5 mediates pyroptosis and contributes to restriction
of L. pneumophila replication both in vitro and in vivo (Derré and Isberg, 2004; Growney
and Dietrich, 2000; Kofoed and Vance, 2011; Wright et al., 2003; Zamboni et al., 2006;
Zhao et al., 2011). Flagellin-deficient L. pneumophila (ΔflaA Lp) evade NAIP5-mediated
restriction and replicate in NAIP5-sufficient macrophages from C57BL/6J (B6) mice, in
part because they do not induce as much caspase-1-dependent cell death as wild-type
(WT) Lp (Molofsky et al., 2006; Ren et al., 2006). NLRC4 also acts upstream of
caspase-1 to induce flagellin-mediated restriction of replication, pore formation in the
host membrane, and IL-1β release (Silveira and Zamboni, 2010; Zamboni et al., 2006).
NLRC4 co-immunoprecipitates with NAIP5, consistent with the model that NLRC4 is an
adaptor for NAIP5 (Kofoed and Vance, 2011; Zamboni et al., 2006; Zhao et al., 2011)
(Figure 1-1). The NAIP5/NLRC4-dependent cell death induced in B6 macrophages
requires cytosolic access, as T4SS-deficient mutants of L. pneumophila (ΔdotA Lp) do
not activate the inflammasome. These data suggest that flagellin is translocated through
the T4SS into the host cytosol during infection, though translocation of flagellin has not
been shown experimentally.
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A/J mice express a hypomorphic allele of NAIP5 (Diez et al., 2000), and A/J
macrophages still activate caspase-1 in response to WT Lp under certain infection
conditions (Lamkanfi et al., 2007). However, using Naip5-/- macrophages, it was shown
that NAIP5 is required for caspase-1 activation in response to WT Lp (Lightfield et al.,
2008). Interestingly, NAIP6 also interacts with L. pneumophila flagellin (Kofoed and
Vance, 2011; Zhao et al., 2011). However, NAIP6 is insufficient for the restriction of L.
pneumophila, as Naip5-/- macrophages and mice are permissive for infection (Lightfield
et al., 2008), which may be due to lower expression levels of NAIP6 relative to NAIP5 in
primary macrophages (Wright et al., 2003). NAIP5 and NLRC4 also contribute to the
control of L. pneumophila replication by enhancing fusion of the Legionella-containing
vacuole (LCV) with lysosomes during infections performed at a low multiplicity of
infection (MOI) (Amer et al., 2006; Fortier et al., 2007). In addition, flagellin-dependent
NLRC4 signaling leads to caspase-7-mediated restriction of L. pneumophila via
enhanced lysosomal degradation of the bacterium (Akhter et al., 2009). NLRC4mediated restriction in vivo is also partially caspase-1-independent through an unknown
mechanism (Pereira et al., 2011). However, caspase-1 activation downstream of NLRC4
clearly induces pyroptosis and leads to IL-18 secretion both in vitro and in vivo,
contributing to IFN-γ production and the subsequent resolution of pulmonary infection
(Archer et al., 2009; Brieland et al., 2000; Case et al., 2009; Spörri et al., 2006). Thus,
the NAIP5/NLRC4 inflammasome may control L. pneumophila replication through
multiple mechanisms.

Not surprisingly, infection conditions, including MOI, can affect the detection of caspase1 activation in response to L. pneumophila, as higher MOIs likely enhance the number of
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macrophages that harbor bacteria. At higher MOIs, infection of B6 macrophages induces
both NLRC4-dependent and NLRC4-independent inflammasome activation. NLRC4independent caspase-1 activation and IL-1β and IL-18 secretion require ASC, although
the identity of the L. pneumophila-derived signal sensed via ASC and the NLR upstream
of ASC remain unknown (Case et al., 2009). Caspase-1 cleavage in the absence of ASC
can be detected in either the supernatant or the cytosol, depending on the MOI
(Abdelaziz et al., 2011a; Case et al., 2009). ASC also drives formation of a punctate
structure containing caspase-1 and NLRC4 in L. pneumophila-infected macrophages
(Case and Roy, 2011). At early timepoints, pore formation is not observed in the
absence of NLRC4, though cell death still occurs in the absence of ASC. Recruitment of
NLRC4 into the ASC complex appears to dampen NLRC4 activity because pyroptosis
occurs at a higher rate in the absence of ASC (Case and Roy, 2011). However, further
studies are needed to elucidate the temporal and spatial coordination of the ASC- and
NLRC4-dependent inflammasomes and how they are triggered by L. pneumophila.

I. Inflammasome activation and autophagy
In murine macrophages, autophagy is induced shortly after phagocytosis of L.
pneumophila, as components of the autophagy pathway co-localize with the LCV (Amer
and Swanson, 2005). LCVs in A/J macrophages show delayed autophagosome
maturation compared to LCVs in B6 macrophages, potentially contributing to increased
replication of the bacterium. When expression of the autophagy component autophagy
protein 5 (ATG5) is silenced, L. pneumophila replication in A/J macrophages increases.
Additionally, replication of L. pneumophila decreases slightly when autophagy is induced
exogenously, suggesting that autophagy contributes to restriction of L. pneumophila
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replication (Matsuda et al., 2009). Under low MOI infection conditions where there is
minimal induction of pyroptosis, it was revealed that the induction of autophagy dampens
pyroptosis in response to L. pneumophila, and turnover of autophagosomes requires
NAIP5, NLRC4, and caspase-1 (Byrne et al., 2013). Collectively, these data suggest that
NAIP5 inflammasome activation contributes to the restriction of L. pneumophila
replication by inducing autophagy and/or pyroptosis, depending on the MOI and amount
of flagellin present. How competing host and bacterial factors influence the outcome of
inflammasome activation and autophagy during infection remains unclear and may be
clarified by studies examining the temporal regulation of inflammasome activation and
autophagy at a single-cell level.

J. Legionella pneumophila and non-canonical inflammasome activation
Caspase-11 responds to L. pneumophila that escape from the vacuole and aberrantly
enter the cytosol (Aachoui et al., 2013), a process that is not thought to occur
physiologically during infection with WT Lp (Figure 1-3). The T4SS-translocated effector
SdhA is critical for bacterial growth in primary murine macrophages (Laguna et al., 2006;
Liu et al., 2008). Macrophages infected with ΔsdhA Lp undergo cell death because SdhA
is required to maintain LCV membrane integrity (Creasey and Isberg, 2012). Therefore,
ΔsdhA Lp aberrantly enter the host cytosol where they become degraded, induce type I
IFN, and activate caspase-1 via AIM2 (Creasey and Isberg, 2012; Ge et al., 2012;
Monroe et al., 2009). In addition, ΔsdhA Lp induce rapid caspase-11-dependent cell
death independently of bacterial flagellin (Aachoui et al., 2013). It appears that AIM2
responds to cytosolic L. pneumophila by producing IL-1β, whereas caspase-11 mediates
cell death. However, L. pneumophila does not normally enter the cytosol, so the
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upstream mediators of caspase-11 activation may be different for ΔsdhAΔflaA bacteria
that enter the cytosol and ΔflaA bacteria that remain within the vacuole. Therefore, it
remains unclear if caspase-11 is activated by L. pneumophila that remain within their
natural vacuole during infection.

Though ΔflaA Lp avoid NAIP5/NLRC4-mediated pyroptosis and can replicate in B6
macrophages, ΔflaA Lp trigger an additional form of cell death (Case et al., 2009), and it
is unclear if this cell death is mediated by caspase-11. However, caspase-11 has been
shown to have a cell-intrinsic role in restricting growth of WT L. pneumophila. Caspase11 contributes to NAIP5/NLRC4-mediated inflammasome activation and restricts WT Lp
by enhancing phago-lysosomal fusion (Akhter et al., 2012). In its non-lytic role, caspase11 modulates actin polymerization and phosphorylation of cofilin to promote lysosomal
trafficking of pathogenic, but not non-pathogenic, bacteria. Additionally, caspase-11
contributes to control of WT Lp replication in vivo (Akhter et al., 2012). However, it is not
known if a separate, non-canonical caspase-11-dependent inflammasome is activated
by ΔflaA Lp independently of NAIP5/NLRC4. Non-canonical inflammasome activation is
a recently described phenomenon, so there are many questions that remain
unanswered. As L. pneumophila rapidly and robustly activates caspase-1 while residing
within the LCV, it is likely that caspase-11 is activated during infection as well.

K. Inflammasome activation in human cells
Unlike macrophages from most inbred mouse strains, human cells are permissive for L.
pneumophila replication. The mechanisms underlying inflammasome-mediated control of
L. pneumophila replication in human cells are unclear. Humans express only one
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homolog of the numerous murine NAIP paralogs (Scharf et al., 1996) (Figure 1-2). The
homolog, human NAIP (hNAIP), restricts growth of WT Lp (Vinzing et al., 2008).
Additionally, the human NLRC4 homolog, human IPAF (hIPAF), also restricts L.
pneumophila replication. Overexpression of full-length hNAIP in HEK293T cells
increases cell death in response to L. pneumophila (Boniotto et al., 2012), and
overexpression of hNAIP in the murine macrophage RAW264.7 cell line mediates
flagellin-induced pyroptosis and IL-1β secretion (Katagiri et al., 2012), suggesting that it
may function similarly to NAIP5. However, unlike NAIP5, hNAIP does not coimmunoprecipitate with flagellin and instead interacts with the T3SS needle protein
(Yang et al., 2013; Zhao et al., 2011) (Figure 1-2). Thus, it is unclear whether hNAIP
senses flagellin or another L. pneumophila-derived ligand, how hNAIP restricts L.
pneumophila replication, and if hNAIP contributes to cell death or IL-1β secretion in
primary human cells.

The implication that the IPAF/NAIP/caspase-1-dependent inflammasome contributes to
restriction of L. pneumophila is pervasive, though caspase-1 activation in response to L.
pneumophila has not been explicitly shown in primary cells from humans, a naturally
susceptible host. Immortalized human alveolar epithelial cells activate caspase-1 in
response to L. pneumophila, though primary human monocytes and monocyte-derived
macrophages (MDMs) do not produce detectable levels of processed or active caspase1 (Abdelaziz et al., 2011b; Furugen et al., 2008; Santic et al., 2007). Additionally, the
expression of ASC is moderately down-regulated in infected monocytes, potentially
contributing to evasion of inflammasome activation in human cells by L. pneumophila
(Abdelaziz et al., 2011b). Future studies in primary MDMs and human alveolar
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macrophages are needed to clarify the role of the inflammasome in restricting L.
pneumophila replication in human cells (Figure 1-4).

Another striking difference between mice and humans is that humans do not actually
encode caspase-11 (Figure 1-5). Instead, humans encode two putative functional
orthologs—caspase-4 and caspase-5 (Kamada et al., 1997; Kamens et al., 1995;
Munday et al., 1995). In immortalized epithelial cells, caspase-4 mediates IL-18 release
in response to infection with S. Typhimurium (Knodler et al., 2014). Additionally,
overexpression of either caspase-4 or caspase-5 in THP-1 cells, an immortalized human
monocytic cell line, restricts growth of WT L. pneumophila (Akhter et al., 2012).
However, it is unclear if caspase-4 or caspase-5 is a functional homolog of caspase-11
in primary human macrophages, and a role for caspase-4 or caspase-5 in activating the
inflammasome in response to L. pneumophila has not been interrogated.

L. Dissertation Aims
As L. pneumophila robustly activates innate immune responses in macrophages, it is a
valuable tool for understanding how host cells are capable of mounting an immune
response against intracellular pathogens. Additionally, L. pneumophila causes a severe
form of pneumonia in humans, so understanding how the bacterium interacts with innate
immune cells could provide novel insights into potential therapeutic targets during
disease. Though caspase-1 is activated during L. pneumophila infection, murine
macrophages still undergo cell death in a poorly characterized, caspase-1-independent
manner, and the mechanism by which IL-1α is released during infection is unclear.
Additionally, it is unclear how the inflammasome is activated in response to L.
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pneumophila in primary human macrophages, as there are many important genetic
differences between mice and humans. Therefore, the aims of the work presented in this
dissertation were as follows:

1) To interrogate a role for caspase-11 in inflammasome activation in response to L.
pneumophila and to determine if similar responses are mounted against other bacterial
pathogens that use virulence-associated secretion systems.

Previous studies suggest that caspase-11 is activated in response to pathogens that
escape the vacuole and replicate within the macrophage cytosol. However, many
intracellular pathogens remain within vacuoles during infection of host cells, and it is
unclear if caspase-11 is activated to mount an immune response against these vacuolar
pathogens. In CHAPTER 3, we use caspase-1-deficient and caspase-11-deficient
macrophages to determine the roles of caspase-1 and caspase-11 individually during
infection with L. pneumophila. We find that caspase-11 controls IL-1α release and cell
death and contributes to caspase-1-dependent IL-1β secretion. Caspase-11 activation
requires the presence of the bacterial T4SS. Unlike during infection with other Gramnegative bacterial pathogens, we find that caspase-11 activation against L. pneumophila
does not require IFNAR or TRIF. Finally, we show that caspase-11 is also activated in
response to another Gram-negative bacterial pathogen, Yersinia pseudotuberculosis,
and activation of caspase-11 requires the presence of the evolutionarily distinct T3SS.
Therefore, caspase-11 robustly responds to the activities of virulence-associated
secretion systems and controls IL-1α release during infection.
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2) To investigate if IL-1α and IL-1β have non-redundant roles in vivo during a pulmonary
model of L. pneumophila infection.

Previous studies suggest that though IL-1α and IL-1β bind the same receptor in vivo,
they can play non-redundant roles in bacterial clearance and neutrophil recruitment. As
IL-1α and IL-1β release are controlled by different intracellular mechanisms, it is possible
that they play distinct roles during infection. In CHAPTER 3, we use neutralizing
antibodies to deplete IL-1α and IL-1β during pulmonary L. pneumophila infection. We
find that loss of IL-1α decreases neutrophil recruitment to the airway space during
infection, whereas loss of IL-1β alone does not affect neutrophil recruitment. However,
loss of both cytokines in combination has a dramatic effect on neutrophil recruitment and
control of bacterial burdens. Therefore, IL-1α and IL-1β appear to have both distinct and
overlapping roles in controlling pulmonary L. pneumophila infection.

3) To determine host factors that contribute to inflammasome activation in human
macrophages in response to L. pneumophila and to determine if similar responses are
mounted against other bacterial pathogens that use virulence-associated secretion
systems.

There are many striking genetic differences between mice and humans. For
inflammasome activation, humans do not encode caspase-11 but encode two putative
orthologs—caspase-4 and caspase-5. It is unclear if caspase-4 or caspase-5 is a
functional homolog of caspase-11 during infection of human macrophages. In CHAPTER
4, we use siRNA to target caspase-4 in primary human macrophages and examine
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inflammasome activation. We find that L. pneumophila robustly triggers inflammasome
activation in human macrophages in a manner that requires the T4SS, and this
inflammasome activation is dependent on caspase-4. However, in contrast to murine
cells, we find that caspase-4 controls IL-1α release and cell death but has no effect on
IL-1β secretion. Finally, we find that caspase-4 controls IL-1α release for Y.
pseudotuberculosis and S. Typhimurium, two distantly related Gram-negative bacterial
pathogens that use a T3SS to access the host cell cytosol during infection. Therefore,
caspase-4 has a conserved role in human macrophages in inflammasome activation
against Gram-negative bacterial pathogens.

Another difference between mice and humans is that humans only encode one single
NAIP protein, while mice encode many NAIP paralogs. Human NAIP is not thought to
detect flagellin. Therefore, intracellular flagellin is not thought to be recognized by human
cells during bacterial infection. However, in CHAPTER 5, we use bacterial mutants
lacking flagellin to investigate a role for flagellin in activating the inflammasome in
primary human macrophages. For both L. pneumophila and S. Typhimurium, we find
that both IL-1α and IL-1β release are dependent on the presence of bacterial flagellin,
suggesting that flagellin is actually sensed by human cells to activate the inflammasome
during infection.
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Figure 1-1. Canonical caspase-1-dependent inflammasomes are activated by
distinct NLRs. Canonical inflammasomes activate caspase-1 to induce release of IL-1
family cytokines and a pro-inflammatory form of cell death known as pyroptosis. Each
NLR upstream of caspase-1 responds to distinct stimuli to activate the inflammasome.
NLRP1 senses anthrax lethal toxin and also responds to Toxoplasma gondii infection.
NLRP3 responds to a wide variety of stimuli, including extracellular ATP, uric acid
crystals, and reactive oxygen species (ROS). NLRP3 is thought to respond to general
endogenous ‘cell stress’ signals. NLRC4 is an important adaptor for NAIP5-mediated
recognition of cytosolic flagellin. AIM2, and PYHIN protein, detects cytosolic doublestranded DNA. The adaptor protein ASC bridges the interaction between the NLR or
PYHIN protein and caspase-1 and allows for oligomerization and caspase-1 autoprocessing for activation.
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flagellin. NAIP2 detects the inner rod component of the T3SS, and NAIP1 responds
specifically to the needle protein of the T3SS. In contrast to mice, humans encode a
single NAIP protein. Human NAIP does not bind to flagellin and specifically responds to
the needle protein of the T3SS.
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Figure 1-3. The inflammasome-mediated response to L. pneumophila in murine
macrophages. L. pneumophila that do not express a functional T4SS (ΔdotA Lp) traffic
to the lysosome, but wild-type L. pneumophila (WT Lp) use the T4SS to translocate
effectors into the host cytosol to establish a replicative niche, the Legionella-containing
vacuole (LCV), and block fusion with lysosomes. WT Lp triggers canonical caspase-1dependent inflammasome activation through detection of translocated flagellin by
NAIP5/NLRC4. ASC contributes to IL-1β secretion in response to WT Lp. Caspase-11
responds to bacteria that aberrantly enter the cytosol (ΔsdhA Lp) due to loss of LCV
membrane integrity. Translocated flagellin triggers trafficking of WT Lp to the
autophagosome, and induction of autophagy negatively regulates pyroptosis if there are
low levels of flagellin in the host cell cytosol. Dashed lines represent vesicular trafficking
patterns. Solid lines represent pathways for activation of the host response. Arrows at
the end of lines represent induction, while flat bars at the end of lines represent
inhibition.
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Figure 1-4. The inflammasome-mediated response to L. pneumophila in human
cells. L. pneumophila that do not express a functional T4SS (ΔdotA Lp) traffic to the
lysosome, but wild-type L. pneumophila (WT Lp) use the T4SS to translocate effectors
into the host cytosol to establish a replicative niche, the Legionella-containing vacuole
(LCV), and block fusion with lysosomes. The presence of flagellin triggers signaling
through hNAIP/hIPAF that blocks replication of WT Lp, though it is unclear if caspase-1
is involved in restriction. T4SS activity down-regulates the expression of ASC.
Overexpression of caspase-4 or caspase-5 blocks replication of WT Lp. Dashed lines
represent vesicular trafficking patterns. Solid lines represent pathways for activation of
the host response. Arrows at the end of lines represent induction, while flat bars at the
end of lines represent inhibition.
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Figure 1-5. Humans do not encode caspase-11. Unlike mice, humans do not encode
caspase-11. Instead, as the result of a duplication event, humans encode two putative
functional orthologs—caspase-4 and caspase-5.
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CHAPTER 2
MATERIALS AND METHODS
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Ethics statement
These studies were carried out in strict accordance as defined in the federal regulations
set forth in the Animal Welfare Act (AWA), the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health, and the
guidelines of the University of Pennsylvania Institutional Animal Use and Care
Committee. The protocols were approved by the Institutional Animal Care and Use
Committee at the University of Pennsylvania (protocols #803465 and #803459).

Primary human samples
All studies on human peripheral blood mononuclear cells (PBMCs) were performed in
compliance with the requirements of the US Department of Health and Human Services
and the principles expressed in the Declaration of Helsinki. Samples obtained from the
University of Pennsylvania Human Immunology Core are considered to be a secondary
use of de-identified human specimens and are exempt via Title 55 Part 46, Subpart A of
46.101 (b) of the Code of Federal Regulations.

Bacterial strains
All experiments using L. pneumophila were performed with Legionella pneumophila
serogroup 1 strains. Macrophages were infected with Lp02 (thyA), a thymidine
auxotroph derived from strain Lp01 (Marra et al., 1992) or the ΔdotA (T4SS-) (Berger et
al., 1994) and ΔflaA (FlaA-) (Ren et al., 2006) isogenic mutant strains. For in vivo
studies, mice were infected with the Lp02 ΔflaA or the JR32 (Sadosky et al., 1993) ΔflaA
isogenic mutant strain where indicated. For in vitro and in vivo studies, 48 hours prior to
infection, L. pneumophila strains were grown in a stationary patch on charcoal yeast
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extract (CYE) agar plates at 37°C. Escherichia coli BL21 strains were cultured in LB
broth for 16 hours at 37˚C prior to infection. All experiments using S. Typhimurium were
performed with Salmonella enterica serovar Typhimurium SL1344 strains. The strain
SL1344 and the ΔsipB (T3SS-) and ΔfliCfljB (FliCFljB-) isogenic mutant strains were
used. S. Typhimurium strains were grown overnight in LB broth with aeration at 37°C.
Three hours prior to infection, S. Typhimurium strains were diluted into fresh LB with
300mM NaCl and then grown for 3 hours standing at 37°C to induce SPI-1 expression.
All experiments using Y. pseudotuberculosis were performed with Yersinia
pseudotuberculosis IP2666 strains. The strain IP2666 ΔyopHOJMEK (Δ6 Yp) (Lilo et al.,
2008) and the ΔyopB (T3SS-) isogenic mutant (Palmer et al., 1998) strain were used. Y.
pseudotuberculosis strains were grown overnight in 2xYT broth with aeration at 26°C.
Three hours prior to infection, Y. pseudotuberculosis strains were diluted into fresh 2xYT
with 20mM sodium oxalate and 20mM MgCl2 and then grown for 1 hour with aeration at
26°C followed by 2 hours with aeration at 37°C.

Mice
C57BL/6J (B6) mice were purchased from Jackson Laboratories. Casp1-/-Casp11-/(Kuida et al., 1995), Casp1-/- (unpublished data, T.S. and R.A.F.), Casp11-/- (Wang et al.,
1998), Asc-/- (Sutterwala et al., 2006), Nlrc4-/- (Lara-Tejero et al., 2006), Asc-/-Nlrc4-/(Case et al., 2009), Ifnar-/- (Müller et al., 1994), Trif-/- (Yamamoto et al., 2003), Il1r1-/(Glaccum et al., 1997), and Nlrp3-/- (Martinon et al., 2006) mice are all on the B6
background. Asc-/-, Nlrc4-/-, and Nlrp3-/- mice were originally generated by Millenium
Pharmaceuticals and were a kind gift of Richard Flavell. Animals were maintained in
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accordance with the guidelines of the University of Pennsylvania Institutional Animal Use
and Care Committee.

In vivo infection studies
8-12 week-old mice were anesthetized by intraperitoneal injection of a
ketamine/xylazine/PBS solution at a dose of 100mg/kg ketamine and 10mg/kg xylazine.
Mice were infected intranasally with 40µl of a bacterial suspension containing 1x106 CFU
L. pneumophila or PBS vehicle control. For antibody neutralization experiments, mice
were injected intraperitoneally with 100µg anti-IL-1α antibody (clone ALF-161), 100µg
anti-IL-1β antibody (clone B122), 100µg of each anti-IL-1α and anti-IL-1β antibody, or
100µg Armenian hamster IgG1 isotype control antibody (eBioscience) 16 hours prior to
intranasal infection. At the indicated timepoints after infection, mice were sacrificed, and
the bronchoalveolar lavage fluid (BALF) and lungs were harvested. To determine
bacterial load, the lungs were mechanically homogenized in sterile distilled H2O and a
portion of the lysate was spread onto CYE plates. Animal experiments were performed
in accordance with approved University of Pennsylvania Institutional Animal Care and
Use Committee protocols and procedures.

Murine macrophage experiments
Bone marrow was collected from the femurs and tibiae of mice by manually disrupting
the bones with a mortar and pestle in RPMI and filtering the cells through a 70µM
strainer. Bone marrow cells were differentiated into macrophages by culturing the cells in
RPMI containing 30% L929 cell supernatant, 20% FBS, 100 IU/mL penicillin, and
100µg/mL streptomycin at 37˚C in a humidified incubator. The macrophages were
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replated one day prior to infection in RPMI containing 15% L929 cell supernatant and
10% FBS. For experiments involving LPS-primed macrophages, macrophages in 48-well
plates (2.0x105 cells/well) were pretreated with 0.5µg/mL LPS for 2.5 hours and either
mock-infected with PBS, infected with L. pneumophila at an MOI=10 for 4 hours, or
treated with 2.5mM ATP (Sigma-Aldrich) for 1 or 4 hours where indicated. For
experiments performed in the absence of LPS priming, macrophages in 48-well plates
(2.0x105 cells/well) were either mock-infected with PBS, infected with L. pneumophila at
an MOI=10 for 16 or 20 hours, or infected with E. coli at an MOI=25 for 1 hour followed
by gentamycin treatment (100µg/mL) for 15 hours. To assess the involvement of
caspase-1 catalytic activity, macrophages were treated with 20µM or 40µM of the
caspase-1 inhibitor YVAD-cmk (Bachem) or an equivalent volume of dimethyl sulfoxide
(DMSO) (vehicle control) 0.5 hours prior to infection. For L. pneumophila and E. coli
infections, bacteria were centrifuged down onto the macrophages at 1200 RPM for ten
minutes prior to incubation. For Y. pseudotuberculosis infection, bacteria were washed
three times with pre-warmed DMEM, added to the cells at an MOI=20, and centrifuged
down onto the macrophages at 1000 rpm for 5 min. Cells were incubated at 37°C for 1
hour post-infection followed by addition of 100 µg/mL gentamicin. Supernatants were
harvested 4 hours post infection for ELISA and LDH analysis.

Human macrophage experiments
THP-1 cells (ATCC TIB-202) were maintained in RPMI supplemented with 10% heatinactivated FBS, 0.05mM β-mercaptoethanol, 100 IU/mL penicillin, and 100µg/mL
streptomycin at 37°C in a humidified incubator. One day prior to infection, THP-1 cells
were replated in media without antibiotics at a concentration of 2.0x105 cells/well of a 48
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well plate and incubated overnight with 200nM phorbol 12-myristate 13-acetate (PMA) to
induce differentiation into macrophages. The media was replaced with warm media
without antibiotics on the day of infection.

Primary human peripheral blood mononuclear cells (PBMCs) from de-identified healthy
human donors were obtained from the University of Pennsylvania Human Immunology
Core. PBMCs were pelleted at 200xg for 12 minutes and washed two times with PBS
containing 0.5% BSA and 2mM EDTA. Monocytes were negatively selected using the
Pan Monocyte Isolation Kit, Human (Miltenyi), which enriches for both CD14 and CD16
expressing human monocytes. After selection, monocytes were cultured in RPMI
supplemented with 10% heat-inactivated FBS, 2mM L-glutamine, 100 IU/mL penicillin,
100µg/mL streptomycin, and 50ng/mL recombinant human M-CSF (Gemini Bio
Products). Cells were cultured for 4 days in 10mL of media in 10cm dishes at 0.5x106
cells/mL and then fresh media with 50ng/mL M-CSF was added and cells were cultured
for an additional 2 days to complete differentiation into macrophages. One day prior to
infection, monocyte-derived macrophages (MDMs) were gently detached and replated in
media without antibiotics and with 25ng/mL M-CSF at a concentration of 1.25x105
cells/well of a 48 well plate.

In experiments where macrophages were primed with LPS, cells were pre-treated with
0.5µg/mL LPS (Sigma-Aldrich) for 3 hours prior to infection. In experiments where
macrophages were treated with YVAD, cells were pre-treated with 40µM Ac-YVAD-cmk
(Bachem) or DMSO vehicle control for 0.5 hours prior to infection, and inhibitors were
left on the cells for the remainder of the experiments. For infection with L. pneumophila,
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bacteria were resuspended in PBS and added to the cells at an MOI=10 by spinning the
bacteria onto the plate at 1200rpm for 10 minutes. Cells were infected for 4 hours when
primed with LPS and 20 hours when unprimed. For infection with either S. Typhimurium
or Y. pseudotuberculosis, bacteria were pelleted at 8000rpm for 3 minutes after
induction and washed with PBS. Bacteria were then resuspended in PBS and added to
the cells at an MOI=20 by spinning the bacteria onto the plate at 1200rpm for 10
minutes. Cells were infected for 1 hour before gentamycin was added to the media at
100µg/mL and then infection continued for an additional 3 hours. For all experiments,
mock-infected cells were treated with PBS.

In experiments where macrophages were treated with LPS or IFNβ, cells were either left
untreated (unstim.) or treated with 0.05 or 0.5µg/mL of E. coli LPS (055:B5 from Sigma)
or 100 or 1000 U (Units) of IFNβ (recombinant human IFNβ purified in mammalian cells
from R&D Systems) for the indicated amounts of time. In experiments where nigericin
was used, cells were primed with LPS for 5 hours and then 10µM nigericin was added
for an additional 2 hours.

THP-1 cells deficient for ASC (ASC-def) (Invivogen) and control empty vector containing
THP-1 cells (Null) were maintained in RPMI supplemented with 15% heat-inactivated
FBS, 100 IU/mL penicillin, 100µg/mL streptomycin, 100µg/mL Normocin (Invivogen), and
200µg/mL Hygromycin (for selection maintenance) at 37°C in a humidified incubator.
One day prior to infection, ASC-def and Null THP-1 cells were replated in media without
antibiotics at a concentration of 2.0x105 cells/well of a 48 well plate and incubated
overnight with 200nM phorbol 12-myristate 13-acetate (PMA) to induce differentiation
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into macrophages. The media was replaced with warm media without antibiotics on the
day of infection.

siRNA knockdown experiments
All Silencer Select siRNA oligos were purchased from Ambion via Life Technologies. For
caspase-1, the siRNAs used were siRNA ID s2407, s2408, and s2409. For caspase-4,
the siRNAs used were siRNA ID s2413, s2414, and s2415. The two available Silencer
Select negative control siRNAs were purchased (Silencer Select Negative Control No.1
siRNA and Silencer Select Negative Control No.2 siRNA). Two days prior to infection,
either THP-1 cells or primary human MDMs were replated in media without antibiotics in
48-well plates as described above. One day prior to infection, 10-30nM total pooled
siRNA was transfected into the macrophages using Hiperfect (Qiagen), following the
manufacturer’s protocol for “Transfection of Differentiated Macrophage Cell Lines,
Including THP-1.” After 24 hours, the media was replaced with fresh warm media without
antibiotics, and infections were performed as described above.

Transfection of intracellular LPS
Primary human MDMs replated at a concentration of 1.25x105 cells/well of a 48 well
plate were primed with 0.4µg/mL Pam3CSK4 (Invivogen) for 4 hours. The media was
then replaced with fresh replating media, and cells were either treated with LPS alone (2
or 5µg/mL), mock transfected with Fugene HD (Promega) alone, or treated with a
mixture of 0.75µL Fugene HD (0.25% v/v) plus LPS (2 or 5µg/mL) per well in 300µL
media per well. Plates were then centrifuged at 2000rpm for 2 minutes before culturing
at 37°C for 20 hours.
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Cytotoxicity assays
Cells were infected or treated as described above, and harvested supernatants were
assayed for loss of cellular membrane integrity via lactate dehydrogenase (LDH) activity.
LDH release was quantified using the LDH Cytotoxicity Detection Kit (Clontech),
following the manufacturer’s protocol.

Immunoblot analysis
Cells were lysed directly in 1X SDS-PAGE sample buffer, and low volume (100 or
120µL/well of a 48 well plate) supernatants were mixed 1:1 with 2X SDS-PAGE sample
buffer containing Complete Mini EDTA-free Protease Inhibitor Cocktail (Roche).
Samples were boiled for 5 minutes, and proteins were separated by SDS-PAGE on a
12% gel and transferred to Immobilon P PVDF membranes (Millipore). Primary
antibodies against mouse caspase-1 p10 (Santa Cruz Biotechnology), mouse caspase11 (Sigma, clone 17D9), mouse IL-1β (R&D systems), human IL-1β (clone 3A6, Cell
Signaling Technology), mature human IL-1β (clone 8516, R&D Systems), human
caspase-1 p10 (polyclonal, Santa Cruz), cleaved human caspase-5 (polyclonal, Cell
Signaling Technology), full-length human caspase-5 (clone EP876Y, GeneTex), human
caspase-4 (polyclonal, Cell Signaling Technology), human ASC (polyclonal, Enzo Life
Sciences), and β-actin (Sigma) were used. Anti-rabbit IgG (Cell Signaling Technology),
anti-mouse IgG (Cell Signaling Technology), and anti-rat IgG (Santa Cruz Biotechnology
or Jackson Immuno) HRP-conjugated secondary antibodies were used. For detection,
SuperSignal West Dura or SuperSignal West Femto (Pierce Thermo Scientific) was
used as the HRP substrate.
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ELISA
Harvested supernatants from infected murine macrophages or the BALF from infected
mice were assayed using capture and detection antibodies specific for IL-18 (MBL), IL1α, IL-1β, IL-12p40 (BD Biosciences), and TNF (Biolegend). For human macrophages,
cells were infected as described above, and the levels of cytokines were quantified in the
harvested supernatants using paired antibody kits for human IL-1α (R&D Systems), IL1β (BD Biosciences), and TNF (Biolegend).

qRT-PCR analysis
Cells were lysed directly in 350µL buffer RLT Plus with β-mecaptoethanol as per
instructions in the RNeasy Plus Kit (Qiagen). Suspensions were vortexed and
subsequently disrupted in a QIAshredder spin column (Qiagen) following the
manufacturer’s protocol. RNA was isolated following the manufacturer’s protocol in the
RNeasy Plus handbook (Qiagen). RNA was reverse transcribed into cDNA with
Superscript II (Invitrogen) following the manufacturer’s protocol. Quantitative PCR was
performed with the CFX96 Real-time system from Bio-Rad using the SooFast EvaGreen
Supermix with Low ROX kit (Bio-rad). The following primers were used (from
PrimerBank): CASP4 forward- CAAGAGAAGCAACGTATGGCA, CASP4 reverseAGGCAGATGGTCAAACTCTGTA, CASP5 forward- TTCAACACCACATAACGTGTCC,
CASP5 reverse- GTCAAGGTTGCTCGTTCTATGG, HPRT1 forwardCCTGGCGTCGTGATTAGTGAT, and HPRT1 reverseAGACGTTCAGTCCTGTCCATAA. For analysis, caspase-4 or caspase-5 mRNA levels
were normalized to HPRT mRNA levels for each sample, and samples were normalized
to untreated cells using the 2−ΔΔCT (cycle threshold) method to calculate fold induction.
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Flow cytometry
To determine neutrophil recruitment to the airway, BALF cells were stained with
Live/Dead Fixable Dead Cell Stain (Invitrogen), and antibodies specific for CD45, Gr-1
(eBioscience), and Ly6G (Biolegend). Data were collected with an LSRII flow cytometer
(BD Biosciences), and post-collection data was analyzed using FlowJo (Treestar). Cells
were pre-gated on singlets and live cells. Neutrophils were identified as being CD45+,
Gr-1+, and Ly6G+.

Statistical analysis
Graphpad Prism software was used for the graphing of data and all statistical analysis.
For murine data, statistical significance was determined by the unpaired two-tailed
Student’s t test, one-way ANOVA with Tukey post-test, or two-way ANOVA with
Bonferroni post-test. For human data, statistical significance was determined using the
unpaired two-way Student’s t-test for experiments in human cell lines and the paired
two-way t-test for experiments comparing different treatments of primary human cells.
For human data, all data are graphed so that each data point represents the mean of
triplicate infected wells from independent experiments, and all statistical analyses were
performed comparing the means of each experiment. Each individual experiment was
performed a minimum of three separate times for human cell lines and at least 4 times
using cells from different donors for primary human macrophages. Differences were
considered statistically significant if the P value was <0.05.
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CHAPTER 3
CASPASE-11 ACTIVATION IN RESPONSE TO BACTERIAL SECRETION SYSTEMS
THAT ACCESS THE HOST CYTOSOL

This chapter appeared as a published peer-reviewed article titled “Caspase-11 activation
in response to bacterial secretion systems that access the host cytosol” by Cierra N.
Casson, Alan M. Copenhaver, Erin E. Zwack, Hieu T. Nguyen, Till Strowig, Bahar
Javdan, William P. Bradley, Thomas C. Fung, Richard A. Flavell, Igor E. Brodsky, and
Sunny Shin. PLoS Pathogens, 2013.
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A. Abstract
Inflammasome activation is important for antimicrobial defense because it induces cell
death and regulates the secretion of IL-1 family cytokines, which play a critical role in
inflammatory responses. The inflammasome activates caspase-1 to process and secrete
IL-1β. However, the mechanisms governing IL-1α release are less clear. Recently, a
non-canonical inflammasome was described that activates caspase-11 and mediates
pyroptosis and release of IL-1α and IL-1β. Caspase-11 activation in response to Gramnegative bacteria requires TLR4 and TRIF-dependent IFN production. Whether
additional bacterial signals trigger caspase-11 activation is unknown. Many bacterial
pathogens use specialized secretion systems to translocate effector proteins into the
cytosol of host cells. These secretion systems can also deliver flagellin into the cytosol,
which triggers caspase-1 activation and pyroptosis. However, even in the absence of
flagellin, these secretion systems induce inflammasome activation and the release of IL1α and IL-1β, but the inflammasome pathways that mediate this response are unclear.
We observe rapid IL-1α and IL-1β release and cell death in response to the T4SS or
T3SS of Legionella pneumophila and Yersinia pseudotuberculosis. Unlike IL-1β, IL-1α
secretion does not require caspase-1. Instead, caspase-11 activation is required for both
IL-1α secretion and cell death in response to the activity of these secretion systems.
Interestingly, whereas caspase-11 promotes IL-1β release in response to the T4SS
through the NLRP3/ASC inflammasome, caspase-11-dependent release of IL-1α is
independent of both the NAIP5/NLRC4 and NLRP3/ASC inflammasomes as well as
TRIF and type I IFN signaling. Furthermore, we find both overlapping and non-redundant
roles for IL-1α and IL-1β in mediating neutrophil recruitment and bacterial clearance in
response to pulmonary infection by L. pneumophila. Our findings demonstrate that
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virulent, but not avirulent, bacteria trigger a rapid caspase-11-dependent innate immune
response important for host defense.

B. Author summary
The inflammasome, a multiprotein complex, is critical for host defense against bacterial
infection. The inflammasome activates the host protease caspase-1 to process and
secrete IL-1β. Another caspase, caspase-11, can cause cell death and IL-1α release.
The bacterial signals that trigger caspase-11 activation are poorly understood. A
common feature of many bacterial pathogens is the ability to inject virulence factors and
other bacterial molecules into the host cell cytosol by means of a variety of virulenceassociated secretion systems. These secretion systems can introduce bacterial flagellin
into the host cytosol, which leads to caspase-1 activation and cell death. However, many
bacteria lack or down-regulate flagellin yet still activate the inflammasome. Here, we
show that the T4SS of Legionella pneumophila and the T3SS of Yersinia
pseudotuberculosis rapidly trigger caspase-11 activation in a flagellin-independent
manner. Caspase-11 activation mediates two separate inflammasome pathways: one
leading to IL-1β processing and secretion, and one leading to cell death and IL-1α
release. Furthermore, we find these caspase-11-regulated cytokines are critical for
neutrophil recruitment to the site of infection and clearance of non-flagellated Legionella
in vivo. Overall, our findings show that virulent bacteria activate a rapid caspase-11dependent immune response that plays a critical role in host defense.
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C. Introduction
Antibacterial defense is initiated by germline-encoded PRRs, which detect conserved
PAMPs (Janeway, 1989; Janeway and Medzhitov, 2002; Medzhitov, 2007). Plasma
membrane-bound PRRs, such as the TLRs, detect PAMPs present in the extracellular
space and endosomal compartments, whereas cytosolic PRRs, such as the NLRs,
survey the host cytosol for the presence of invasive pathogens (Fritz et al., 2006; Harton
et al., 2002; Inohara et al., 2005; Janeway and Medzhitov, 2002; Ting et al., 2006).
Invasive microorganisms or other cellular stresses induce assembly of cytosolic protein
complexes known as inflammasomes, which play a critical role in host defense (Davis et
al., 2011; Martinon et al., 2002; Miao et al., 2010a; Rathinam et al., 2012a).
Inflammasomes respond to a wide variety of activators, including bacterial pore-forming
toxins and bacterial PAMPS, such as flagellin or RNA (Boyden and Dietrich, 2006;
Franchi et al., 2006; Kanneganti et al., 2006; Mariathasan et al., 2006; Miao et al., 2006;
Molofsky et al., 2006; Ren et al., 2006). Particular NLRs respond to their cognate stimuli
and recruit the adapter protein ASC and pro-caspase-1 through homotypic proteinprotein interactions between pyrin and CARD domains, leading to auto-processing and
activation of caspase-1 (Dostert et al., 2008; Hornung et al., 2009; Kofoed and Vance,
2011; Srinivasula et al., 2002; Sutterwala et al., 2006). Caspase-1 is responsible for
processing and secreting IL-1 family cytokines and mediates a pro-inflammatory cell
death termed pyroptosis (Cookson and Brennan, 2001; Fink and Cookson, 2005;
Martinon et al., 2002; Rathinam et al., 2012a).

Caspase-11 participates in the activation of a non-canonical inflammasome that induces
cell death and the secretion of IL-1α and IL-1β in response to Gram-negative pathogens,
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such as Escherichia coli and Vibrio cholerae, and to particular toxins, such as the
cholera toxin B subunit (Broz et al., 2012; Gurung et al., 2012; Kayagaki et al., 2011;
Rathinam et al., 2012b). This non-canonical, caspase-11-dependent response to Gramnegative bacteria is independent of virulence-associated secretion systems that deliver
bacterial molecules into the host cytosol and requires LPS-induced TLR4 signaling
through the adaptor TRIF and TRIF-dependent type I IFN production. Type I IFN
signaling through the type I IFN receptor (IFNAR) is required for caspase-11
upregulation and activation, but how type I IFN mediates activation of caspase-11 is not
well-defined (Broz et al., 2012; Gurung et al., 2012; Rathinam et al., 2012b). Caspase-11
contributes to NLRP3-dependent activation of caspase-1 and subsequent caspase-1dependent IL-1β secretion and cell death. Caspase-11 also facilitates an NLRP3- and
caspase-1-independent pathway that results in cell death and release of IL-1α (Broz et
al., 2012; Gurung et al., 2012; Kayagaki et al., 2011; Rathinam et al., 2012b). This
caspase-11-dependent, caspase-1-independent pathway is responsible for LPS-induced
septic shock in vivo (Kayagaki et al., 2011; Wang et al., 1998). Although caspase-11 is
activated in response to signals from Gram-negative pathogens and certain pore-forming
toxins, whether caspase-11 contributes to inflammasome activation in response to
virulence-associated secretion systems that deliver bacterial ligands into host cytosol is
unknown.

Bacterial pathogens use evolutionarily conserved secretion systems, such as the T3SS
or T4SS, to translocate effector proteins into the cytosol of host cells (Cornelis, 2006;
Juhas et al., 2008). In addition to bona fide virulence factors, these secretion systems
also translocate bacterial molecules such as flagellin or structural components of the
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secretion machinery itself, which results in inflammasome activation (Brodsky and
Monack, 2009; Miao et al., 2006; 2010b; Molofsky et al., 2006; Ren et al., 2006; Sun et
al., 2007). Legionella pneumophila, an opportunistic pathogen that causes a severe
pneumonia known as Legionnaires’ disease (Fraser et al., 1977; McDade et al., 1977),
uses its dot/icm-encoded T4SS as a virulence factor to translocate bacterial effector
proteins into the host cell cytosol and establish a replicative vacuole (Berger and Isberg,
1993; Ensminger and Isberg, 2009; Hubber and Roy, 2010; Marra et al., 1992; Nagai et
al., 2002; Roy et al., 1998; Segal et al., 1998; Vogel et al., 1998). L. pneumophila
induces T4SS-dependent inflammasome activation through two genetically distinct
pathways (Case et al., 2009). T4SS-mediated translocation of flagellin into the cytosol
triggers caspase-1 activation and pyroptosis through the NLR NAIP5 in conjunction with
another NLR, NLRC4 (Amer et al., 2006; Case et al., 2009; Lightfield et al., 2008;
Molofsky et al., 2006; Ren et al., 2006; Zamboni et al., 2006). Caspase-1 activation is
also triggered independently of the NLRC4/flagellin pathway through the adaptor protein
ASC, but the bacterial factor that is recognized and the upstream proteins that regulate
this pathway remain unknown (Case and Roy, 2011; Case et al., 2009). However,
although ASC is necessary for robust secretion of IL-1β in response to L. pneumophila
as well as a number of pathogens, such as Salmonella or Yersinia species, ASC is
dispensable for induction of pyroptosis that is rapidly triggered in response to these
infections. We therefore considered the possibility that in addition to its role in delayed
inflammasome activation in response to Gram-negative bacteria, caspase-11 might
participate in rapid cell death and release of IL-1α in response to the presence of
bacterial pathogens that access the host cell cytosol by means of type IV and type III
secretion systems.
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Here, we demonstrate that IL-1α and IL-1β are rapidly released in response to bacterial
T4SS activity independently of bacterial flagellin. In this system, we find that IL-1β
secretion requires caspase-1, but caspase-1 is dispensable for cell death and IL-1α
release in response to a functional L. pneumophila T4SS. Instead, caspase-11 is
required for both IL-1α release and cell death in response to L. pneumophila T4SS
activity. Consistent with recent findings, caspase-11 contributes to optimal NLRP3mediated caspase-1 activation and IL-1β secretion in response to L. pneumophila.
However, caspase-11-dependent IL-1α release and cell death in L. pneumophilainfected cells are independent of the NAIP5/NLRC4 and NLRP3/ASC inflammasomes. In
contrast to the role of TRIF and IFNAR in the response against other Gram-negative
bacteria, caspase-11 activation and cytokine release in response to the T4SS of L.
pneumophila are independent of both TRIF and IFNAR signaling. We further
demonstrate that T3SS activity of the unrelated pathogen Yersinia pseudotuberculosis
induces a similarly rapid caspase-11-dependent response that also leads to cell death
and release of IL-1α and IL-1β. Finally, we find that both IL-1α and IL-1β are critical in
vivo for neutrophil recruitment and bacterial clearance. Overall, our data show that
caspase-11 is poised to respond robustly to a conserved feature of pathogenic bacteria,
bacterial access to the host cytosol through specialized secretion systems. This
establishes caspase-11 as a critical regulator of immune system-mediated discrimination
of pathogenic and nonpathogenic bacteria.

50	
  

	
  

D. Results
LPS priming induces rapid IL-1α and IL-1β secretion in response to L.
pneumophila T4SS activity
L. pneumophila infection induces IL-1α and IL-1β secretion that requires T4SS activity
(Case et al., 2009; Shin et al., 2008). IL-1β secretion is regulated by a flagellindependent NAIP5/NLRC4 inflammasome and a poorly defined ASC inflammasome that
both activate caspase-1 (Case and Roy, 2011; Case et al., 2009). The mechanisms
underlying IL-1α secretion are less clear, but IL-1α secretion is still robustly induced by
flagellin-deficient L. pneumophila, which do not activate the NAIP5/NLRC4
inflammasome (Shin et al., 2008). Recent studies have described a non-canonical
inflammasome triggered in response to Gram-negative bacteria. This non-canonical
inflammasome requires LPS for the upregulation and activation of caspase-11 and
subsequent IL-1α and IL-1β release (Broz et al., 2012; Gurung et al., 2012; Kayagaki et
al., 2011; Rathinam et al., 2012b). Whether caspase-11 is also activated in response to
bacteria that use specialized secretion systems to translocate bacterial molecules into
the host cytosol is unknown. We thus hypothesized that LPS priming would upregulate
caspase-11, pro-IL-1α, and pro-IL-1β and allow for more robust and rapid IL-1α and IL1β secretion in response to T4SS activity. To test this hypothesis, we first compared IL1α and IL-1β release in unprimed and LPS-primed bone marrow-derived macrophages
(BMDMs). As shown previously (Shin et al., 2008; Zamboni et al., 2006), unprimed
BMDMs secrete robust levels of IL-1α and IL-1β by 20 hours post-infection with wild-type
L. pneumophila (WT Lp) (Figure 3-1A). Slightly attenuated levels of secreted IL-1α and
IL-1β are observed with flagellin-deficient L. pneumophila (ΔflaA Lp), which do not
activate the NAIP5/NLRC4 inflammasome (Broz et al., 2012; Gurung et al., 2012;

51	
  

	
  

Kayagaki et al., 2011; Molofsky et al., 2006; Rathinam et al., 2012b; Ren et al., 2006).
Secretion of both cytokines is significantly diminished during infection with L.
pneumophila lacking DotA, an essential component of the T4SS (ΔdotA Lp), and is
significantly diminished in caspase-1/caspase-11-deficient (Casp1-/-Casp11-/-)
macrophages as well (Figure 3-1A). The diminished IL-1 secretion induced by ΔdotA Lp
is not due to a lack of pro-IL-1 production, as ΔdotA Lp and WT Lp induce robust levels
of pro-IL-1β (Figure 3-2A). At 4 hours post-infection, unprimed macrophages do not
secrete IL-1 (Figure 3-1B). However, LPS-primed cells rapidly secrete IL-1α and IL-1β,
and this secretion is abrogated in Casp1-/-Casp11-/- macrophages (Figure 3-1B).
Secretion of IL-18, another IL-1 family cytokine, also requires T4SS activity and is
eliminated in Casp1-/-Casp11-/- cells (Figure 3-2B). Comparable levels of the caspase1/caspase-11-independent cytokines IL-12 and TNF-α are secreted in the absence and
presence of LPS priming (Figure 3-2C and 3-2D). These data suggest that LPS priming
upregulates a factor required for rapid IL-1α and IL-1β release in response to L.
pneumophila T4SS activity.

Caspase-1 catalytic activity is required for IL-1β but not IL-1α secretion
Secretion of IL-1β in response to both canonical and non-canonical inflammasome
activation requires caspase-1 (Broz et al., 2012; Kayagaki et al., 2011; Thornberry et al.,
1992). In contrast, IL-1α release downstream of the non-canonical inflammasome
depends on caspase-11, and does not require caspase-1 (Kayagaki et al., 2011). To test
if the catalytic activity of caspase-1 is required for IL-1α secretion in response to L.
pneumophila, we inhibited caspase-1 catalytic activity with the pharmacological inhibitor
YVAD-cmk (YVAD). Consistent with previous studies (Broz et al., 2010), IL-1β secretion
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in response to L. pneumophila is substantially inhibited by YVAD. However, YVAD has
no effect on IL-1α secretion, indicating that IL-1α release in response to L. pneumophila
does not require caspase-1 catalytic activity (Figure 3-1C), as has been shown for other
inflammasome activators (Gross et al., 2012). Given that IL-1α secretion occurs more
rapidly upon LPS priming, is abrogated in Casp1-/-Casp11-/- macrophages, and does not
require caspase-1 catalytic activity, we considered the possibility that caspase-11 might
participate in inflammasome activation during L. pneumophila infection.

Caspase-11 contributes to inflammasome activation in response to flagellindeficient L. pneumophila
To test the genetic requirement for caspase-11 in the inflammasome response to L.
pneumophila, we infected BMDMs from either caspase-1-deficient (Casp1-/-) or caspase11-deficient (Casp11-/-) mice. In the absence of flagellin, caspase-11 is required for IL-1α
secretion, whereas it is not essential for IL-1β secretion but contributes to maximal
secretion (Figure 3-3A). These data suggest that caspase-11 is activated in response to
L. pneumophila infection independently of flagellin. Indeed, there is robust processing
and secretion of caspase-11 in response to WT and ΔflaA Lp (Figure 3-4). In
accordance with previous findings (Broz et al., 2010; Kayagaki et al., 2011), caspase-1
is absolutely required for IL-1β secretion. In contrast, we observe robust IL-1α release
even in the absence of caspase-1. Both IL-1α and IL-1β release in response to ΔflaA Lp
are caspase-11-dependent in both primed and unprimed macrophages (Figure 3-3, 35A, and 3-5B), making L. pneumophila distinct from other Gram-negative bacteria that
require priming to induce robust caspase-11 upregulation and activation (Rathinam et
al., 2012b). Thus, while caspase-11 contributes to maximal caspase-1-dependent IL-1β
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secretion, it is both necessary and sufficient for IL-1α release in response to flagellindeficient L. pneumophila.

Cell death in B6 BMDMs is partially flagellin-dependent but is flagellin-independent in
Casp1-/- BMDMs (Figure 3-3B). Importantly, cell death in response to flagellin-deficient L.
pneumophila requires caspase-11, thus correlating caspase-11-dependent cell death
with IL-1α release from host cells. In contrast, and consistent with previous findings
(Kayagaki et al., 2011), LPS+ATP induces canonical caspase-1-dependent pyroptosis
and secretion of IL-1α and IL-1β that is independent of caspase-11. Because caspase-1
must be processed to mediate IL-1β secretion (Broz et al., 2010), we examined whether
caspase-1 processing is decreased in the absence of caspase-11, which could account
for the decreased IL-1β secretion in response to ΔflaA Lp. Caspase-1 processing is
slightly attenuated but not abrogated in response to ΔflaA Lp in Casp11-/- macrophages,
consistent with the slight decrease in IL-1β secretion (Figure 3-3C and 3-5C). Thus,
flagellin-deficient L. pneumophila trigger a canonical caspase-1-dependent
inflammasome as well as a non-canonical caspase-11-dependent inflammasome.

Caspase-11 activation is independent of ASC and NLRC4
The ASC and NAIP5/NLRC4 inflammasomes are required for caspase-1 activation and
IL-1β secretion in response to L. pneumophila (Case et al., 2009). To determine if these
inflammasomes are also required for caspase-11 activation and IL-1α release, we
infected ASC/NLRC4-deficient (Asc-/-Nlrc4-/-) BMDMs with L. pneumophila. Asc-/-Nlrc4-/BMDMs do not secrete IL-1β in response to either WT Lp, ΔflaA Lp, or LPS+ATP.
However, Asc-/-Nlrc4-/- BMDMs still release IL-1α in response to ΔflaA Lp in primed and
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unprimed macrophages (Figure 3-6A and 3-7). Thus, unlike IL-1β, IL-1α is released
independently of flagellin, ASC, and NLRC4. Accordingly, despite an absence of
processed caspase-1 p10, robust levels of processed caspase-11 p26 are detected in
the supernatants of Asc-/-Nlrc4-/- cells infected with either WT or ΔflaA Lp but not in
response to LPS+ATP (Figure 3-6B).

We next sought to determine whether IL-1α is also released independently of ASC and
NLRC4 during in vivo infection. Because flagellin-deficient L. pneumophila do not
activate the NLRC4 inflammasome (Case et al., 2009; Molofsky et al., 2006; Ren et al.,
2006), infecting Asc-/- mice with ΔflaA Lp eliminates both the ASC and NLRC4
inflammasome pathways. Importantly, the level of IL-1β in the bronchoalveolar lavage
fluid (BALF) 24 hours post-infection is significantly attenuated in Asc-/- mice infected with
ΔflaA Lp (Figure 3-6C). In contrast, the level of IL-1α in the BALF is unaffected even in
the absence of both the ASC and NLRC4 inflammasomes. Both IL-1α and IL-1β release
are significantly diminished in caspase-1/caspase-11-deficient mice (Figure 3-8).
Collectively, our data indicate that L. pneumophila triggers caspase-11 activation and IL1α release independently of the ASC and NLRC4 inflammasomes during both in vitro
and in vivo infection.

Caspase-11 mediates both NLRP3-dependent and NLRP3-independent
inflammasome responses
L. pneumophila induces caspase-1 activation and IL-1β and IL-18 secretion through two
genetically distinct pathways, one involving ASC and one involving NLRC4 (Figure 3-9A,
3-10A, and 3-10B) (Case et al., 2009). The upstream host and bacterial components of
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the ASC-dependent response to L. pneumophila are still unknown, but are independent
of the flagellin/NAIP5/NLRC4 pathway (Figure 3-9A and 3-10B) (Case et al., 2009).
Because caspase-11 contributes to maximal IL-1β secretion in response to ΔflaA Lp, we
further investigated the ASC-dependent mechanism of inflammasome activation.
NLRP3, an NLR involved in inflammasome-dependent responses to a wide variety of
pathogens, requires ASC to mediate caspase-1 processing during both canonical and
non-canonical inflammasome activation (Kanneganti et al., 2006; Kayagaki et al., 2011;
Mariathasan et al., 2004; 2006; Martinon et al., 2002). We therefore investigated the role
of NLRP3 in the response to ΔflaA Lp. Notably, IL-1β and IL-18 secretion are abrogated
during infection of NLRP3-deficient (Nlrp3-/-) BMDMs with ΔflaA Lp in both primed and
unprimed macrophages (Figure 3-9B and 3-11A, B, and C). Consistently, we do not
detect processed caspase-1 p10 in the supernatants of Nlrp3-/- macrophages infected
with ΔflaA Lp (Figure 3-9C). Thus, NLRP3 functions together with ASC, caspase-1, and
caspase-11 to control IL-1β secretion in response to flagellin-deficient L. pneumophila.
However, IL-1α release and cell death following infection with flagellin-deficient L.
pneumophila are independent of NLRP3 (Figure 3-9B and 3-11A), indicating that
caspase-11 also mediates an NLRP3-independent response towards flagellin-deficient
L. pneumophila. Accordingly, NLRP3-dependent IL-1β secretion in response to flagellindeficient L. pneumophila was inhibited by extracellular potassium, whereas NLRP3independent caspase-11-dependent IL-1α secretion and cell death were not affected
(Figure 3-11D and 3-11E).
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Non-canonical inflammasome responses to L. pneumophila occur independently
of TRIF and IFNAR
Recent data demonstrate that caspase-11 activation in response to a wide variety of
Gram-negative bacteria requires TLR4 signaling through its adaptor TRIF and
subsequent type I IFN production (Broz et al., 2012; Gurung et al., 2012; Rathinam et
al., 2012b). To determine if L. pneumophila engages a similar TRIF and IFNARdependent pathway for caspase-11 activation, we infected TRIF-deficient (Trif-/-) and
IFNAR-deficient (Ifnar-/-) BMDMs. Unlike the response to E. coli, L. pneumophila
infection of unprimed macrophages triggered robust cell death and secretion of IL-1α
and IL-1β that was independent of IFNAR and TRIF (Figure 3-12A and 3-12B).
Consistently, priming with the TLR1/2 agonist Pam3CSK4, which results in TRIF- and
IFNAR-dependent cytokine secretion and cell death in response to E. coli (Rathinam et
al., 2012b), still induced cell death and cytokine secretion in TRIF- and IFNAR-deficient
cells in response to L. pneumophila (Figure 3-13A and 3-13B). These data suggest that
during L. pneumophila infection, caspase-11 is upregulated and activated independently
of TRIF and IFNAR signaling. Indeed, caspase-11 is still robustly processed and
secreted independently of IFNAR and TRIF (Figure 3-12C and 3-14). Notably,
substantially upregulated levels of pro-caspase-11 are not observed in the lysates of
cells infected with WT or ΔflaA Lp because both the pro and cleaved forms of caspase11 are rapidly secreted into the cell supernatant upon infection (Figures 3-12C and 314). Accordingly, lysates from IFNAR- and TRIF-deficient macrophages infected with L.
pneumophila express comparable levels of pro-caspase-11 to wild-type macrophages,
whereas TRIF and IFNAR do contribute to upregulation of pro-caspase-11 in response
to E. coli (Figure 3-15A, B, and C). When the macrophages are primed with LPS prior to
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infection, there is a moderate contribution of TRIF and IFNAR signaling to
inflammasome activation, consistent with the observation that LPS stimulates the TLR4TRIF-IFNAR axis involved in caspase-11 upregulation (Figure 3-13C and 3-13D).
Because the caspase-11-dependent response to L. pneumophila is TRIF-independent,
we investigated whether the TLR signaling adaptor MyD88 contributes to caspase-11
upregulation. When immortalized macrophages deficient for both MyD88 and Trif
(iMyd88-/-Trif-/-) were infected, caspase-11 upregulation was diminished in response to
both WT and ΔflaA Lp (Figure 3-16A and 3-16B), and we were unable to detect
caspase-11 activation. Thus, although TRIF is not required for caspase-11 activation, a
TLR-dependent signal is likely required as the loss of both MyD88 and TRIF eliminates
caspase-11 upregulation and activation.

Caspase-11 mediates inflammasome activation in response to Yersinia
pseudotuberculosis type III secretion system activity
Because caspase-11 activation in response to L. pneumophila expressing a functional
T4SS is so rapid and robust, we sought to test whether this robust caspase-11dependent inflammasome activation might be a general response to the activity of
specialized secretion systems that allow for bacterial access to the host cytosol. The
Yersinia pseudotuberculosis T3SS induces inflammasome activation independently of
bacterial flagellin and the known secreted effector proteins, and this inflammasome
activation is important for bacterial clearance (Brodsky et al., 2010). As wild-type
Yersinia induces cell death that is independent of both caspase-1 and -11 and requires
the secreted effector YopJ (Brodsky et al., 2010; Lilo et al., 2008), we instead infected
Casp1-/-Casp11-/-, Casp1-/-, and Casp11-/- BMDMs with a strain of Y. pseudotuberculosis

58	
  

	
  

that expresses a T3SS but lacks the six known secreted effectors (Δ6 Yp). Similarly to L.
pneumophila infection, both IL-1α and IL-1β release in response to Δ6 Yp are caspase11-dependent (Figure 3-17A). Again, caspase-1 is absolutely required for IL-1β
secretion, whereas IL-1α is released independently of caspase-1. Secretion of IL-12, an
inflammasome-independent cytokine, is unaffected (Figure 3-18). Cell death in response
to Δ6 Yp is both caspase-1 and caspase-11-dependent, with a more dramatic reduction
in death in Casp11-/- BMDMs (Figure 3-17B). Furthermore, Y. pseudotuberculosisinduced release of both IL-1α and IL-1β requires the presence of a functional T3SS, as
Y. pseudotuberculosis unable to form a functional T3SS pore in the host cell plasma
membrane (ΔyopB Yp) do not induce secretion of either cytokine. These data indicate a
general role for caspase-11 in the induction of rapid cell death and robust release of IL1α and IL-1β in response to bacterial secretion systems that are capable of accessing
the host cell cytosol, but may be independent of the activities of specific bacterial
effector proteins.

IL-1α and IL-1β control bacterial burden and neutrophil recruitment in vivo
As caspase-11 contributes to flagellin-independent IL-1α and IL-1β release from infected
macrophages in vitro and IL-1α and IL-1β secretion is flagellin-independent in vivo, we
wanted to determine the contribution of IL-1α and IL-1β to host defense against L.
pneumophila in vivo. IL-1α and IL-1β both bind the IL-1R, which signals through the
MyD88 adaptor protein (Adachi et al., 1998; Burns et al., 1998; Dower et al., 1986). As
MyD88 is critical for control of L. pneumophila replication during in vivo infection but
deletion of an individual MyD88-dependent TLR or a combination of TLRs does not
recapitulate MyD88 deficiency, it is likely that other MyD88-dependent receptors,
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including the IL-1R, may play a role (Archer and Roy, 2006; Archer et al., 2009; Hawn et
al., 2007; 2006; Spörri et al., 2006). IL-1R signaling contributes to chemokine production
by non-hematopoietic cells during infection with wild-type, flagellin-expressing L.
pneumophila (LeibundGut-Landmann et al., 2011). However, the role of IL-1R signaling
during infection with flagellin-deficient L. pneumophila, which do not activate the
NAIP5/NLRC4 inflammasome, has not been investigated. We therefore infected B6 and
IL-1R-deficient (Il1r1-/-) mice intranasally with ΔflaA Lp and measured bacterial burden in
the lung over the course of seven days. Though both B6 and Il1r1-/- mice received similar
initial bacterial burdens, Il1r1-/- mice show a defect in bacterial clearance as early as 24
hours post-infection (Figure 3-19A). Bacterial burden remains elevated in the absence of
IL-1R signaling, with the Il1r1-/- mice still exhibiting a log-increase in bacterial load at 120
hours post-infection. As IL-1R signaling is important for neutrophil recruitment (Miller et
al., 2006), we examined whether Il1r1-/- mice have a defect in neutrophil recruitment to
the pulmonary airway during L. pneumophila infection. Indeed, Il1r1-/- mice exhibit a
significant decrease in neutrophil recruitment to the airway 24 hours post-infection,
possibly contributing to their inability to efficiently clear the pathogen (Figure 3-19B and
3-19C).

The IL-1R signals in response to both IL-1α and IL-1β; however, these cytokines can
play non-redundant roles in anti-bacterial defense (Mayer-Barber et al., 2011). To
determine the relative contributions of IL-1α and IL-1β to neutrophil recruitment and
bacterial clearance during L. pneumophila infection, we utilized neutralizing antibodies to
selectively block either IL-1α or IL-1β prior to infection. Specific cytokine neutralization in
the BALF could be observed 24 hours post-infection (Figure 3-20). Critically, IL-1α
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neutralization alone significantly diminishes the percentage of neutrophils recruited to
the BALF at 24 hours post-infection and results in a half-log increase in bacterial CFUs,
in marked contrast to isotype control antibody or neutralization of IL-1β, which on its own
did not have a significant effect (Figure 3-19D, E, and F). However, neutralization of both
IL-1α and IL-1β fully recapitulates the magnitude of neutrophil reduction and defect in
bacterial clearance observed in the Il1r1-/- mice. Collectively, these data indicate that
although there are some overlapping roles for these cytokines during L. pneumophila
infection, IL-1α plays a distinct role from IL-1β in driving neutrophil recruitment to the
airway and mediating bacterial clearance.

E. Discussion
Inflammasomes respond robustly to conserved features of pathogenic microbes, such as
pore-forming toxins or specialized secretion systems that access the host cytosol.
Inflammasomes therefore play a central role in enabling the immune system to
discriminate between virulent and avirulent bacteria (Vance et al., 2009). Recent reports
show a role for caspase-11 in regulating the activation of a non-canonical inflammasome
that promotes cell death as well as IL-1α and IL-1β secretion. This non-canonical
inflammasome responds to both pathogenic and non-pathogenic Gram-negative bacteria
independently of specialized secretion systems that translocate bacterial molecules into
the host cytosol (Broz et al., 2012; Gurung et al., 2012; Kayagaki et al., 2011; Rathinam
et al., 2012b). This pathway involves the TRIF- and IFNAR-dependent upregulation and
activation of caspase-11 and occurs with relatively delayed kinetics in comparison to the
response to pathogenic bacteria. Intriguingly, we find that the activity of the L.
pneumophila Dot/Icm T4SS leads to rapid and robust caspase-11 activation
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independently of the TRIF-IFNAR axis, and this activation triggers rapid cell death and
release of both IL-1α and IL-1β (Figure 3-21). We extend these results to show that the
evolutionarily distinct T3SS of another pathogen, Y. pseudotuberculosis, also rapidly
triggers caspase-11-dependent responses. Collectively, our findings demonstrate that
caspase-11 is critical for inflammasome activation in response to the secretion systems
of virulent bacteria that enable bacterial molecules to access the host cell cytosol and
demonstrate that IL-1α and IL-1β together play a crucial protective role during acute
infection in vivo.

We demonstrate that in response to the activity of bacterial secretion systems that
enable cytosolic access, caspase-11 contributes to NLRP3-mediated inflammasome
activation and caspase-1-dependent IL-1β secretion and to a second ASC and NLRC4independent pathway that does not require caspase-1 and leads to cell death as well as
robust IL-1α release. These L. pneumophila-induced pathways are similar to recent
findings with a number of Gram-negative bacterial pathogens, including C. rodentium, E.
coli, and S. Typhimurium (Broz et al., 2012; Gurung et al., 2012; Kayagaki et al., 2011;
Rathinam et al., 2012b). However, we observe rapid and robust T4SS-dependent
activation of these two caspase-11-mediated pathways by L. pneumophila, whereas the
response to Gram-negative bacteria lacking specialized secretion systems occurs less
robustly and with much slower kinetics. Intriguingly, we observe a similarly rapid
caspase-11-dependent induction of cell death and IL-1 release in response to the
structurally and evolutionarily unrelated T3SS of Y. pseudotuberculosis. Importantly, this
pathway is independent of host sensing of flagellin, as it is triggered by flagellin-deficient
L. pneumophila, and Y. pseudotuberculosis downregulates flagellin expression when the
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T3SS is expressed (Minnich and Rohde, 2007). Thus, our data suggest that the
caspase-11 inflammasome is poised to respond robustly and rapidly to the activity of
bacterial secretion systems that are capable of delivering microbial products into the
host cell cytosol and may enable the host to respond to pathogens that evade flagellindependent responses. This could have significance for understanding the role of
caspase-11 activation at mucosal sites colonized by large numbers of commensal
bacteria. At mucosal barriers, it would be expected that the non-canonical
inflammasome pathway would not be robustly activated by commensal bacteria but
could respond rapidly to the presence of bacterial secretion systems that enable
pathogen access to the host cytosol.

Our findings are consistent with recent observations that the L. pneumophila Dot/Icm
T4SS triggers the caspase-11-dependent non-canonical inflammasome (Case et al.,
2013), as well as the finding that bacteria that enter the cytosol either due to failure to
maintain integrity of their replicative vacuoles or natural entry into the cytoplasm also
trigger rapid caspase-11 activation (Aachoui et al., 2013). Thus, the pathway that leads
to caspase-11 activation appears to be particularly sensitive to pathogens that ‘violate
the sanctity of the cytosol’ (Lamkanfi and Dixit, 2009), either through the activity of
specialized secretion systems that translocate bacterial molecules into the cytosol or
through their direct entry into the host cell cytosol. Whether other pathogens that
replicate within the cytosol, such as Listeria or Shigella, or cytosolic viruses possess
mechanisms to evade this pathway remains to be determined.
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L. pneumophila T4SS-mediated activation of caspase-11 differs from the other pathways
of non-canonical inflammasome activation in several ways. First, L. pneumophilamediated activation of caspase-11 does not require TRIF or IFNAR signaling. We
observe a moderate dependence on TRIF and IFNAR signaling when macrophages are
primed with LPS prior to infection, consistent with LPS-dependent upregulation of
caspase-11 expression through the TLR4-TRIF-IFNAR axis (Broz et al., 2012; Gurung et
al., 2012; Rathinam et al., 2012b). However, in the absence of LPS priming, TRIF and
IFNAR signaling are dispensable for L. pneumophila-dependent caspase-11 activation.
In this context, it is likely that MyD88 compensates for the absence of TRIF, as cells
deficient for both MyD88 and TRIF failed to activate caspase-11 in response to L.
pneumophila. Thus, although the TLR4-TRIF-IFNAR axis is required for caspase-11
activation in response to Gram-negative bacteria, a MyD88-dependent signal is sufficient
for caspase-11 activation in response to pathogens that utilize virulence-associated
secretion systems to translocate bacterial molecules into the host cytosol. It is possible
that different signals are capable of activating caspase-11 through distinct pathways, but
these pathways occur with distinct kinetics because they may indicate distinct levels of
pathogenicity. Thus, while caspase-11 is robustly upregulated by LPS priming, this
upregulation alone is insufficient for rapid activation in response to bacteria that lack
specialized secretion systems, as ΔdotA or ΔyopB bacteria do not induce rapid cell
death, even in primed cells. Collectively, these data indicate a two-signal model for rapid
caspase-11 activation during infection with virulent bacteria, where bacterial PAMPs
induce caspase-11 upregulation, but rapid caspase-11 activation requires a second,
secretion system-dependent signal (Figure 3-21).
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The specific secretion system-dependent signals responsible for caspase-11 activation
are currently unknown. While rapid activation of caspase-11 requires the presence of a
functional type III or type IV secretion system or cytosolic access of the bacteria,
whether the signal is an as-yet-undefined translocated bacterial molecule or a cellular
response to the pore forming activity of these systems remains to be determined. The
delayed NLRP3- and caspase-11-dependent response to Gram-negative bacteria
suggests that in addition to LPS-induced upregulation of inflammasome components,
bacterial mRNA provides an additional signal for activating the NLRP3 inflammasome
(Kanneganti et al., 2006; Sander et al., 2011), although the role of caspase-11 in this
response has not been formally demonstrated. Activity of the type III or IV secretion
systems may bypass the need for bacterial mRNA. Alternatively, these secretion
systems may translocate bacterial RNA (Auerbuch et al., 2009; Monroe et al., 2009;
Vance et al., 2009), and the rapid caspase-11-dependent response they induce could be
due to more rapid delivery of bacterial mRNA into the host cell cytosol.

Furthermore, the host factors required for activation of the NLRP3-independent caspase11-dependent inflammasome also remain to be identified. As this pathway is
independent of flagellin sensing, NLRP3, ASC, and NLRC4, an unknown upstream
sensor and/or adaptor may be involved in caspase-11 activation in response to a
translocated bacterial substrate or an endogenous signal induced by infection. This
sensor may also be upregulated by type I IFN signaling itself (Broz et al., 2012; Gurung
et al., 2012; Rathinam et al., 2012b).
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Our data show that IL-1α release during L. pneumophila infection is controlled by two
independent pathways, one involving the flagellin-dependent NAIP5/NLRC4 and
caspase-1-dependent inflammasome and a second pathway involving the NLRP3independent caspase-11-dependent inflammasome (Figure 3-21). Though we
demonstrate that IL-1α release has an important biological consequence in vivo for
neutrophil recruitment and bacterial clearance, it is unclear if IL-1α release is regulated
by unconventional secretion, as is the case for IL-1β (Keller et al., 2008). As both
pathways that control IL-1α release also lead to cell death, our data are consistent with a
model in which IL-1α is an endogenous alarmin that is released during cell death
(Bianchi, 2007).

Interestingly, caspase-11 also contributes to control of flagellin-expressing L.
pneumophila by serving as a component of an NLRC4-dependent inflammasome that
promotes trafficking of the L. pneumophila-containing vacuole to lysosomes (Akhter et
al., 2012). Thus, caspase-11 may function in multiple ways to control L. pneumophila
infection. Importantly, we find that IL-1α, IL-1β, and IL-1R signaling play an important
role in the control of L. pneumophila infection through efficient neutrophil recruitment to
the airway. IL-1α and IL-1β play both distinct and overlapping roles in mediating
neutrophil recruitment and controlling bacterial replication, as depletion of IL-1α alone
showed a more pronounced defect in neutrophil recruitment and bacterial clearance than
depletion of IL-1β alone, but loss of both cytokines resulted in a further reduction of
neutrophil recruitment and an increased defect in bacterial clearance. Further analysis is
required to define the relative contributions of the various caspase-11-mediated effector
functions to the control of L. pneumophila replication in vivo.
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In conclusion, these studies demonstrate that T3SS and T4SS activities trigger rapid and
robust activation of caspase-11. This activation contributes to maximal NLRP3dependent IL-1β secretion as well as to NLRP3-independent IL-1α release and host cell
death. The downstream effector functions of these pathways are important for host
defense against L. pneumophila in vivo, as IL-1α and IL-1β promote neutrophil
recruitment to L. pneumophila-infected lungs and control pulmonary bacterial replication.
Our results highlight the contribution of caspase-11 to rapid inflammasome activation
and discrimination between pathogenic and nonpathogenic bacteria.
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Figure 3-1: LPS priming induces rapid IL-1α and IL-1β secretion in response to L.
pneumophila T4SS activity. (A) Unprimed B6 or Casp1-/-Casp11-/- BMDMs were
infected with WT L. pneumophila (WT Lp), Δdot Lp, ΔflaA Lp, or PBS (mock infection) for
20 hours. (B) B6 or Casp1-/-Casp11-/- BMDMs were either unprimed or primed with
0.5µg/mL LPS for 2.5 hours and infected with WT Lp, ΔdotA Lp, ΔflaA Lp, or PBS for 4
hours. (C) B6 BMDMs were pretreated with either 20µM or 40µM of the caspase-1
inhibitor YVAD-cmk or DMSO vehicle control for 0.5 hours and infected with WT Lp,
ΔdotA Lp, ΔflaA Lp, or PBS for 20 hours. Levels of IL-1α and IL-1β in the supernatants
were measured by ELISA. Graphs show the mean ± SEM of triplicate wells. Data are
representative of three or four independent experiments. *** is p<0.001 by 2-way
ANOVA with Bonferroni post-test. NS is not significant.
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Figure 3-2. Caspase-1/caspase-11-deficient cells do not have a gross defect in
cytokine secretion. (A) Unprimed B6 or Casp1-/-Casp11-/- BMDMs were infected with
WT L. pneumophila (Lp), ΔdotA Lp, ΔflaA Lp, or PBS (mock infection) for 20 hours.
Levels of full-length IL-1β (pro-IL-1β) and β-actin (loading control) in the cell lysates were
determined by immunoblot analysis. (B) B6 or Casp1-/-Casp11-/- BMDMs were primed
with 0.5µg/mL LPS for 2.5 hours and infected with WT Lp, ΔdotA Lp, ΔflaA Lp, or PBS
for 4 hours. The level of IL-18 in the supernatants was measured by ELISA. (C)
Unprimed B6 or Casp1-/-Casp11-/- BMDMs were infected with WT Lp, ΔdotA Lp, ΔflaA
Lp, or PBS for 20 hours. Levels of IL-12 p40 and TNF-α in the supernatants were
measured by ELISA. (D) B6 or Casp1-/-Casp11-/- BMDMs were primed with 0.5µg/mL
LPS for 2.5 hours and infected with WT Lp, ΔdotA Lp, ΔflaA Lp, or PBS for 4 hours.
Levels of IL-12 p40 and TNF-α in the supernatants were measured by ELISA. Graphs
show the mean ± SEM of triplicate wells. Data are representative of two (B) or three (A,
C, and D) independent experiments.
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Figure 3-3. Caspase-11 controls the release of IL-1α and IL-1β and pyroptosis in
response to flagellin-deficient L. pneumophila. B6, Casp1-/-Casp11-/-, Casp1-/-, or
Casp11-/- BMDMs were primed with 0.5µg/mL LPS for 2.5 hours and infected with WT L.
pneumophila (WT Lp), ΔdotA Lp, ΔflaA Lp, or PBS (mock infection) or treated with
2.5mm ATP for 1 (C) or 4 (A,B) hours. (A) Levels of IL-1α and IL-1β in the supernatants
were measured by ELISA. Graphs show the mean ± SEM of triplicate wells. (B) Cell
death (% cytotoxicity) was measured by LDH release into the supernatants relative to
Triton X-100-lysed cells. Graphs show the mean ± SEM of triplicate wells. (C) Levels of
processed caspase-1 (casp-1 p10) in the supernatants and full-length caspase-1 (procasp-1) and β-actin in the cell lysates were determined by immunoblot analysis. Data are
representative of three independent experiments. *** is p<0.001 by two-way ANOVA
with Bonferroni post-test, ** is p<0.01 by two-way ANOVA with Bonferroni post-test, and
* is p<0.05 by unpaired t-test. NS is not significant.
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Figure 3-4. Caspase-11 is rapidly upregulated and secreted in response to L.
pneumophila. B6 or Casp1-/-Casp11-/- BMDMs were primed with 0.5µg/mL LPS for 2.5
hours and infected with WT L. pneumophila (Lp), ΔdotA Lp, ΔflaA Lp, or PBS (mock
infection) for 4 hours. Levels of full-length caspase-11 (pro-casp-11) and active caspase11 (casp11 p26) in the supernatants, and pro-casp-11 and β-actin (loading control) in the
cell lysates were determined by immunoblot analysis.
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Figure 3-5. Caspase-11 is activated in response to L. pneumophila independently
of macrophage priming. (A) Unprimed B6 and Casp1-/- BMDMs or (B) B6, Casp1-/Casp11-/-, and Casp11-/- BMDMs were infected with WT L. pneumophila (Lp), ΔdotA Lp,
ΔflaA Lp, or PBS (mock infection) for 20 hours. Levels of IL-1α and IL-1β in the
supernatants were measured by ELISA. Graphs show the mean ± SEM of triplicate
wells. (C) B6, Casp1-/-, or Casp11-/- BMDMs were primed with 0.5µg/mL LPS for 2.5
hours and infected with WT Lp, ΔdotA Lp, ΔflaA Lp, or PBS for 4 hours or treated with
LPS+2.5mm ATP for 1 hour. Levels of mature IL-1β in the supernatant were determined
by immunoblot analysis. Data are representative of two independent experiments.
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Figure 3-6. Caspase-11 activation is independent of ASC and NLRC4. (A) Unprimed
B6, Casp1-/-Casp11-/-, or Asc-/-Nlrc4-/- BMDMs were infected with WT L. pneumophila
(WT Lp), ΔdotA Lp, ΔflaA Lp, or PBS (mock infection) for 20 hours, and levels of IL-1α
and IL-1β in the supernatants were measured by ELISA. Graphs show the mean ± SEM
of triplicate wells. (B) Unprimed B6, Casp1-/-Casp11-/-, or Asc-/-Nlrc4-/- BMDMs were
infected with WT Lp, ΔdotA Lp, ΔflaA Lp, or PBS (mock infection) for 20 hours or treated
with LPS+ATP for 1 hour. Levels of processed caspase-1 (casp-1 p10) and caspase-11
(casp-11 p26) in the supernatants, and pro-caspase-1, pro-caspase-11, and β-actin
(loading control) in the cell lysates were determined by immunoblot analysis. (C) 8-12
week old B6 and Asc-/- mice were infected intranasally with either 1x106 ΔflaA Lp or
PBS. Bronchoalveolar lavage fluid (BALF) was collected 24 hours post-infection, and
levels of IL-1α and IL-1β were measured by ELISA. Graphs show the mean ± SEM of 9
mice per group. Dashed line represents the limit of detection. Data are representative of
three independent experiments (A,B) or are displayed as the pooled results of two
independent experiments (C). *** is p<0.001 by two-way ANOVA with Bonferroni posttest. ** is p<0.01 by unpaired t-test. NS is not significant.
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Figure 3-7. IL-1α release is ASC/NLRC4-independent. B6, Casp1-/-Casp11-/-, or Asc-/Nlrc4-/- BMDMs were primed with 0.5µg/mL LPS for 2.5 hours and infected with WT L.
pneumophila (Lp), ΔdotA Lp, ΔflaA Lp, or PBS (mock infection) or treated with 2.5mm
ATP for 4 hours. Levels of IL-1α and IL-1β in the supernatants were measured by
ELISA. Graphs show the mean ± SEM of triplicate wells. Data are representative of
three independent experiments.

74	
  

	
  

Figure 3-8. Both IL-1α and IL-1β secretion are caspase-1/caspase-11-dependent in
vivo. 8-12 week old B6 or Casp1-/-Casp11-/- mice were infected intranasally with 1x106
ΔflaA Lp. BALF was collected 24 hours post-infection, and levels of IL-1α and IL-1β were
measured by ELISA. Graphs show the mean ± SEM of three mice per group. Dashed
line represents the limit of detection. * is p<0.05 by unpaired t-test.
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Figure 3-9. Caspase-11 mediates both NLRP3-dependent and NLRP3-independent
immune responses. (A) B6, Casp1-/-Casp11-/-, Asc-/-, Nlrc4-/-, or Asc-/-Nlrc4-/- BMDMs
were primed with 0.5µg/mL LPS for 2.5 hours and infected with WT L. pneumophila (WT
Lp), ΔdotA Lp, ΔflaA Lp, or PBS (mock infection) or treated with 2.5mm ATP for 4 hours.
Levels of IL-1α and IL-1β in the supernatants were measured by ELISA and cell death
(% cytotoxicity) was measured by LDH release into the supernatants relative to Triton X100-lysed cells. Graphs show the mean ± SEM of triplicate wells. (B and C) B6 or Nlrp3-/BMDMs were primed with 0.5µg/mL LPS for 2.5 hours and infected with WT Lp, ΔdotA
Lp, ΔflaA Lp, or PBS (mock infected) or treated with 2.5mm ATP for 1 hour (C) or 4
hours (B). (B) Levels of IL-1α and IL-1β in the supernatants were measured by ELISA
and cell death (% cytotoxicity) was measured by LDH release into the supernatants
relative to Triton X-100-lysed cells. Graphs show the mean ± SEM of triplicate wells. (C)
Levels of processed caspase-1 (casp-1 p10) in the supernatants and pro-caspase-1 in
the cell lysates were determined by immunoblot analysis. Data are representative of two
(A,C) or three (B) independent experiments. *** is p<0.001 by one-way ANOVA with
Tukey post-test. NS is not significant.
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Figure 3-10. Mature IL-1β secretion is not always concordant with cell death. B6,
Casp1-/-Casp11-/-, Asc-/-, Nlrc4-/-, or Asc-/-Nlrc4-/- BMDMs were primed with 0.5µg/mL LPS
for 2.5 hours and infected with WT L. pneumophila (Lp), ΔdotA Lp, ΔflaA Lp or PBS
(mock infection) for 4 hours or treated with 2.5mm ATP for 1 hour. (A) Levels of mature
IL-1β in the supernatants, and full-length IL-1β (pro-IL-1β) and β-actin (loading control) in
the cell lysates were determined by immunoblot analysis. Data are representative of two
independent experiments. (B) The level of IL-18 in the supernatants was measured by
ELISA. Graphs show the mean ± SEM of triplicate wells.
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Figure 3-11. Flagellin-independent, NLRP3-dependent IL-1β secretion occurs
independently of macrophage priming. (A) Unprimed B6 or Nlrp3-/- BMDMs were
infected with WT L. pneumophila (Lp), ΔdotA Lp, ΔflaA Lp, or PBS (mock infection) for
16 hours. Levels of IL-1α and IL-1β in the supernatants were measured by ELISA. (B)
B6 or Nlrp3-/- BMDMs were primed with 0.5µg/mL LPS for 2.5 hours and infected with
WT Lp, ΔdotA Lp, ΔflaA Lp or PBS (mock infection) or treated with 2.5mM ATP for 4
hours. The level of IL-18 in the supernatants was measured by ELISA. (C) B6 or Nlrp3-/BMDMs were infected with WT Lp, ΔdotA Lp, ΔflaA Lp, or PBS (mock infection) for 16
hours. The level of IL-18 in the supernatants was measured by ELISA. (D and E) B6
BMDMs were primed with 0.5µg/mL LPS for 2.5 hours and infected with WT Lp, ΔdotA
Lp, ΔflaA Lp or PBS (mock infection) or treated with 2.5mM ATP for 4 hours. Where
indicated, media alone, 50mM KCl, or 50mM NaCl were added prior to infection. (D)
Levels of IL-1α and IL-1β in the supernatants were measured by ELISA. (E) Cell death
was measured by LDH release. Graphs show the mean ± SEM of triplicate wells. Data
are representative of two independent experiments (A-C).
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Figure 3-12. Non-canonical inflammasome responses to L. pneumophila occur
independently of TRIF and IFNAR. (A) Unprimed B6, Ifnar-/-, or Trif-/- BMDMs were
infected with WT L. pneumophila (WT Lp), ΔdotA Lp, ΔflaA Lp, E. coli, or PBS (mock
infection) for 16 hours. Levels of IL-1α and IL-1β in the supernatants were measured by
ELISA. (B) Unprimed B6, Ifnar-/-, or Trif-/- BMDMs were infected with WT Lp, ΔdotA Lp,
ΔflaA Lp, or PBS (mock infection) for 16 hours. Cell death (% cytotoxicity) was
measured by LDH release into the supernatants relative to Triton X-100-lysed cells.
Graphs show the mean ± SEM of triplicate wells. (C) B6, Ifnar-/-, or Trif-/- BMDMs were
primed with 0.4µg/mL Pam3CSK4 for 4 hours and infected with WT Lp, ΔdotA Lp, ΔflaA
Lp, or PBS for 16 hours. Levels of full-length caspase-11 (pro-casp-11) and processed
caspase-11 (casp11 p26) in the supernatants and pro-casp-11 and β-actin (loading
control) in the cell lysates were determined by immunoblot analysis. Data are
representative of two independent experiments.
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Figure 3-13. TRIF/IFNAR-independent IL-1 release occurs with Pam3CSK4-primed
macrophages. (A) B6, Ifnar-/-, or Trif-/- BMDMs were primed with 0.4µg/mL Pam3CSK4
for 4 hours and infected with WT L. pneumophila (Lp), ΔdotA Lp, ΔflaA Lp, E. coli, or
PBS (mock infection) for 16 hours. The levels of IL-1α and IL-1β in the supernatants
were measured by ELISA. (B) B6, Ifnar-/-, or Trif-/- BMDMs were primed with 0.4µg/mL
Pam3CSK4 for 4 hours and infected with WT Lp, ΔdotA Lp, ΔflaA Lp, or PBS for 16
hours. Cell death (% cytotoxicity) was measured by LDH release. (C) B6, Ifnar-/-, or Trif-/BMDMs were primed with 0.5µg/mL LPS for 2.5 hours and infected with WT Lp, ΔdotA
Lp, ΔflaA Lp, or PBS for 4 hours. Cell death was measured by LDH release. (D) B6,
Ifnar-/-, or Trif-/- BMDMs were primed with 0.5µg/mL LPS for 2.5 hours and infected with
WT Lp, ΔdotA Lp, ΔflaA Lp, or PBS for 4 hours. Levels of IL-1α and IL-1β in the
supernatants were measured by ELISA. Graphs show the mean ± SEM of triplicate
wells. Data are representative of two independent experiments.
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Figure 3-14. Caspase-11 is upregulated and secreted in an IFNAR- and TRIFindependent manner. Unprimed B6, Ifnar-/-, or Trif-/- BMDMs were infected with WT Lp,
ΔdotA Lp, ΔflaA Lp, or PBS for 16 hours. Levels of full-length caspase-11 (pro-casp-11)
and active caspase-11 (casp11 p26) in the supernatants, and pro-casp-11 and β-actin
(loading control) in the cell lysates were determined by immunoblot analysis.
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Figure 3-15. Detection of caspase-11 protein upregulation in cell lysates is
moderate in response to L. pneumophila. (A) Unprimed B6, Ifnar-/-, or Trif-/- BMDMs
were infected with WT Lp, ΔdotA Lp, ΔflaA Lp, E. coli, or PBS (mock infection) for 16
hours. (B) B6, Ifnar-/-, or Trif-/- BMDMs were primed with 0.4µg/mL Pam3CSK4 for 4
hours and infected with WT Lp, ΔdotA Lp, ΔflaA Lp, E. coli, or PBS for 16 hours. (C) B6,
Ifnar-/-, or Trif-/- BMDMs were primed with 0.5µg/mL LPS for 2.5 hours and infected with
WT Lp, ΔdotA Lp, ΔflaA Lp, E. coli, or PBS for 4 hours. Levels of full-length caspase-11
(pro-casp-11) and β-actin (loading control) in the cell lysates were determined by
immunoblot analysis.
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Figure 3-16. Caspase-11 is not upregulated in the absence of both MyD88 and
TRIF. (A) Immortalized B6 (iB6) or MyD88/Trif-deficient (iMyd88-/-Trif-/-) BMDMs were
primed with 0.4µg/mL Pam3CSK4 for 4 hours and infected with WT Lp, ΔdotA Lp, ΔflaA
Lp, E. coli, or PBS (mock infection) for 16 hours. (B) iB6 or iMyd88-/-Trif-/- macrophages
were primed with 0.5µg/mL LPS for 4 hours and infected with WT Lp, ΔdotA Lp, ΔflaA
Lp, or PBS (mock infection) for 4 hours. Levels of full-length caspase-11 (pro-casp-11)
and β-actin (loading control) were determined by immunoblot analysis.
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Figure 3-17. Caspase-11 mediates inflammasome activation in response to a
functional Yersinia type III secretion system. BMDMs from B6, Casp1-/-Casp11-/-,
Casp1-/-, or Casp11-/- mice were primed with 0.05µg/mL LPS for 4 hours and infected
with type III secretion system-deficient Y. pseudotuberculosis (ΔyopB Yp), effectorless
Y. pseudotuberculosis ΔHOJMEK (Δ6 Yp), or PBS (mock infection) or treated with
2.5mm ATP for 4 hours. (A) Levels of IL-1α and IL-1β in the supernatants were
measured by ELISA. (B) Cell death (% cytotoxicity) was measured by lactate
dehydrogenase (LDH) release relative to Triton X-100-lysed cells. Graphs show the
mean ± SEM of triplicate wells. Data are representative of two independent experiments.
*** is p<0.001 and ** is p<0.01 by two-way ANOVA with Bonferroni post-test. NS is not
significant. This experiment was performed by Erin E. Zwack in Igor Brodsky’s
laboratory.
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Figure 3-18. Caspase-11-deficient cells secrete comparable amounts of IL-12 in
response to Y. pseudotuberculosis. B6, Casp1-/-Casp11-/-, Casp1-/-, or Casp11-/- mice
were primed with 0.05µg/mL LPS for 2.5 hours and infected with type III secretion
system-deficient Y. pseudotuberculosis (ΔyopB Yp), effectorlessY. pseudotuberculosis
ΔHOJMEK (Δ6 Yp), or PBS (mock infection) or treated with 2.5mm ATP for 4 hours. The
level of IL-12 p40 in the supernatants was measured by ELISA. Graphs show the mean
± SEM of triplicate wells. Data are representative of two independent experiments. This
experiment was performed by Erin E. Zwack in Igor Brodsky’s laboratory.
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Figure 3-19. IL-1α and IL-1β control bacterial burden and neutrophil recruitment in
vivo. (A) 8-12 week old B6 or Il1r1-/- mice were infected with 1x106 ΔflaA L. pneumophila
intranasally (IN). Lungs were plated to quantify CFU per gram. Graph shows the mean ±
SEM of three or four infected mice per group. Dashed line represents the limit of
detection. (B and C) B6 or Il1r1-/- mice were infected with 1x106 ΔflaA Lp IN. 24 hours
post-infection, bronchoalveolar lavage fluid (BALF) was collected and the percentage of
neutrophils in the BALF was quantified by flow cytometry. Percentages are reported as
the frequency of live cells in the BALF. (B) Representative flow cytometry plots showing
the percentage of Gr-1+Ly6G+ neutrophils. (C) Graph showing the percentage of
neutrophils. Each point represents an individual mouse and lines indicate the mean of 4
mice per group. (D, E, and F) B6 mice were injected intraperitoneally (IP) with either
PBS, 100µg isotype control antibody (iso), 100µg anti-IL-1α antibody, 100µg anti-IL-1β
antibody, or 100 µg each of anti-IL-1α and anti-IL-1β (anti-IL-1α/β) 16 hours before
infection. The mice were then intranasally infected with either 1x106 ΔflaA Lp or mock
infected with PBS. (D and E) 24 hours post-infection, BALF was collected and flow
cytometry was performed to quantify the percentage of neutrophils. (D) Representative
flow cytometry plots showing the percentage of Gr-1+Ly6G+ neutrophils. (E) Graph
showing the percentage of neutrophils. Each point represents an individual mouse, lines
indicate the mean of 8 mice per group, and error bars represent SEM. Shown are the
pooled results of two independent experiments. (F) 72 hours post-infection, the lungs
were plated to quantify CFU per gram. Each point represents an individual mouse. Line
indicates the mean of 4 infected mice per group with error bars representing SEM. *** is
p<0.001 by one-way ANOVA with Tukey post-test or unpaired t-test (C). **is p<0.01 and
*is p<0.05 by unpaired t-test. NS is not significant.
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Figure 3-20. Intraperitoneally injected antibodies neutralize cytokine in the BALF.
8-12 week old B6 mice were injected intraperitoneally (IP) with either PBS, 100µg antiIL-1α antibody, 100µg anti-IL-1β antibody, or 100µg each of anti-IL-1α and anti-IL-1β
(anti-IL-1α/β) 16 hours before infection. The mice were then infected with either 1x106
ΔflaA Lp or mock infected with PBS intranasally (IN). 24 hours post-infection,
bronchoalveolar lavage fluid (BALF) was collected and the levels of IL-1α and IL-1β
were measured by ELISA. Labels indicate what was received intraperitoneally (IP) and
what was received intranasally (IN). Graphs show the mean ± SEM of 8 mice per group
and represent the pooled results of two independent experiments.
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Figure 3-21. Caspase-11 controls multiple pathways of inflammasome activation in
response to bacterial secretion systems that access the host cytosol. Three
distinct inflammasome pathways are induced upon interaction of virulent bacteria with
host cells. Translocation of flagellin into the host cytosol by specialized secretion
systems triggers a NAIP5/NLRC4/caspase-1 inflammasome that leads to cell death, IL1α, and IL-1β release. Virulent bacteria induce two separate pathways of caspase-11dependent inflammasome activation through a two-signal model. First, TLR stimulation
by PAMPs (signal one) leads to upregulation of pro-IL-1α, pro-IL-1β, NLRP3, and procaspase-11. Next, cytosolic detection of virulence activity, namely type III or type IV
secretion (signal two), leads to caspase-11 processing and activation. Active caspase-11
contributes to NLRP3-mediated inflammasome activation and caspase-1-dependent IL1β secretion. Caspase-11 also mediates caspase-1-independent cell death and IL-1α
release through a pathway that is independent of the NLRP3/ASC and NAIP5/NLRC4
inflammasomes and involves an unknown host sensor.
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CHAPTER 4
HUMAN CASPASE-4 MEDIATES NON-CANONICAL INFLAMMASOME ACTIVATION
AGAINST GRAM-NEGATIVE BACTERIAL PATHOGENS

This chapter appeared as a published peer-reviewed article titled “Human caspase-4
mediates non-canonical inflammasome activation against Gram-negative bacterial
pathogens” by Cierra N. Casson, Janet Yu, Valeria M. Reyes, Frances O. Taschuk,
Anjana Yadav, Alan M. Copenhaver, Hieu T. Nguyen, Ronald G. Collman, and Sunny
Shin. Proceedings of the National Academy of Sciences of the United States of America,
2015.
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A. Abstract
Inflammasomes are critical for host defense against bacterial pathogens. In murine
macrophages infected by Gram-negative bacteria, the canonical inflammasome
activates caspase-1 to mediate pyroptotic cell death and release of IL-1 family cytokines.
Additionally, a non-canonical inflammasome controlled by caspase-11 induces cell death
and IL-1 release. However, humans do not encode caspase-11. Instead, humans
encode two putative orthologs—caspase-4 and caspase-5. Whether either ortholog
functions similarly to caspase-11 is poorly defined. Therefore, we sought to define the
inflammatory caspases in primary human macrophages that regulate inflammasome
responses to Gram-negative bacteria. We find that human macrophages activate
inflammasomes specifically in response to diverse Gram-negative bacterial pathogens
that introduce bacterial products into the host cytosol using specialized secretion
systems. In primary human macrophages, IL-1β secretion requires the caspase-1
inflammasome, while IL-1α release and cell death are caspase-1-independent. Instead,
caspase-4 mediates IL-1α release and cell death. Our findings implicate human
caspase-4 as a critical regulator of non-canonical inflammasome activation that initiates
defense against bacterial pathogens in primary human macrophages.

B. Significance statement
The innate immune system provides a first line of defense against invading pathogens.
The inflammasome is an innate immune complex that activates inflammatory caspases
upon infection, causing cell death and IL-1 cytokine release, which initiate defense
against Gram-negative bacterial pathogens but also mediate septic shock. Many
inflammasome studies have been performed using cells from mice, but mice and
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humans differ in their complement of inflammatory caspases. Instead of caspase-11,
humans encode the putative orthologs caspase-4 and caspase-5. Here, we show that
caspase-4 plays a conserved role in inflammasome activation in response to virulent
Gram-negative pathogens in primary human macrophages. Our findings provide
important insight into how inflammasomes are regulated in human cells.

C. Introduction
PRRs of the innate immune system are critical for promoting defense against bacterial
pathogens (Janeway and Medzhitov, 2002). Cytosolic PRRs are key for discriminating
between pathogenic and non-pathogenic bacteria, as many pathogens access the host
cytosol, a compartment where microbial products are typically not found (Harton et al.,
2002). Cytosolic PRRs respond to patterns of pathogenesis that are often associated
with virulent bacteria, such as the use of pore-forming toxins or injection of effector
molecules through specialized secretion systems (Vance et al., 2009). A subset of
cytosolic PRRs induce the formation of multi-protein complexes known as
inflammasomes (Martinon et al., 2002). In mice, the canonical inflammasome activates
caspase-1, an inflammatory caspase that mediates cell death and IL-1 family cytokine
secretion (Kuida et al., 1995; Li et al., 1995). Additionally, the non-canonical
inflammasome activates caspase-11 in response to many Gram-negative bacteria
(Aachoui et al., 2013; Broz et al., 2012; Case et al., 2013; Casson et al., 2013; Gurung
et al., 2012; Kayagaki et al., 2011; Lamkanfi and Dixit, 2014; Rathinam et al., 2012b).
The canonical and non-canonical inflammasomes differentially regulate release of IL-1α
and IL-1β (Kayagaki et al., 2011). Caspase-11 mediates LPS-induced septic shock in
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mice (Kayagaki et al., 2011; Wang et al., 1998), and caspase-11 responds to
cytoplasmic LPS independently of TLR4 (Hagar et al., 2013; Kayagaki et al., 2013).

In addition to its pathologic role in septic shock, the non-canonical inflammasome is
critical for host defense in mice (Aachoui et al., 2013; Akhter et al., 2012). However, in
humans, it is unclear whether an analogous non-canonical inflammasome exists. While
mice encode caspase-11, humans encode two putative functional orthologs—caspase-4
and caspase-5 (Kamada et al., 1997; Kamens et al., 1995; Munday et al., 1995). All
three inflammatory caspases bind directly to LPS in vitro (Shi et al., 2014). In murine
macrophages, caspase-1 and -11 have both distinct and overlapping roles in the release
of IL-1α and IL-1β and the induction of cell death (Kayagaki et al., 2011). However, the
precise role of the human inflammatory caspases in the context of infection by bacterial
pathogens remains unclear.

To elucidate how human inflammasome activation is regulated, we investigated the
contribution of inflammatory caspases to the response against Gram-negative bacterial
pathogens in human macrophages. Here, we show that both canonical caspase-1dependent and non-canonical caspase-1-independent inflammasomes are activated in
primary human macrophages and that caspase-4 mediates caspase-1-independent
inflammasome responses against several bacterial pathogens, including Legionella
pneumophila, Yersinia pseudotuberculosis, and Salmonella Typhimurium. Importantly,
non-canonical inflammasome activation in human macrophages is specific for virulent
strains of these bacteria that translocate bacterial products into the host cytosol via
virulence-associated type III or type IV secretion systems. Thus, caspase-4 is critical for
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non-canonical inflammasome responses against virulent Gram-negative bacteria in
human macrophages.

D. Results
L. pneumophila induces both IL-1α and IL-1β release from human macrophages.
In murine macrophages, a canonical inflammasome leads to caspase-1 activation and
IL-1β secretion, while a non-canonical inflammasome results in caspase-11 activation,
cell death, and IL-1α and IL-1β release (Kayagaki et al., 2011). In human macrophages,
it is unclear whether both canonical (caspase-1-dependent) and non-canonical
(caspase-1-independent) inflammasomes are activated during bacterial infection
(Lamkanfi and Dixit, 2014). To determine if both canonical and non-canonical
inflammasomes are activated, we first used Legionella pneumophila, a pathogen that
triggers robust inflammasome activation in murine macrophages and causes a severe
form of pneumonia, Legionnaires’ disease, in humans (McDade et al., 1977). To
replicate within macrophages, L. pneumophila uses a T4SS to inject effector proteins
into the host cell cytosol (Berger and Isberg, 1993; Isberg et al., 2009; Marra et al.,
1992). Because L. pneumophila activates both the canonical and non-canonical
inflammasomes in murine macrophages (Case et al., 2013; Casson et al., 2013), we
examined whether the bacterium induces IL-1α and IL-1β release from human
macrophages as well. First, we differentiated and infected the THP-1 monocytic cell line.
Upon infection, THP-1 cells underwent death and released IL-1α and IL-1β in a manner
requiring the presence of the bacterial T4SS (Figure 4-1A). THP-1 cells infected with
bacterial mutants lacking a functional T4SS (T4SS- Lp) did not activate the
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inflammasome but still upregulated pro-IL-1β, suggesting that the cells are capable of
sensing T4SS- Lp (Figure 4-1B).

Inflammasome activation has been extensively analyzed in murine macrophages and in
murine and human monocytic and epithelial cell lines. In human epithelial cell lines, noncanonical inflammasome activation leads to IL-18 release and cell death during
Salmonella Typhimurium infection (Knodler et al., 2014). Additionally, non-canonical
inflammasome activation occurs in a number of transformed cell lines in response to
intracellular LPS (Knodler et al., 2014; Shi et al., 2014). However, we have limited
understanding of inflammasome biology in primary human innate immune cells,
particularly with respect to pathways that regulate IL-1α and IL-1β release. We therefore
infected primary human monocyte-derived macrophages (MDMs) from healthy human
donors with L. pneumophila. Importantly, cell death and IL-1 release in primary human
macrophages required the presence of the bacterial T4SS (Figure 4-1C). Although
T4SS-deficient bacteria did not elicit IL-1β secretion, pro-IL-1β was upregulated in all
infected donor cells (Figure 4-1D). Mature IL-1β was detected in the supernatants of
cells infected with wild-type L. pneumophila (WT Lp) but not with T4SS- Lp (Figure 4-2).
The absence of inflammasome activation in T4SS- Lp-infected cells was not due to a
lack of priming, as MDMs that were first directly primed with LPS and then infected with
T4SS- Lp also did not activate the inflammasome (Figure 4-1E and 4-1F). Thus, L.
pneumophila triggers robust T4SS-dependent inflammasome responses in primary
human macrophages.
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Caspase-1-dependent and -independent inflammasome pathways are activated
during infection of human macrophages.
To determine whether both canonical (caspase-1-dependent) and non-canonical
(caspase-1-independent) inflammasomes are triggered in human macrophages, we first
examined the contribution of caspase-1 to inflammasome responses. We infected
primary human MDMs and found that L. pneumophila infection induced caspase-1
cleavage into a 10kDa (p10) subunit that was released into the supernatant (Figure 43A). Caspase-1 was processed in response to WT Lp and not T4SS- Lp, suggesting that
cytosolic sensing of T4SS activity controls caspase-1 cleavage into its active form. We
next asked whether caspase-1 catalytic activity is required for inflammasome activation
in human macrophages. We pre-treated primary human MDMs with Ac-YVAD-cmk
(YVAD), a chemical inhibitor of caspase-1 activity, and examined inflammasome
responses. In primary MDMs, caspase-1 activity played a major role in controlling IL-1β
secretion in response to WT Lp (Figure 4-3B). Inhibition of caspase-1 catalytic activity
had no significant effect on cell death or IL-1α release. This implies that as in murine
cells, caspase-1-independent pathways contribute to IL-1α release in human cells, and
these results were consistent with what was observed in THP-1 cells (Figure 4-3C).
Importantly, the caspase-1-independent cytokine TNF was unaffected by inhibitor
treatment. To further strengthen the link between caspase-1 and IL-1β secretion in
human macrophages, we also knocked down caspase-1 in THP-1 cells (Figure 4-3D).
Caspase-1 knockdown did not affect expression of caspase-4 or pro-IL-1β during
infection with WT Lp but significantly reduced IL-1β secretion (Figure 4-3E). Thus,
caspase-1 mediates IL-1β release but not IL-1α release, suggesting that another
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inflammatory caspase may mediate IL-1α release during bacterial infection of human
macrophages.

Caspase-4 contributes to non-canonical inflammasome activation in L.
pneumophila-infected primary human macrophages.
As IL-1α release and cell death were independent of caspase-1, we considered the
possibility that other inflammatory caspases mediate this response via non-canonical
inflammasome activation. In murine macrophages, caspase-11 is robustly activated and
cleaved in response to L. pneumophila (Casson et al., 2013), but whether caspase-4 or 5 is activated during infection of primary human cells is not known. Notably, we observed
that caspase-4 was processed into a 32kDa (p32) subunit in primary human MDMs
infected with WT Lp but not T4SS- Lp, again implying that primary human macrophages
respond to the activity of the virulence-associated T4SS (Figure 4-4A). In contrast, we
did not observe caspase-5 processing in response to WT Lp (Figure 4-5).

In murine macrophages, caspase-11 is upregulated in response to LPS, type I IFN, and
IFNγ (Aachoui et al., 2013; Rathinam et al., 2012b). In immortalized epithelial cells,
caspase-4 and -5 are both transcriptionally induced by IFNγ, and caspase-5 is
upregulated by LPS in THP-1 cells (Lin et al., 2000; Ossina et al., 1997). However, the
effect of type I IFN and LPS on caspase-4 and -5 expression in primary MDMs has not
been examined. In MDMs, we observed that though both caspase-4 and -5 were
transcriptionally induced by LPS and IFNβ (Figure 4-6A), only caspase-4 was
translationally upregulated in response to both stimuli, while caspase-5 protein levels
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increased in response to LPS but not IFNβ (Figure 4-6B). Thus, similar to murine
caspase-11, caspase-4 is upregulated by both LPS and type I IFN.

Because caspase-4 is processed specifically in response to WT Lp and is upregulated
by both LPS and type I IFN, we interrogated whether caspase-4 has a role in
inflammasome activation. We used siRNA to knockdown caspase-4 expression in
primary human MDMs and observed robust silencing of caspase-4 and no effect on
caspase-1 (Figure 4-4B). Caspase-4 played a significant role in mediating cell death in
MDMs from four out of five donors, and knockdown of caspase-4 significantly reduced
IL-1α release for every set of donor cells tested (Figure 4-4C). However, in contrast to
the role of caspase-11 in murine cells (Kayagaki et al., 2011), knockdown of caspase-4
did not significantly affect IL-1β secretion or maturation from primary MDMs (Figure 44D). Release of TNF, an inflammasome-independent cytokine, was unaffected by
silencing caspase-4. Similar results were obtained in LPS-primed primary MDMs
infected with L. pneumophila (Figure 4-7A and 4-7B). Additionally, both IL-1β maturation
and caspase-1 processing did not require caspase-4 during infection of THP-1 cells,
though IL-1α release was still dependent on caspase-4 (Figure 4-4E and 4-7C). In
contrast, when we infected THP-1 cells that are deficient for the inflammasome adaptor
ASC (ASC-def), IL-1β release was greatly diminished (Figure 4-8A and 4-8B), thus
placing ASC upstream of caspase-1 activation and IL-1β release. These data support a
key role for caspase-4 in non-canonical inflammasome activation in primary human
macrophages during L. pneumophila infection. Furthermore, these data imply that noncanonical inflammasome activation in human macrophages in response to L.
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pneumophila infection specifically regulates IL-1α release and cell death separately from
IL-1β secretion.

Caspase-4 mediates cell death and IL-1 release in primary human macrophages in
response to intracellular LPS
Intracellular LPS is a trigger for non-canonical, caspase-11-dependent inflammasome
activation in murine macrophages (Hagar et al., 2013; Kayagaki et al., 2013). Both
human caspase-4 and -5 directly bind LPS, and transfection of LPS induces caspase-4dependent cell death in human monocytic, keratinocyte, and epithelial cell lines and IL18 release from a human colonic epithelial cell line (Knodler et al., 2014; Shi et al.,
2014). However, it is unknown whether primary human macrophages respond to
cytosolic LPS by activating the non-canonical inflammasome and if so, whether
caspase-4 is responsible. Therefore, we first determined whether transfecting LPS into
primary human MDMs induces inflammasome activation. We observed that transfection
of LPS into primary human macrophages induced cell death, whereas extracellular LPS
treatment did not (Figure 4-9A). Silencing of caspase-4 prior to LPS transfection resulted
in a significant reduction in cell death for every donor (Figure 4-9B and 4-9C), and both
IL-1α and IL-1β release were also significantly reduced (Figure 4-9C). In agreement with
prior studies (Martinon et al., 2002), we also found that primary MDMs treated with
extracellular LPS for 20 hours induced cleavage of caspase-5, but LPS transfection did
not increase this processing (Figure 4-10A). These data indicate that caspase-4 is
primarily responsible for non-canonical inflammasome responses to intracellular LPS in
primary human macrophages, but unlike the response to bacterial infection, caspase-4
appears to control both IL-1α and IL-1β release during LPS transfection (Figure 4-14).
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Caspase-4 has a conserved role in non-canonical inflammasome activation
against Gram-negative bacterial pathogens.
In murine macrophages, caspase-11 controls non-canonical inflammasome responses
to a wide variety of Gram-negative bacteria, and caspase-11 is activated in response to
bacteria that introduce bacterial products into the host cytosol via virulence-associated
secretion systems (Broz et al., 2012; Casson et al., 2013; Gurung et al., 2012; Rathinam
et al., 2012b). We thus hypothesized that caspase-4 has a conserved role in
inflammasome activation against other pathogens that use specialized secretion
systems to deliver bacterial components into the host cytosol. Similarly to the L.
pneumophila T4SS, other Gram-negative pathogens, including Salmonella enterica
serovar Typhimurium and Yersinia pseudotuberculosis, use a T3SS to inject bacterial
effectors that modify host signaling (Galán et al., 2014). Though the T3SS is
evolutionarily quite distinct from the T4SS, both secretion systems perform analogous
functions to introduce bacterial products into the host cytosol. Therefore, we infected
primary human MDMs with S. Typhimurium and Y. pseudotuberculosis to test whether
these bacteria also activate non-canonical inflammasome responses in human cells. S.
Typhimurium triggered robust cell death and IL-1 release in a manner requiring the
Salmonella pathogenicity island I (SPI-1) T3SS, as bacteria lacking SPI-1 (T3SS- St)
induced little inflammasome activation (Figure 4-11A). Because Y. pseudotuberculosis
encodes effectors that block inflammasome activation (Brodsky et al., 2010; LaRock and
Cookson, 2012), we infected macrophages with a strain of Y. pseudotuberculosis lacking
the six known secreted effectors (Δ6 Yp), as Δ6 Yp induces robust caspase-11dependent inflammasome activation in murine macrophages (Casson et al., 2013). For
Y. pseudotuberculosis, robust inflammasome activation in human macrophages also
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required the T3SS (Figure 4-11B). For both bacteria, the inflammasome-independent
cytokine TNF was secreted independently of the presence of a T3SS.

We next tested whether caspase-4 has a conserved role in inflammasome responses
against Y. pseudotuberculosis and S. Typhimurium by using siRNA to knockdown
caspase-4 in primary human MDMs (Figure 4-12A and 4-12B). Indeed, caspase-4
silencing in MDMs significantly reduced IL-1α release (Figure 4-11D and 4-11E). Similar
to infection with L. pneumophila, IL-1β secretion was caspase-4-independent during
infection with Y. pseudotuberculosis, and IL-1β secretion and maturation and caspase-1
processing were also caspase-4-independent during S. Typhimurium infection (Figure 413). Additionally, infection of ASC-def THP-1 cells showed that ASC is required for IL-1β
release during both Y. pseudotuberculosis and S. Typhimurium infection, again placing
ASC upstream of caspase-1 (Figure 4-8C). Caspase-4 knockdown also significantly
reduced cell death upon Y. pseudotuberculosis infection (Figure 4-12C), though cell
death during S. Typhimurium infection was independent of caspase-4, implying that at
least two distinct pathways that mediate cell death are activated in human cells during
infection (Figure 4-12D). Furthermore, upon infection with wild-type S. Typhimurium (WT
St), caspase-4 was processed into the p32 subunit and released into the supernatant
(Figure 4-11C). Caspase-4 processing requires the presence of the T3SS, as infection
with T3SS- St did not induce caspase-4 cleavage. Unlike caspase-4, caspase-5 was not
processed during either Y. pseudotuberculosis or S. Typhimurium infection (Figure 410B). Thus, supporting our findings with L. pneumophila, caspase-4 mediates noncanonical, caspase-1-independent inflammasome activation during infection with Y.
pseudotuberculosis and S. Typhimurium as well. Collectively, these data implicate
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caspase-4 as a critical mediator of inflammasome activation against Gram-negative
bacterial pathogens that translocate bacterial products into the cytosol of primary human
macrophages.

E. Discussion
Our data demonstrate that caspase-4 regulates non-canonical inflammasome responses
against Gram-negative bacterial pathogens in primary human macrophages. Recent
findings also indicate a role for caspase-4 in non-hematopoietic cells, as caspase-4
mediates secretion of IL-18, another IL-1 family cytokine, in epithelial cell lines infected
with Salmonella Typhimurium (Knodler et al., 2014). Interestingly, Shigella flexneri
encodes an effector protein that blocks caspase-4 activity (Kobayashi et al., 2013), and
overexpression of caspase-4 in cell lines restricts growth of L. pneumophila (Akhter et
al., 2012), supporting a critical role for caspase-4 in defense against bacterial
pathogens. Further studies will be important for understanding how caspase-4 responds
specifically to virulent bacteria. As human caspase-4 can bind LPS directly and
enhances inflammasome activation in response to LPS when ectopically expressed in
mouse macrophages (Kajiwara et al., 2014; Shi et al., 2014), caspase-4 may respond to
LPS that is somehow released into the cytosol during infection with virulent bacteria. In
murine cells, IFN-inducible GBPs enhance disruption of phagosomes carrying bacterial
cargo and allow bacterial products to enter the host cell cytosol, thus promoting
caspase-11 activation (Meunier et al., 2014; Pilla et al., 2014). It would be of interest to
determine if GBPs enhance caspase-4 activation in human macrophages as well.
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As L. pneumophila and S. Typhimurium reside within pathogen-containing vacuoles and
Y. pseudotuberculosis has an extracellular lifestyle, it is still unclear if caspase-4 is also
activated by Gram-negative bacterial pathogens that reside within the macrophage
cytosol. Presumably, as virulent strains of these pathogens reside and replicate within
the cytosol, their LPS could be sensed directly via caspase-4. However, many of these
pathogens may have also evolved to evade caspase-4-mediated sensing by blocking
caspase-4 activity, as demonstrated by S. flexneri (Kobayashi et al., 2013), or by
encoding LPS that is not readily detectable, as is the case for Francisella novicida in
murine macrophages (Hagar et al., 2013).

We observed that although caspase-11 contributes to IL-1β release from murine
macrophages in response to both cytosolic LPS and bacterial infection, caspase-4
contributes to IL-1β release in response to cytosolic LPS but does not play a major role
in controlling IL-1β release from human macrophages during bacterial infection. We
found that human ASC is upstream of caspase-4-independent caspase-1 activation and
IL-1β secretion in response to bacterial infection. We speculate that ASC works in
conjunction with NLRP3 to activate caspase-1 during Gram-negative bacterial infection,
as NLRP3 is recruited to ASC foci during infection of THP-1 cells with S. Typhimurium
(Man et al., 2014), and both ASC and NLRP3 contribute to IL-1β secretion (Li et al.,
2008). It is possible that during bacterial infection, another cytosolic PAMP dominantly
triggers a canonical NLRP3/ASC/caspase-1 inflammasome and IL-1β release
independently of caspase-4. Alternatively, even though we do not detect caspase-5
processing, it is possible that caspase-5 contributes to caspase-1 activation and IL-1β
secretion independently of caspase-4 during bacterial infection (Figure 4-14).
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Intriguingly, in addition to our finding that caspase-4 is activated during bacterial
infection, caspase-4 is also activated in response to ER stress (Hitomi et al., 2004) and
ultraviolet B (UVB)-irradiation (Sollberger et al., 2012). This implies that both exogenous
and endogenous stressors may trigger caspase-4 activation and that a common
mechanism may be involved. Both UVB-irradiation and ER stress result in elevated
cytoplasmic calcium, which has been linked to inflammasome activation (Feldmeyer et
al., 2007; Murakami et al., 2012; Sano and Reed, 2013). As L. pneumophila intercepts
ER-derived vesicles to establish its replicative vacuole (Horwitz and Silverstein, 1980;
Swanson and Isberg, 1995), it is possible that perturbations to ER and calcium
homeostasis during bacterial infection provide common signals that induce caspase-4
activation.

Overall, our data implicate caspase-4 as a critical mediator of host defense against
virulent Gram-negative bacteria in primary human macrophages and reveal unexpected
differences in the regulation of non-canonical inflammasome pathways in murine and
human cells. Caspase-4 plays an important role as an innate immune effector for
discrimination between pathogenic and nonpathogenic bacteria in humans, and further
studies will examine the basis for differences in how non-canonical inflammasomes
function in different organisms. Like caspase-11 in mice, caspase-4 may play a dual role
in humans to both protect the host and mediate septic shock during bacterial infection.
Therefore, studying caspase-4 is critical for our understanding of how the human
immune system coordinates an appropriate response during bacterial infection.
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Figure 4-1. L. pneumophila induces both IL-1α and IL-1β release from human
macrophages. (A-D) PMA-differentiated THP-1 cells (A and B) or primary human MDMs
(C and D) were infected with wild-type L. pneumophila (WT Lp), T4SS-deficient L.
pneumophila (T4SS- Lp), or mock infected with PBS for 20 hours. (E and F) Primary
human MDMs were primed with LPS and infected with WT Lp, T4SS- Lp, or mock
infected for 4 hours. Cell death (% cytotoxicity) was measured using LDH release assay
and normalized to mock infected cells. IL-1α and IL-1β levels in the supernatants were
measured by ELISA. Immunoblot analysis was performed on lysates for full-length IL-1β
(pro-IL-1β), and blots were re-probed for β-actin as a loading control. Western blots (B,
D, and F) are representative of at least 3 independent experiments. Shown are the
pooled results of 4 independent experiments in THP-1 cells (A) or the pooled results of 6
independent infections of cells from different healthy human donors (C and E). Each
data point shows the mean of triplicate infected wells. For (A), * is p<0.05 and ** is
p<0.01 by unpaired t-test. For (C and E), *** is p<0.001, ** is p<0.01, and * is p<0.05 by
paired t-test. Dashed line is the limit of detection.
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Figure 4-2. Primary human macrophages secrete mature IL-1β in response to WT
L. pneumophila. Primary human MDMs were infected with wild-type L. pneumophila
(WT Lp), T4SS-deficient L. pneumophila (T4SS- Lp), or mock infected with PBS for 20
hours. Immunoblot analysis was performed on supernatants for cleaved IL-1β (mature
IL-1β) and lysates for pro-IL-1β, and blots were re-probed for β-actin as a loading
control. Western blots are representative of at least 2 independent experiments.
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Figure 4-3. Caspase-1-dependent and -independent inflammasomes are activated
during infection of human macrophages. (A) Primary human MDMs were infected
with WT Lp, T4SS- Lp, or mock infected 20 hours. Immunoblot analysis was performed
on supernatants for cleaved caspase-1 (casp-1 p10) and lysates for full-length caspase1 (pro-casp-1). Lysates were re-probed for β-actin. (B and C) Primary human MDMs (B)
or PMA-differentiated THP-1 cells (C) were pre-treated with 40µM caspase-1 inhibitor
(YVAD) or vehicle control (DMSO) and infected with WT Lp or mock infected for 20
hours. (D and E) PMA-differentiated THP-1 cells were transfected with control siRNA or
siRNA against caspase-1 and infected with WT Lp or mock infected for 20 hours.
Immunoblot analysis was performed on lysates for pro-casp1, pro-casp4, and pro-IL-1β,
and blots were re-probed for β-actin. Cell death was measured using LDH release assay
and normalized to mock infected cells. IL-1α, IL-1β, and TNF levels in the supernatants
were measured by ELISA. Western blots (A and D) are representative of 3 independent
experiments. Shown are the pooled results of 4 independent infections of cells from
different donors (B) or the pooled results of 4 (C) or 3 (E) independent experiments in
THP-1 cells. Each data point shows the mean of triplicate infected wells. * is p<0.05 by
paired t-test (B and E) or unpaired t-test (C). NS is not significant. Dashed line is the limit
of detection.

107	
  

	
  

Figure 4-4. Caspase-4 contributes to non-canonical inflammasome activation in L.
pneumophila-infected primary human macrophages. (A) Primary human MDMs were
infected with WT Lp, T4SS- Lp, or mock infected for 20 hours. Immunoblot analysis was
performed on supernatants for cleaved caspase-4 (casp4 p32) and lysates for procasp4. Lysates were re-probed for β-actin. (B-E) Primary human MDMs (B-D) or THP-1
cells (E) were transfected with control siRNA or siRNA against caspase-4 and infected
with WT Lp or mock infected for 20 hours. Immunoblot analysis was performed on
supernatants for cleaved IL-1β (mature IL-1β) and cleaved caspase-1 (casp-1 p10) and
lysates for pro-IL-1β, pro-casp1, and pro-casp4, and blots were re-probed for β-actin.
Cell death was measured using LDH release assay and normalized to mock infected
cells. IL-1α, IL-1β, and TNF levels in the supernatants were measured by ELISA.
Western blots (A, B, D, and E) are representative of at least 3 independent experiments.
Shown are the pooled results of 5 independent infections of cells from different donors
(C). Each data point shows the mean of triplicate infected wells. ** is p<0.01 and * is
p<0.05 by paired t-test. NS is not significant. Dashed line is the limit of detection.
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Figure 4-5. Pro-caspase-5 is found in the lysates but is not processed in response
to WT L. pneumophila. Primary human MDMs were infected with WT Lp or mock
infected 20 hours. Immunoblot analysis was performed on supernatants for cleaved
caspase-5 and lysates for full-length caspase-5 (pro-casp5). Western blots are
representative of at least 3 independent experiments.
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Figure 4-6. Caspase-4 is transcriptionally and translationally upregulated by LPS
and IFNβ, whereas caspase-5 is transcriptionally upregulated by LPS and IFNβ but
only translationally upregulated by LPS. (A and B) Primary human MDMs were either
left untreated (unstim) or were treated with LPS or IFNβ at the indicated concentrations
for either 4 or 20 hours. (A) Transcript levels were determined by qRT-PCR, and fold
induction was calculated by normalizing to the HPRT housekeeping gene for each
sample and then to the unstimulated sample for each time point. (B) Immunoblot
analysis was performed on lysates for full-length caspase-4 (pro-casp4) and full-length
caspase-5 (pro-casp5), and blots were re-probed for β-actin as a loading control.
Western blots are representative of 3 independent experiments. Shown are the pooled
results of 3 independent treatments of cells from different donors (A). Each data point
shows the mean of duplicate treated wells.
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Figure 4-7. Caspase-4 contributes to non-canonical inflammasome activation in
LPS-primed L. pneumophila-infected primary human macrophages and THP-1
cells. (A and B) Primary human MDMs were transfected with control siRNA or siRNA
against caspase-4, primed with LPS, and infected with WT Lp or mock infected for 4
hours. (A) Cell death was measured using LDH release assay and normalized to mock
infected cells. IL-1α, IL-1β, and TNF levels in the supernatants were measured by
ELISA. (B) Immunoblot analysis was performed on supernatants for cleaved IL-1β
(mature IL-1β) and lysates for pro-IL-1β, pro-casp1, and pro-casp4, and blots were reprobed for β-actin. Western blots are representative of 3 independent experiments.
Shown are the pooled results of 4 independent infections of cells from different donors
(A). Each data point shows the mean of triplicate infected wells. * is p<0.05 by paired ttest. NS is not significant. Dashed line is the limit of detection.
PMA-differentiated THP-1 cells were transfected with control siRNA or siRNA against
caspase-4 and infected with WT Lp or mock infected for 20 hours. IL-1α and IL-1β levels
in the supernatants were measured by ELISA. Shown are the pooled results of 4
independent experiments in THP-1 cells. Each data point shows the mean of triplicate
infected wells. Control siRNA from Exp#1 is from the same experiment as Fig 2E. * is
p<0.05 by unpaired t-test. NS is not significant. Dashed line is the limit of detection.
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Figure 4-8. ASC is required for IL-1β release in response to Gram-negative
bacterial infection. (A and B) ASC-deficient (ASC-def) or empty vector control (Null)
PMA-differentiated THP-1 cells were infected with WT Lp or mock infected for 20 hours.
(A) Immunoblot analysis was performed on lysates for pro-IL-1β, pro-casp1, pro-casp4,
and ASC, and blots were re-probed for β-actin. (B) IL-1β and TNF levels in the
supernatants were measured by ELISA. (C) ASC-def or Null PMA-differentiated THP-1
cells were primed with LPS and infected with wild-type S. Typhimurium (WT St), T3SSexpressing effectorless Y. pseudotuberculosis (Δ6 Yp), treated with 10µM nigericin for 2
hours as an ASC-dependent control, or mock infected for 4 hours. IL-1β and TNF levels
in the supernatants were measured by ELISA. Western blots are representative of at
least 2 independent experiments. Shown are the pooled results of 4 independent
experiments in THP-1 cells (B and C). Each data point shows the mean of triplicate
infected wells. ** is p<0.01 and *** is p<0.001 by unpaired t-test. NS is not significant.
Dashed line is the limit of detection.
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Figure 4-9. Caspase-4 mediates inflammasome activation in primary human
macrophages in response to intracellular LPS. (A) Primary human MDMs were
primed with Pam3CSK4 and either treated with extracellular LPS at the indicated
concentrations, mock transfected with Fugene alone, or transfected with Fugene and
LPS at the indicated concentrations for 20 hours. (B and C) Primary human MDMs were
transfected with control siRNA or siRNA against caspase-4, primed with Pam3CSK4,
and mock transfected with Fugene alone or transfected with Fugene and 2µg/mL LPS
for 20 hours. Immunoblot analysis was performed on lysates for pro-casp1, pro-casp4,
and pro-IL-1β, and blots were re-probed for β-actin. Cell death was measured using LDH
release assay and normalized to LPS alone (A) or mock transfected cells (C). IL-1α, IL1β, and TNF levels in the supernatants were measured by ELISA. Western blots (B) are
representative of at least 4 independent experiments. Shown are the pooled results of 5
independent infections of cells from different donors (A and C). Each data point shows
the mean of triplicate infected wells. * is p<0.05 by paired t-test. NS is not significant.
Dashed line is the limit of detection.
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Figure 4-10. Caspase-5 does not undergo enhanced cleavage in response to
intracellular LPS, S. Typhimurium, or Y. pseudotuberculosis. (A) Primary human
MDMs were primed with Pam3CSK4 and either treated with 2µg/mL extracellular LPS or
transfected with Fugene and 2µg/mL LPS for 20 hours. (B) Primary human MDMs were
primed with LPS and infected with WT St, Δ6 Yp, mock infected for 4 hours, or treated
with LPS alone for 20 hours. Immunoblot analysis was performed on supernatants for
cleaved caspase-5 (casp5 p10) and lysates for full-length caspase-5 (pro-casp5), and
blots were re-probed for β-actin. Western blots are representative of at least 2
independent experiments.
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Figure 4-11. Caspase-4 has a conserved role in non-canonical inflammasome
activation against Gram-negative bacterial pathogens. (A and C) Primary human
MDMs were primed with LPS and infected with wild-type S. Typhimurium (WT St),
T3SS-deficient S. Typhimurium (T3SS- St), or mock infected for 4 hours. Immunoblot
analysis was performed on supernatants for casp4 p32 and lysates for pro-casp4. Blots
were re-probed for β-actin. (B) Primary human MDMs were primed with LPS and
infected with T3SS-expressing effectorless Y. pseudotuberculosis (Δ6 Yp), T3SSdeficient Y. pseudotuberculosis (T3SS- Yp), or mock infected for 4 hours. (D and E)
Primary human MDMs were transfected with control siRNA or siRNA against caspase-4,
primed with LPS, and infected with Δ6 Yp (D), WT St (E), or mock infected for 4 hours.
Cell death was measured using LDH release assay and normalized to mock infected
cells. IL-1α, IL-1β, and TNF levels in the supernatants were measured by ELISA.
Western blots (C) are representative of at least 3 independent experiments. Shown are
the pooled results of 4 (A and E), 5 (D), or 6 (B) independent infections of cells from
different donors. Each data point shows the mean of triplicate infected wells. * is p<0.05
and ** is p<0.01 by paired t-test. NS is not significant. Dashed line is the limit of
detection.
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Figure 4-12. Caspase-4 contributes to cell death during infection with Y.
pseudotuberculosis but not during infection with S. Typhimurium. Primary human
MDMs were transfected with control siRNA or siRNA against caspase-4, primed with
LPS, and infected with Δ6 Yp (A and C), WT St (B and D), or mock infected for 4 hours.
(A and B) Immunoblot analysis was performed on lysates for pro-casp1, pro-casp4, and
pro-IL-1β, and blots were re-probed for β-actin. (C and D) Cell death was measured
using LDH release assay and normalized to mock infected cells. Western blots (A and B)
are representative of at least 3 independent experiments. Shown are the pooled results
of 6 (C) or 4 (D) independent infections of cells from different donors. Each data point
shows the mean of triplicate infected wells. * is p<0.05 by paired t-test. NS is not
significant. Dashed line is the limit of detection.
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Figure 4-13. IL-1β maturation and caspase-1 cleavage are independent of caspase4 during S. Typhimurium infection. Primary human MDMs were transfected with
control siRNA or siRNA against caspase-4, primed with LPS, and infected with WT St for
4 hours. Immunoblot analysis was performed on supernatants for cleaved IL-1β (mature
IL-1β) and cleaved caspase-1 (casp-1 p10) and lysates for pro-IL-1β, pro-casp1, and
pro-casp4, and blots were re-probed for β-actin. Western blots are representative of at
least 3 independent experiments.
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Figure 4-14. Model for inflammasome activation in primary human macrophages in
response to intracellular LPS and Gram-negative bacterial infection. In the context
of transfection of LPS into primary human MDMs, caspase-4 is required for maximal cell
death and IL-1α and IL-1β release. Presumably, intracellular LPS binds directly to
caspase-4 to induce activation. We speculate that caspase-1 is activated downstream of
caspase-4 to mediate IL-1β release in response to intracellular LPS. In contrast, during
infection of primary human MDMs with Gram-negative bacterial pathogens, IL-1β
secretion appears to be independent of caspase-4. We speculate that the presence of a
type III or type IV secretion system somehow allows bacterial LPS to access the
macrophage cytosol, where LPS binds to and activates caspase-4 to induce cell death
and IL-1α release. As IL-1β secretion is independent of caspase-4 but requires caspase1 and ASC, we speculate that either LPS binds to caspase-5 to enhance caspase-1
activation or another PAMP is sensed via a canonical NLRP3 inflammasome to induce
caspase-1 activation and IL-1β secretion during infection.
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CHAPTER 5
SENSING OF FLAGELLIN INDUCES INFLAMMASOME ACTIVATION IN HUMAN
MACROPHAGES

This chapter contains unpublished data generated by Cierra N. Casson, Valeria M.
Reyes, Frances O. Taschuk, and Sunny Shin.
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A. Introduction
PRRs are critical for initiating immune responses against invading microorganisms
(Janeway and Medzhitov, 2002). Cytosolic PRRs, such as the NLRs, specifically detect
microbial pathogens that have breached the host cell cytosol (Harton et al., 2002), a
cellular compartment that is typically free of microorganisms. A subset of NLRs activate
multi-protein complexes known as inflammasomes, which assemble in the host cytosol
in response to a wide variety of pathogenic insults to activate the enzyme caspase-1
(Rathinam et al., 2012a). Caspase-1 has multiple effector functions, including the
induction of a pro-inflammatory form of cell death known as pyroptosis (Cookson and
Brennan, 2001). Caspase-1 also mediates the release of IL-1 family cytokines, including
IL-1α and IL-1β (Kuida et al., 1995; Li et al., 1995).

In murine macrophages, the host enzyme caspase-11 also participates in inflammasome
activation in response to infection by many Gram-negative bacterial pathogens (Broz et
al., 2012; Case et al., 2013; Casson et al., 2013; Gurung et al., 2012; Kayagaki et al.,
2011; Rathinam et al., 2012b). Caspase-11 is required for IL-1α release and cell death
and contributes to NLRP3- and caspase-1-dependent IL-1β and IL-18 release as well
(Kayagaki et al., 2011). However, humans do not encode caspase-11 (Martinon and
Tschopp, 2007). Instead, humans encode two putative functional orthologs—caspase-4
and caspase-5 (Kamada et al., 1997; Kamens et al., 1995; Munday et al., 1995). Though
caspase-5 was found to co-immunoprecipitate with caspase-1 when the inflammasome
was first described in THP-1 cells (Martinon et al., 2002), recent studies have shown that
human caspase-4 is a functional homolog of murine caspase-11 in that it mediates
cytokine release and cell death during infection. For example, caspase-4 is required for
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IL-18 release from epithelial cell lines during infection with S. Typhimurium (Knodler et
al., 2014). Additionally, caspase-4 mediates IL-1α release from primary human
macrophages in response to Gram-negative bacterial pathogens such as L.
pneumophila, Y. pseudotuberculosis, and S. Typhimurium (Casson et al., 2015).
Caspase-4 also mediates cell death in response to both transfection of intracellular LPS
and Gram-negative bacterial infection in both immortalized cell lines and primary human
macrophages (Casson et al., 2015; Knodler et al., 2014; Shi et al., 2014).

Currently, intracellular LPS is the only known bacterial ligand that triggers the noncanonical caspase-11-dependent inflammasome in murine cells and the non-canonical
caspase-4-dependent inflammasome in human cells (Hagar et al., 2013; Kayagaki et al.,
2013; Shi et al., 2014). However, multiple bacterial ligands are known to activate the
canonical caspase-1-dependent inflammasome in both human and murine cells. Many
bacterial ligands are sensed by host macrophages via a subset of NLRs known as the
NAIP proteins. Though mice encode multiple NAIP paralogs, humans encode only one
NAIP protein (Dietrich, 2001; Endrizzi et al., 2000). Each NAIP protein responds to a
distinct bacterial stimulus. For example, the conserved inner rod component of the
bacterial T3SS triggers murine NAIP2, while the needle protein of the T3SS triggers
NAIP1 in murine cells and NAIP in human cells (Kofoed and Vance, 2011; Yang et al.,
2013; Zhao et al., 2011). Additionally, in murine macrophages, intracellular bacterial
flagellin is a robust trigger for the canonical NAIP5/NLRC4- and caspase-1-dependent
inflammasome (Franchi et al., 2006; Molofsky et al., 2006; Ren et al., 2006; Zamboni et
al., 2006). Flagellin associates with both NAIP5 and NAIP6 to induce inflammasome
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activation, and NLRC4 appears to be an important adaptor downstream of the NAIP
proteins (Kofoed and Vance, 2011; Zhao et al., 2011).

Human cells are not thought to respond to intracellular flagellin because human NAIP
does not co-immunoprecipitate with flagellin, and the presence of cytosolic flagellin does
not trigger the formation of a multi-meric complex containing NAIP and NLRC4 (Zhao et
al., 2011). However, the assays examining inflammasome assembly were performed
using overexpression of various NLRs in a heterologous cell expression system (Kofoed
and Vance, 2011; Zhao et al., 2011). Therefore, it is possible that endogenous human
NAIP could recognize flagellin during physiological infection conditions in primary cells.
Interestingly, there is evidence that human NAIP responds to bacterial flagellin during
infection with L. pneumophila and restricts bacterial growth (Vinzing et al., 2008).
However, a role for NAIP in controlling inflammasome activation and release of IL-1
family cytokines in response to bacterial pathogens has not been examined. Additionally,
it is unclear if flagellin can trigger inflammasome activation in human cells that is
independent of sensing via NAIP. Therefore, we wanted to elucidate if flagellin is a
trigger for IL-1 release during bacterial infection of human cells.

To determine if flagellin triggers inflammasome activation in human macrophages during
Gram-negative bacterial infection, we infected human macrophages with flagellindeficient strains of both S. Typhimurium and L. pneumophila and examined IL-1α and IL1β release. Intriguingly, we find that both IL-1α and IL-1β release are reduced in
response to infection with flagellin-deficient pathogens, suggesting that flagellin is a
trigger for both the canonical and non-canonical inflammasomes in human
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macrophages. Therefore, our data suggest that cytosolic flagellin is sensed in human
macrophages and that flagellin, like LPS, may be an important trigger for caspase-4
activation during bacterial infection.

B. Results
IL-1 release from THP-1 cells in response to S. Typhimurium is dependent on the
presence of bacterial flagellin.
To determine if bacterial flagellin is sensed in human macrophages to induce
inflammasome activation, we first infected the immortalized monocytic THP-1 cell line
with S. Typhimurium. Infection with WT St induces robust IL-1 release, while infection
with flagellin-deficient S. Typhimurium (FliCFljB- St) induces significantly less IL-1α and
IL-1β release (Figure 5-1). IL-1α and IL-1β release in response to S. Typhimurium
require the presence of the bacterial SPI-1 T3SS (Casson et al., 2015). Therefore, the
T3SS is required for flagellin-dependent IL-1 secretion, and cytosolic flagellin introduced
by the presence of the T3SS is likely the trigger for inflammasome activation during
infection. Secretion of TNF, an inflammasome-independent cytokine, was unaffected by
flagellin-deficiency (Figure 5-1). Additionally, the decrease in IL-1β secretion in response
to FliCFljB- St was not due to a general defect in priming, as expression of pro-IL-1β was
not decreased during infection with FliCFljB- St (Figure 5-2).

IL-1 release from primary human macrophages in response to L. pneumophila is
dependent on the presence of bacterial flagellin.
It remains unclear if flagellin triggers release of IL-1α and IL-1β in primary human
macrophages. Therefore, we infected primary human MDMs with L. pneumophila and
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examined inflammasome activation. For every set of donor cells tested, we find that both
IL-1α and IL-1β release are significantly dependent on the presence of bacterial flagellin,
as infection with flagellin-deficient L. pneumophila (FlaA- Lp) induces less IL-1 release
than infection with WT Lp (Figure 5-3). However, secretion of TNF, an inflammasomeindependent cytokine, was unaffected by the absence of flagellin during infection. Again,
IL-1 release in response to L. pneumophila in primary MDMs requires the presence of
the bacterial T4SS (Casson et al., 2015). Therefore, flagellin that gains access to the
macrophage cytosol in the presence of the T4SS is likely the ligand that triggers IL-1
release during infection.

C. Discussion
Our data demonstrate that sensing of bacterial flagellin contributes to IL-1 release from
human macrophages during Gram-negative bacterial infection. Contrary to previous
studies (Yang et al., 2013; Zhao et al., 2011), our data imply that human cells are
capable of responding to cytosolic flagellin and that cytosolic flagellin likely triggers
inflammasome activation. Intriguingly, our data show that the presence of bacterial
flagellin enhances both IL-1α and IL-1β release from human macrophages. Previous
studies have demonstrated that caspase-4 controls IL-1α release in response to both S.
Typhimurium and L. pneumophila (Casson et al., 2015). In contrast to caspase-11 in
murine macrophages (Kayagaki et al., 2011), caspase-4 does not contribute to IL-1β
release from human macrophages in response to Gram-negative bacterial pathogens
(Casson et al., 2015). Instead, caspase-1 mediates IL-1β release separately from
caspase-4. Therefore, our data place flagellin upstream of both caspase-1 and caspase-
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4 as a trigger for both canonical and non-canonical inflammasome activation in human
macrophages.

Although we have uncovered a role for flagellin in inducing IL-1α and IL-1β release from
human macrophages, it is still unclear which NLR responds to cytosolic flagellin during
infection. Presumably, human NAIP is involved in detecting flagellin in human cells, as
NAIP restricts L. pneumophila growth (Vinzing et al., 2008), and the mouse NAIP
paralogs NAIP5 and NAIP6 detect flagellin in murine cells (Kofoed and Vance, 2011;
Zhao et al., 2011). However, as human NAIP is thought to specifically detect the needle
protein of the bacterial T3SS (Yang et al., 2013), it is still unclear if NAIP senses flagellin
during infection of human macrophages. Future studies interrogating a role for NAIP in
mediating IL-1 release during infection with S. Typhimurium and L. pneumophila
infection will be valuable for understanding how flagellin is sensed in human cells.
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Figure 5-1. IL-1α and IL-1β release from THP-1 cells in response to S.
Typhimurium infection is dependent on the presence of bacterial flagellin. PMAdifferentiated THP-1 cells were primed with LPS and infected with wild-type S.
Typhimurium (WT St), flagellin-deficient S. Typhimurium (FliCFljB- St), or mock infected
with PBS for 4 hours. IL-1α and IL-1β levels in the supernatants were measured by
ELISA. Shown are the pooled results of 3 independent experiments in THP-1 cells. Each
data point shows the mean of triplicate infected wells. * is p<0.05 and ** is p<0.01 by
unpaired t-test. Dashed line is the limit of detection.
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Figure 5-2. THP-1 cells do not have a defect in upregulating pro-IL-1β in response
to flagellin-deficient S. Typhimurium. PMA-differentiated THP-1 cells were primed
with LPS and infected with wild-type S. Typhimurium (WT St), T3SS-deficient S.
Typhimurium (T3SS- St), or flagellin-deficient S. Typhimurium (FliCFljB- St) for 4 hours.
Immunoblot analysis was performed on lysates for full-length IL-1β (pro-IL-1β), and blots
were re-probed for β-actin as a loading control. Western blots are representative of 2
independent experiments.
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Figure 5-3. IL-1α and IL-1β release from primary human macrophages in response
to L. pneumophila infection is dependent on the presence of bacterial flagellin.
Primary human MDMs were infected with wild-type L. pneumophila (WT Lp), flagellindeficient L. pneumophila (FlaA- Lp), or mock infected with PBS for 20 hours. IL-1α and
IL-1β levels in the supernatants were measured by ELISA. Shown are the pooled results
of 4 independent infections of cells from different healthy human donors. Each data point
shows the mean of triplicate infected wells. * is p<0.05 and ** is p<0.01 by paired t-test.
Dashed line is the limit of detection.
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CHAPTER 6
DISCUSSION

Sections of this chapter have been adapted from a published peer-reviewed mini-review
titled “Inflammasome-mediated cell death in response to bacterial pathogens that access
the host cell cytosol: lessons from Legionella pneumophila” by Cierra N. Casson and
Sunny Shin. Frontiers in Cellular and Infection Microbiology, 2013.
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In the work presented in this dissertation, we have defined a critical role for caspase-11
in activating the inflammasome in murine macrophages in response to L. pneumophila
and Y. pseudotuberculosis, two Gram-negative bacterial pathogens that use virulenceassociated secretion systems to access the host cell cytosol during infection. We have
also established a distinct role for IL-1α in driving neutrophil recruitment to the airway
space independently of IL-1β during pulmonary L. pneumophila infection. Additionally,
we have identified a conserved role for caspase-4 in human cells in controlling IL-1α
release in response to L. pneumophila, Y. pseudotuberculosis, and S. Typhimurium.
Finally, we have identified bacterial flagellin as a potential activator of both the canonical
and non-canonical inflammasome in human macrophages.

A. Caspase-11 mediates inflammasome activation in murine macrophages in
response to Gram-negative bacterial pathogens
In our studies, we used caspase-1-deficient and caspase-11-deficient macrophages to
define the precise roles of caspase-1 and caspase-11 during infection with L.
pneumophila. Previous studies have demonstrated that caspase-11 induces rapid cell
death in response to bacterial pathogens that escape from the phagosome and enter the
macrophage cytosol, such as B. thailandensis (Aachoui et al., 2013). Caspase-11 is also
activated by L. pneumophila and S. Typhimurium that aberrantly enter the cytosol due to
loss of vacuolar membrane integrity (Aachoui et al., 2013). However, a role for caspase11 in generating an immune response against pathogens that remain outside of the
cytoplasm but use secretion systems to introduce bacterial products into the host cell
cytosol had not been investigated.
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Through our work, we and others have determined that caspase-11 is robustly activated
by L. pneumophila that remain within the pathogen-containing vacuole during infection,
and this caspase-11 activation is independent of bacterial flagellin (Case et al., 2013;
Casson et al., 2013). Though there is a moderate effect of a lack of caspase-11 on IL-1α
release in response to WT Lp, there is a much more dramatic effect when the bacteria
lack flagellin. We speculate that because the presence of cytosolic flagellin is a potent
stimulus for canonical inflammasome activation, NAIP5/NLRC4-dependent caspase-1
activation is dominant during infection with WT bacteria. However, we speculate that
caspase-11 may have evolved to respond rapidly and specifically to pathogens that
access the host cell cytosol but lack or down-regulate flagellin during infection in an
attempt to evade host immune recognition (Minnich and Rohde, 2007), as flagellin is an
important conserved target for innate immune recognition (Vijay-Kumar and Gewirtz,
2009). In our studies, we find that after MyD88- and TRIF-dependent upregulation of
caspase-11, host cells undergo rapid caspase-11-mediated cell death, occurring in less
than 4 hours, in response to ΔflaA Lp. Non-canonical inflammasome activation in
response to ΔflaA Lp requires T4SS-mediated cytosolic access, as ΔdotA Lp do not
activate caspase-11. Like caspase-1-mediated pyroptosis, caspase-11-dependent cell
death leads to release of important inflammatory mediators, such as IL-1α, IL-1β, and IL18. Caspase-11 is required for cell death and IL-1α release and additionally enhances
NLRP3-dependent caspase-1 activation and IL-1β and IL-18 secretion (Figure 6-1).
NLRC4-independent caspase-1 activation and IL-1β and IL-18 secretion require ASC
and NLRP3, although the identity of the L. pneumophila-derived signal sensed via
NLRP3 is still unknown (Case et al., 2009; 2013; Casson et al., 2013).
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Additionally, we extended the finding that caspase-11 responds to Gram-negative
bacterial pathogens that use virulence-associated secretion systems to Y.
pseudotuberculosis, a pathogen that uses a T3SS to access the host cytosol during
infection. It is intriguing that both the presence of the T4SS and T3SS are sensed by
murine macrophages to activate caspase-11, as the T4SS and T3SS are evolutionarily
quite distinct. The pathogenic T4SS most closely resembles secretion systems used for
conjugative transfer (Christie et al., 2014), while the pathogenic T3SS is evolutionarily
related to the flagellar apparatus (Galán et al., 2014). However, the presence of either
secretion system leads to caspase-11 activation, implying that it is probably not a
structural component of the secretion systems that is recognized, as the proteins that
make up the T4SS and T3SS are evolutionarily unrelated (Cambronne and Roy, 2006).
Additionally, it is not likely that a particular conserved bacterial effector activates
caspase-11, as the Y. pseudotuberculosis strain that we used (Δ6 Yp) lacks the six
known secreted Yersinia effectors. Instead, our data raise two potential models for how
caspase-11 is activated in murine macrophages: either a common virulence activity of
the T4SS and T3SS, such as pore formation, is sensed by host cells, or a conserved
PAMP is translocated by both the T4SS and T3SS to activate caspase-11.

B. Potential models for how caspase-11 is activated by virulence-associated
secretion systems
Following from evidence that only Gram-negative and not Gram-positive bacterial
species activate caspase-11 (Rathinam et al., 2012b), recent studies have shown that
cytosolic LPS activates caspase-11 independently of extracellular sensing by TLR4
(Hagar et al., 2013; Kayagaki et al., 2013). Additionally, LPS isolated specifically from L.
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pneumophila is capable of triggering caspase-11-dependent cell death in murine
macrophages (Pilla et al., 2014). Therefore, the most likely current model for how
caspase-11 is activated by bacteria that remain outside of the cytosol but use
specialized secretion systems to deliver bacterial products into the host cell is that the
presence of the T4SS or T3SS somehow allows LPS to gain access to the host cytosol.
One possibility is that the T4SS physically translocates LPS from the bacterial cytoplasm
into the host cytosol. Another possibility is that pores formed by the insertion of the T4SS
into the phagosome membrane allow LPS that has somehow become dissociated from
the bacterial cell wall or LPS from degraded bacteria to enter the cytosol. Yet a third
possibility is that sensors in the host cytoplasm respond to the presence of the T4SS
and induce host-mediate vacuolar disruption, which in turn delivers LPS into the
macrophage cytosol. This last possibility is supported by evidence that a subset of IFNinducible guanylate-binding proteins (GBPs) enhance disruption of pathogen-containing
vacuoles during Gram-negative bacterial infection, which in turn leads to caspase-11
activation (Meunier et al., 2014). Interestingly, GBPs are also required for cell death in
response to transfection of purified L. pneumophila LPS in IFNγ-primed macrophages,
indicating that GPBs may play a role in activating caspase-11 independently of vacuolar
disruption as well (Pilla et al., 2014). How GBPs are able to sense cytosolic LPS to
enhance caspase-11 activation requires further investigation.

Though LPS from L. pneumophila is clearly capable of activating caspase-11 when
transfected directly into the host cytosol (Pilla et al., 2014), it still remains unclear
whether L. pneumophila LPS activates caspase-11 during physiological infection
conditions. The lipid A component of L. pneumophila LPS is distinct from other common
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Gram-negative bacterial pathogens in that it contains branched-chain fatty acids with few
free hydroxyl groups that are nearly twice the length of the acyl chains from other
pathogens (Wong et al., 1979; Zähringer et al., 1995). L. pneumophila LPS is a poor
stimulator of TLR4, likely because it does not interact with the adaptor CD14
(Neumeister et al., 1998). Additionally, the effects of L. pneumophila LPS are not
neutralized by incubation with Polymyxin B, an endotoxin-binding protein (Wong et al.,
1979). Other pathogens that have lipid A components with long acyl chains that are poor
stimulators of TLR4, such as Helicobacter pylori, possess LPS that does not activate
caspase-11 (Kayagaki et al., 2013). Therefore, it is possible that the small amount of L.
pneumophila LPS that may access the cytosol during physiological infection conditions
is not very stimulatory to caspase-11 and is thus not sufficient to induce inflammasome
activation, whereas transfection of large amounts of LPS directly into the cytosol could
surpass a threshold needed to activate caspase-11 (Pilla et al., 2014). Currently, though,
the only bacterial factor that has been shown to initiate non-canonical inflammasome
activation is cytosolic LPS (Hagar et al., 2013; Kayagaki et al., 2013). However, we
speculate that the T4SS and T3SS could certainly allow for other bacterial PAMPs, such
as RNA, to enter the host cytosol as well. For some Gram-negative bacteria, it is thought
that bacterial RNA may access the host cytosol to activate NLRP3 and caspase-11
(Kanneganti et al., 2006; Rathinam et al., 2012b). However, translocation of L.
pneumophila RNA to initiate inflammasome activation has not been verified
experimentally.

Alternatively, it is possible that caspase-11 is not activated by a PAMP at all but is
activated by the host cell responding to pore formation induced by the T3SS or T4SS. As

134	
  

	
  

NLRP3 is known to be activated by a wide variety of pathogen and host-derived stimuli,
including changes in intracellular calcium levels (Brough et al., 2003; Murakami et al.,
2012), it is possible that caspase-11 responds to changes in ion concentrations or other
cellular stress signals induced by the T3SS or T4SS, which may feed forward into the
caspase-11-dependent NLRP3 activation that we observe during infection. Further
studies are needed to clarify what triggers the host response to ΔflaA Lp and to elucidate
the molecular pathways that lead to caspase-11-mediated cell death and cytokine
secretion in murine macrophages.

The model for how ΔsdhAflaA Lp activates caspase-11 is that L. pneumophila that
aberrantly enter the macrophage cytosol expose their LPS directly to caspase-11.
However, ΔsdhAflaA Lp are degraded and activate a type I IFN response when they
enter the cytosol (Creasey and Isberg, 2012), and bacterial DNA is released, which
activates AIM2 (Ge et al., 2012). Therefore, upon degradation, it is possible that other
PAMPs, such as bacterial RNA and cell wall components, are released into the host cell
cytosol and are capable of activating other cytosolic PRRs. Though caspase-11 is
clearly required for cell death in response to ΔsdhAflaA Lp (Aachoui et al., 2013), it is not
definitive that LPS is the bacterial component that is sensed upon entry of ΔsdhAflaA Lp
into the macrophage cytosol. Therefore, we speculate that it is possible that another
PAMP is detected in the cytosol to activate caspase-11 during infection with ΔsdhAflaA
Lp. Whether LPS is the only trigger for caspase-11 or not, caspase-11 is clearly relevant
for defense against many Gram-negative bacterial pathogens, especially those that lack
or down-regulate flagellin during infection to avoid detection via caspase-1.
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C. IL-1α and IL-1β have both distinct and overlapping roles during pulmonary
Legionella pneumophila infection
Through our studies, we uncovered distinct intracellular mechanisms that lead to the
release of IL-1α and IL-1β. We find that IL-1β secretion absolutely requires caspase-1,
while IL-1α release is independent of caspase-1 and requires caspase-11. Therefore,
because they are differentially regulated in vitro, we wanted to elucidate if IL-1α and IL1β could have distinct roles in vivo during infection. Using antibodies that neutralize IL1α and IL-1β, we have shown that IL-1α can act independently of IL-1β during a mouse
model of Legionnaire’s disease. As IL-1α and IL-1β bind the same receptor in vivo
(Dower et al., 1986), it was largely assumed that they have redundant biological roles.
However, previous studies have shown that IL-1α and IL-1β can play unique roles in
vivo. For example, IL-1α and IL-1β are each required individually for survival during a
mouse model of pulmonary infection with M. tuberculosis (Mayer-Barber et al., 2011),
suggesting that they have non-redundant roles. Additionally, IL-1α can drive neutrophil
recruitment into the peritoneal cavity upon introduction of MSU crystals in a mouse
model of gout (Gross et al., 2012). However, it was unknown if IL-1R signaling is
important for control of L. pneumophila replication in the lung and if IL-1α and IL-1β have
non-redundant roles during a mouse model of Legionnaires’ disease.

We have shown that IL-1R signaling in vivo is critical for host defense against pulmonary
L. pneumophila, including neutrophil recruitment to the airway space and control of
bacterial burden. Additionally, we find that neutralizing IL-1α alone has a dramatic effect
on neutrophil recruitment, while neutralizing IL-1β alone has no effect. Therefore, IL-1β
is not sufficient to drive maximal neutrophil recruitment during infection. However, we
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find that neutralization of both IL-1α and IL-1β simultaneously has an even more striking
effect on neutrophil recruitment than neutralization of IL-1α alone, implying that IL-1α
and IL-1β share some overlapping roles during infection. Recent studies have shown
that IL-1α is important for neutrophil recruitment during pulmonary infection with
pathogenic Pseudomonas aeruginosa as well (Moussawi and Kazmierczak, 2014).
Based on our in vitro data, we speculate that IL-1α release in response to ΔflaA Lp is
caspase-11-dependent in vivo, though there are caspase-11-independent sources of IL1α in response to WT Lp in vivo (Barry et al., 2013). Presumably, caspase-11-deficient
mice would also have a defect in neutrophil recruitment to the airway space, though cell
recruitment in caspase-11-deficient mice has not been examined experimentally.

As IL-1α and IL-1β both bind the IL-1R, it is unclear how they elicit different biological
effects in vivo. Currently, we have two potential models for how IL-1α could modulate
neutrophil recruitment independently of IL-1β. First, we speculate that IL-1α and IL-1β
may engage the IL-1R in slightly different manners to elicit different downstream
signaling cascades. For example, binding of IL-1α to the IL-1R may recruit different IL-1
receptor-associated kinases (IRAKs) than IL-1β (Flannery and Bowie, 2010), and
differential recruitment of IRAKs could lead to differences in the production of
chemokines important for neutrophil recruitment, such as C-X-C-motif ligand 1
(CXCL1)/keratinocyte-derived chemokine (KC) (Moser et al., 1990; Oquendo et al.,
1989). Second, we speculate that total abundance or availability of each cytokine to
access the IL-1R may have an effect on signaling in vivo. In general, we see higher total
amounts of IL-1α protein in the BALF during infection, and IL-1α has a higher affinity for
the IL-1R on certain cell types (Dower et al., 1986). Therefore, IL-1α could have a
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dominant role in recruiting neutrophils during L. pneumophila infection because there is
more cytokine available to engage the IL-1R.

In addition to its extracellular role in recruiting immune cells to the airway space during
infection, IL-1α could potentially have a cell-intrinsic role in initiating immune responses
that we did not uncover by using neutralizing antibodies. For example, it is known that
pro-IL-1α translocates into the nucleus where it can interact with histone
acetyltransferases and modulate the transcription of other pro-inflammatory cytokines
(Buryskova et al., 2004; Cheng et al., 2008; Wessendorf et al., 1993). Experiments
comparing infection of IL-1α-deficient mice to mice that have received IL-1α-neutralizing
antibodies would elucidate any cell-intrinsic roles for IL-1α in response to L.
pneumophila. However, in addition to its protective role, IL-1α can be pathological during
bacterial infection as well. For example, IL-1α induces pathological intestinal
inflammation during infection with the gastro-intestinal pathogen Yersinia enterocolitica
(Dube et al., 2001). Therefore, studying the individual roles of IL-1α and IL-1β during
disease could lead to the development of therapeutics that target individual cytokines
rather than the IL-1R, which may ameliorate pathological symptoms while not completely
compromising host defense.

D. Caspase-4 has a conserved role in inflammasome activation against Legionella
pneumophila, Yersinia pseudotuberculosis, and Salmonella Typhimurium
In our studies, we used siRNA to knockdown caspase-4 to elucidate a role for caspase-4
in inflammasome activation in primary human macrophages. Previous data had
demonstrated that LPS can bind directly to caspase-4 and caspase-5 in immortalized
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macrophage, keratinocyte, and epithelial cell lines to induce cell death (Shi et al., 2014).
Additionally, caspase-4 mediates IL-18 release in response to infection with S.
Typhimurium in immortalized human epithelial cells (Knodler et al., 2014). However, a
role for caspase-4 in mediating inflammasome activation, including cytokine release, in
primary human cells had not been investigated.

In primary human MDMs, we find that L. pneumophila induces robust IL-1α and IL-1β
release that is dependent on the presence of the T4SS. While IL-1β secretion requires
caspase-1, IL-1α release is independent of caspase-1 catalytic activity. Thus, L.
pneumophila activates both a canonical caspase-1-dependent and non-canonical
caspase-1-independent inflammasome in human cells. We find that caspase-4 mediates
cell death and IL-1α release in response to L. pneumophila in primary human MDMs.
However, in contrast to murine caspase-11, human caspase-4 does not appear to play a
significant role in mediating IL-1β secretion during infection, highlighting an important
difference between non-canonical inflammasome activation in murine and human
macrophages (Figure 6-2). Additionally, we find that caspase-4 plays a conserved role in
non-canonical inflammasome activation via release of IL-1α in response to both Y.
pseudotuberculosis and S. Typhimurium, Gram-negative bacterial pathogens that use an
evolutionarily unrelated T3SS to access the host macrophage cytosol during infection.
Interestingly, though caspase-4 contributes to cell death during infection with both L.
pneumophila and Y. pseudotuberculosis, cell death is caspase-4-independent during
infection with S. Typhimurium.
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Though caspase-4 does not mediate IL-1β secretion during infection, caspase-4
contributes to both IL-1α and IL-1β release in response to transfection of LPS directly
into the cytosol of primary human macrophages. Therefore, when LPS is the only PAMP
present in the cytosol, it likely binds directly to caspase-4 and induces inflammasome
activation, including IL-1α and IL-1β release and cell death. However, our data imply that
in the context of infection with Gram-negative bacterial pathogens, a caspase-4independent inflammasome pathway is triggered to induce IL-1β secretion. This
caspase-4-independent inflammasome requires caspase-1 and ASC, and we speculate
that NLRP3 is upstream of ASC for caspase-1 activation, as NLRP3 and ASC mediate
IL-1β release in THP-1 cells in response to S. Typhimurium infection (Li et al., 2008) and
NLRP3 is recruited to ASC foci during infection (Man et al., 2014). It is possible that a
PAMP other than LPS, such as bacteria RNA (Kanneganti et al., 2006), is sensed via
NLRP3 during infection of primary human macrophages. Conversely, it is possible that
NLRP3 responds to cell stress induced by the presence of the T3SS or T4SS to activate
caspase-1. Either way, our data suggest that caspase-1 activation is dominant over
caspase-4 activation to control IL-1β secretion during Gram-negative bacterial infection
of human macrophages. One explanation for how caspase-1 mediates IL-1β secretion
during infection is that activation of caspase-1 somehow dampens the ability of caspase4 to induce IL-1β release in response to binding LPS. For example, it is possible that
activation of caspase-1 in human macrophages during infection could sequester IL-1β
away from caspase-4. An alternative explanation for how caspase-1 mediates IL-1β
secretion during infection is that LPS does not physically bind to caspase-4 in the
context of bacterial infection and instead engages an upstream NLR that specifically
activates caspase-4 for IL-1α release and cell death. Though LPS is clearly capable of
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binding directly to caspase-4 (Shi et al., 2014), it has not been shown experimentally that
LPS physically interacts with caspase-4 during actual bacterial infection. Therefore, it is
possible that LPS could trigger caspase-4 in two manners: direct binding, which induces
both IL-1α and IL-1β, or indirect activation via an as-yet-unidentified upstream NLR,
which specifically induces IL-1α release.

E. Is LPS the only trigger for the non-canonical inflammasome?
As is the case for murine caspase-11, intracellular LPS is the only bacterial ligand that
has been identified to activate human caspase-4 (Shi et al., 2014). However, unlike
caspase-11, caspase-4 is activated by more stimuli than just Gram-negative bacterial
infection. For example, caspase-4 cleavage is induced in neuroblastoma and epithelial
cell lines in response to tunicamycin- and thapsigargin-induced ER stress (Hitomi et al.,
2004). Tunicamycin induces ER stress by triggering the unfolded protein response
(UPR) through blocking N-linked glycosylation that happens in the ER (Hong et al.,
2004; Kuo and Lampen, 1974), while thapsigargin induces ER stress by depleting ER
calcium stores (Jackson et al., 1988; Sano and Reed, 2013). Additionally, caspase-4 is
activated by UVB irradiation in keratinocytes to control IL-1β and IL-18 release, though
caspase-4 is upstream of caspase-1 activation in response to UVB irradiation
(Sollberger et al., 2012). Interestingly, these data imply that caspase-4 is activated by a
seemingly broad array of stimuli, ranging from bacterial infection to ER stress to
irradiation. However, there may be commonalities between these triggers that induce
caspase-4 activation.
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As there is no bacterial LPS present during ER stress or UVB irradiation, there are two
potential models for how caspase-4 is activated in human cells. First, caspase-4 could
be activated by different ligands under different conditions. For example, it is known that
LPS binds directly to the CARD domain of caspase-4 to induce activation (Shi et al.,
2014). Therefore, it is possible that during bacterial infection, LPS binds to the CARD
domain of caspase-4, but during ER stress and UVB irradiation, a host protein mimics
the properties of LPS and also binds to the CARD domain of caspase-4 to induce
activation. Alternatively, caspase-4 could be activated by different triggers under
different conditions via activation of different upstream NLRs. For example, NLRP3 and
ASC are known to be upstream of caspase-4-mediated inflammasome activation in
keratinocytes (Feldmeyer et al., 2007; Sollberger et al., 2012).

The second hypothesis for how caspase-4 is activated in human cells is that host cells
respond to a common stress signal induced by Gram-negative bacterial infection, ER
stress, and UVB irradiation to induce caspase-4 activation. When L. pneumophila
establishes its replicative niche within host cells, the bacterium hijacks ER-derived
vesicles to form the LCV (Horwitz and Silverstein, 1980; Swanson and Isberg, 1995).
This modulation of vesicle trafficking could presumably trigger an ER-related stress
response within host cells. Both ER stress and UVB irradiation induce elevated
cytoplasmic calcium levels, which has been linked to inflammasome activation in
multiple cell types (Feldmeyer et al., 2007; Murakami et al., 2012; Sano and Reed,
2013). Therefore, perturbations of calcium homeostasis or ER function could potentially
be a common mechanism downstream of all stimuli that lead to caspase-4 activation. In
the context of Gram-negative bacterial infection, LPS could be a second signal required
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for activation of caspase-4. However, we speculate that LPS might be the trigger for
caspase-4 activation when bacterial pathogens reside and replicate within the cytosol,
but endogenous stress signals, such as changes in calcium concentrations, might be the
actual trigger for caspase-4 activation by pathogens that remain outside of the host cell
cytosol but use specialized secretion systems to access the cytosol during infection.
Additionally, our preliminary data provocatively suggest that flagellin may be a major
trigger for both canonical and non-canonical inflammasome activation during infection
with both L. pneumophila and S. Typhimurium.

F. Flagellin as a trigger for inflammasome activation in human macrophages
Through our preliminary studies, we have shown that bacteria that lack flagellin have a
defect in triggering IL-1α and IL-1β release from human macrophages compared to wildtype bacteria. We find that both IL-1α and IL-1β secretion are reduced during infection
with flagellin-deficient L. pneumophila and S. Typhimurium. The decrease in IL-1
secretion does not appear to be due to a general priming defect, as cells infected with
flagellin-deficient bacteria have no defect in upregulating pro-IL-1β. However, the current
paradigm is that human cells do not actually respond to cytosolic flagellin, as human
NAIP does not associate with flagellin (Zhao et al., 2011). Instead, human NAIP is
thought to associate specifically with the needle protein of the T3SS (Yang et al., 2013).
However, the biochemical assays performed to assess the binding partners of human
NAIP involved overexpression of inflammasome components in a heterologous system
in 293T cells. Therefore, it is still possible that flagellin associates with endogenous
NAIP during bacterial infection of macrophages. Additionally, there is evidence that
human NAIP responds to flagellin during infection with L. pneumophila. Flagellin-
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deficient L. pneumophila grow better than WT Lp in THP-1 cells, suggesting that
recognition of flagellin restricts bacterial growth, and growth of WT Lp is equivalent to
that of ΔflaA Lp when NAIP is knocked down using siRNA (Vinzing et al., 2008).
Therefore, there is previous evidence that flagellin is sensed by human macrophages
during bacterial infection.

As both IL-1α and IL-1β release are affected by flagellin deficiency, our data imply that
both canonical and non-canonical inflammasome activation are triggered by flagellin.
However, we find that IL-1α and IL-1β release are controlled by two separate
inflammasome pathways during Gram-negative bacterial infection of human
macrophages, with IL-1α requiring caspase-4 and IL-1β requiring caspase-1 for
secretion. Therefore, our data potentially place flagellin as common inflammasome
trigger upstream of both caspase-1 and caspase-4 (Figure 6-2). We speculate that
flagellin could activate a single NLR, such as human NAIP, that then associates with
both caspase-1 and caspase-4 to induce inflammasome activation. However, it is still
unclear if NAIP is required for IL-1α and IL-1β release in human macrophages. If flagellin
triggers non-canonical inflammasome activation via caspase-4, our data would introduce
a paradigm shift in how we think about inflammasome activation during Gram-negative
bacterial infection, as LPS is the only bacterial ligand currently thought to activate
caspase-4 (Shi et al., 2014).

G. Potential for pathogenic inhibition of the inflammasome
Many viruses encode proteins that inhibit inflammasome activation. The first viral protein
identified as a caspase-1 inhibitor is a serpin encoded by cowpox virus (Ray et al.,
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1992). Subsequently, it was found that vaccinia virus encodes a homologous protein that
blocks IL-1β secretion from human cells (Kettle et al., 1997). Additionally, other
members of the poxvirus family encode proteins that mimic the cellular pyrin domainonly proteins (cPOPs) (Johnston et al., 2005), which block inflammasome activation by
binding to ASC (Bedoya et al., 2007; Dorfleutner et al., 2007; Stehlik et al., 2003).

Though many bacteria have mechanisms to avoid or dampen inflammasome activation,
few bacteria encode proteins analogous to the viral serpins that target caspase-1 directly
(Taxman et al., 2010). Some strains of Pseudomonas aeruginosa encode a
phospholipase, ExoU, which blocks activation of caspase-1, though it remains unclear if
inhibition by ExoU occurs through a direct interaction with caspase-1 or by targeting of
an upstream mediator of inflammasome activation (Sutterwala et al., 2007). Additionally,
Mycobacterium tuberculosis encodes a zinc metalloprotease that blocks inflammasome
activation through a poorly defined mechanism (Master et al., 2008). Y.
pseudotuberculosis encodes an effector protein, YopK, that block recognition of the
T3SS (Brodsky et al., 2010). However, Y. pseudotuberculosis also encodes the effector
YopM, which physically interacts with murine caspase-1 to block inflammasome
activation (LaRock and Cookson, 2012).

Currently, no bacterial effectors have been identified that counteract the activity of
caspase-11. However, certain cytosolic Gram-negative bacterial pathogens may have
evolved to modify their LPS so that it is not readily detected by caspase-11. For
example, Francisella novicida, which replicates within the macrophage cytosol, evades
caspase-11-mediated detection by encoding LPS with tetra-acylated lipid A that does not
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stimulate caspase-11 (Hagar et al., 2013). Intriguingly, though no bacterial proteins have
been identified that antagonize caspase-11, Shigella flexneri encodes an effector
protein, OspC3, that blocks caspase-4 activity (Kobayashi et al., 2013). Whether other
Gram-negative pathogens that live within the host cytosol, such as Burkholderia
thailandensis, which robustly triggers caspase-11, have evolved to encode effectors to
evade caspase-4-mediated detection in human cells remains an important area for
further investigation.

H. A role for caspase-5 in inflammasome activation in human macrophages?
In our studies, we did not detect caspase-5 cleavage in response to infection with
virulent L. pneumophila, Y. pseudotuberculosis, or S. Typhimurium. Though caspase-5
cleavage is indicative of activation, caspases do not need to be processed to perform all
of their effector functions. For example, though caspase-1 requires cleavage to induce
IL-1β secretion, caspase-1 can still mediate pyroptotic cell death independently of autoprocessing (Broz et al., 2010). Therefore, it is possible that caspase-5 has a role in
inflammasome activation against pathogens that use virulence-associated secretion
systems that does not require caspase-5 cleavage. Notably, as caspase-4 is surprisingly
not involved in IL-1β secretion during infection of human macrophages, we speculate
that caspase-5 could have a role in enhancing caspase-1-dependent IL-1β release. It is
possible that the two putative functional orthologs of murine caspase-11 have evolved to
carry out distinct subsets of the functions of caspase-11. Specifically, caspase-4 may
have evolved to direct IL-1α release, while caspase-5 may have evolved to direct IL-1β
secretion. As both caspase-4 and caspase-5 bind directly to LPS, it is likely that LPS is a
trigger for both caspase-4 and caspase-5 activation during Gram-negative bacterial
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infection. Alternatively, both caspase-4 and caspase-5 could interact with NAIP to
mediate the cytosolic sensing of bacterial flagellin. Elucidating a role for caspase-5 in
inflammasome activation will be informative for understanding the biological roles of the
two human homologs of murine caspase-11.

I. Future directions
There are many questions that remain to be answered to understand non-canonical
inflammasome activation in both murine and human macrophages. In murine
macrophages, it is unclear if LPS is the trigger for caspase-11 activation during infection
with L. pneumophila and Y. pseudotuberculosis. Mutating the LPS synthesis genes in
either bacterium would be challenging because defects in LPS synthesis could lead to
membrane integrity issues in the bacteria. For examples, mutants of E. coli that are
defective in acylation of lipid A fail to grow in rich media and lyse upon centrifugation
(Vorachek-Warren et al., 2002). Therefore, LPS mutants may be more sensitive to lysis
during infection of macrophages and could release additional PAMPs into the host
cytosol. However, Y. pseudotuberculosis switches from making mostly penta-acylated
LPS when grown at 21°C to making mostly tetra-acylated LPS when grown at 37°C
(Rebeil et al., 2004). As the tetra-acylated LPS from the closely related Yersinia pestis
does not trigger caspase-11 (Hagar et al., 2013), it is possible that forcing Y.
pseudotuberculosis to express only tetra-acylated LPS would be a useful tool for
determining if LPS is the only PAMP sensed via caspase-11 during actual bacterial
infection.
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In human macrophages, it is also unclear if LPS is the trigger for caspase-4 during
infection. Additionally, it is unclear if caspase-5, the other putative functional ortholog of
murine caspase-11, plays a role in inflammasome activation. As caspase-5 is difficult to
target using siRNA, it is possible that clustered regularly interspaced short palindromic
repeats (CRISPR) technology (Cong et al., 2013; Jinek et al., 2012; Wang et al., 2014)
could be used to target caspase-5 in human macrophages to elucidate a role for
caspase-5 in inflammasome activation during Gram-negative bacterial infection. Though
siRNA knockdown of caspase-4 results in a significant decrease in IL-1α release, IL-1α
release is not absolutely abrogated. Therefore, either the small amount of caspase-4
protein left in the cell after knockdown is enough to induce some inflammasome
activation, or another enzyme, such as caspase-5, is involved in inflammasome
activation as well. Targeting caspase-5 would be valuable for interrogating if caspase-5
enhances caspase-1-dependent IL-1β secretion from human macrophages, just as
caspase-11 enhances caspase-1 activation in murine cells.

As flagellin-deficient L. pneumophila and S. Typhimurium show decreased
inflammasome activation, flagellin is potentially a trigger for both canonical and noncanonical inflammasome activation in human macrophages. However, even though
macrophages infected with flagellin-deficient bacteria do not show a defect in
upregulation of pro-IL-1β, it is still possible that TLR5-mediated extracellular sensing of
flagellin is involved in priming inflammasome activation in human macrophages. To test
this possibility, we could use antibodies that bind and neutralize the ability of TLR5 to
detect flagellin during infection with WT Lp and WT St to determine if TLR5-mediated
sensing of flagellin is involved in regulating inflammasome activation. To assess if
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intracellular flagellin is a trigger for inflammasome activation, we could use the
established system of introducing purified flagellin into the cytosol by fusing flagellin to
the N-terminal domain of anthrax lethal factor and delivering it into the cytosol by using
protective antigen (Moltke et al., 2012). This system has been used to demonstrate that
flagellin is a trigger for inflammasome activation in murine macrophages (Moltke et al.,
2012). Alternatively, we could express L. pneumophila or S. Typhimurium flagellin in
Listeria monocytogenes, a Gram-positive bacterial pathogen that does not encode LPS
and ruptures the vacuole to replicate within the macrophage cytosol. Expression of
flagellin by L. monocytogenes enhances inflammasome activation in murine
macrophages (Warren et al., 2011).

J. Concluding remarks
Overall, the studies performed in this dissertation have revealed that both murine
caspase-11 and its homolog human caspase-4 are critical for mediating inflammasome
activation against Gram-negative bacterial pathogens. Additionally, our experiments
have uncovered important differences between the regulation of IL-1 family cytokine
release in murine and human macrophages. Studying the inflammasome pathways
triggered by the pathogen L. pneumophila has shaped our knowledge of how host cells
are poised to respond to intracellular pathogens, and the pathways triggered by L.
pneumophila are applicable to infection by other Gram-negative bacterial pathogens,
including Y. pseudotuberculosis and S. Typhimurium. Whether the bacterium utilizes a
T3SS or T4SS to access the host cytosol, additionally delivers flagellin into the
cytoplasm, or physically enters the cytosol itself, the host has evolved multiple ways to
restrict replication of the pathogen and trigger an appropriate immune response.
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Figure 6-1. Model for non-canonical inflammasome activation by Gram-negative
bacterial pathogens that use virulence-associated secretion systems in murine
macrophages. Upon infection of murine macrophages, the use of the T3SS or T4SS to
access the host cell cytosol to establish a replicative niche enhances vacuolar
disruption, potentially in combination with murine GBPs, and bacterial LPS gains access
to the cytosol. Once in the cytosol, LPS binds directly to caspase-11 to induce IL-1α
release and cell death. Additionally, caspase-11 somehow enhances NLRP3- and
caspase-1-dependent IL-1β secretion.
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Figure 6-2. Model for non-canonical inflammasome activation by Gram-negative
bacterial pathogens that use virulence-associated secretion systems in human
macrophages. Upon infection of human macrophages, the use of the T3SS or T4SS to
access the host cell cytosol to establish a replicative niche allows bacterial flagellin and
LPS to gain access to the cytosol. Once in the cytosol, LPS binds directly to caspase-4
to induce IL-1α release and cell death. Additionally, flagellin is sensed, presumably
through human NAIP, and somehow enhances both NLRP3/caspase-1-dependent IL-1β
secretion and caspase-4-dependent IL-1α release and cell death. It remains unclear if
caspase-5 responds to cytosolic flagellin to contribute to caspase-1-dependent IL-1β
secretion.
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